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1. Abbreviations 
ABCE1 ABC-family ATPase 1 
AGO Argonaute protein 
AREs AU (adenylate-uridylate)-rich elements 
Bam Bag-of-marbles protein 
Bgcn Benign gonial cell neoplasm  
BTG2 B-cell translocation gene 2 
CAF1/40/130 CCR4-associated factor 1/40/130 
CBM CAF40-binding motif of Roquin, Bam and NOT4 
CC Coiled coil 
CCCH Zinc finger motif containing Cys-Cys-Cys-His, which coordinate a zinc 
ion 
CCR4 Carbon catabolite repressor 4 
CCR4-NOT Carbon catabolite repressor 4; Negative on TATA-less 
CN9BD CAF40/CNOT9-binding domain of NOT1 
DCP2 Decapping enzyme subunit 2 
DDX6 DEAD-box helicase 6 
DEAD-box  Helicase domain characterized by a Asp-Glu-Ala-Asp tetrad 
DEDD Exonuclease domain characterized by a catalytic Asp-Glu-Asp-Asp 
tetrad 
Dm, D. melanogaster Drosophila melanogaster 
DNA Deoxyribonucleic acid 
dsRNA Double-stranded RNA 
EEP Exonuclease-endonuclease-phosphatase domain 
eIF Eukaryotic translation initiation factor 
EJC Exon junction complex 
eRFs Eukaryotic release factors 
GSC Germline stem cell 
GW182 182kDa protein containing glycine-tryptophan repeats 
HEAT Helical hairpin repeats 
HEK293T Human embryonic kidney 293T cells 
HeLa Henrietta Lacks; immortal cell line derived from cervical cancer cells 
Hs Homo sapiens; human 
kDa kilodalton 
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LRR Leucin-rich repeat domain 
LTN1 E3 ubiquitin-protein ligase listerin 1 
Mei-P26 Meiotic-P26 
Met-tRNAimet Initiator methionine transfer RNA 
MIF4G Middle domain of eukaryotic initiation factor 4G 
miRISC MicroRNA-induced silencing complex 
miRNA MicroRNA 
mRNA Messenger RNA 
mRNP Messenger-ribonucleoprotein particle 
NAC Nascent polypeptide-associated complex 
NGD No-go decay 
NMD Nonsense-mediated decay 
NOT1 Negative on TATA-less protein 1 
NSD Nonstop decay 
ORF Open reading frame 
PABP Poly(A)-binding protein 
PAN2/3 Poly(A) nuclease 2/3 
PAP Poly(A) polymerase 
PIC Pre-initiation complex 
Poly(A) Poly-adenosine stretch 
pre-mRNA Precursor messenger RNA 
PTM Post-translational modification 
RBP RNA-binding protein 
RING Really interesting new gene; E3 ubiquitin ligase domain type 
RNA Ribonucleic acid 
RNA pol II RNA polymerase II 
RNP Ribonucleoprotein 
RRM RNA-recognition motif 
rRNA Ribosomal RNA 
Sc, S. cerevisiae Saccharomyces cerevisiae, baker’s yeast / budding yeast 
SHD NOT1 superfamily homology domain 
shRNA Short hairpin RNA 
SLiM Short linear motif 
Sp, S. pombe Schizosaccharomyces pombe, fission yeast 
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Sxl Sex-lethal 
TNRC6 Trinucleotide repeat-containing gene 6 protein, human homolog of 
GW182 
Tob Transducer of erbB-2 protein 
TRAMP Trf4/Air2/Mtr4p polyadenylation 
tRNA Transfer RNA 
TTP Tristetraprolin 
Tut Tumorous testis protein 
UBC Ubiquitin conjugating protein 
UTR Untranslated region 
XRN1 5’-to-3’ exoribonuclease 1 
ZnF Zinc finger domain 
ZNF598 Zinc finger protein 598 
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2.1 Summary 
The multi-subunit CCR4-NOT complex is an important regulator of gene expression in 
eukaryotes. It affects most steps of the messenger RNA (mRNA) lifecycle, but as the major 
deadenylase in cells, its most studied function is the enzymatic removal of the 3’-poly(A) tail of 
mRNAs. In the past years, several studies were carried out to shed light on how the CCR4-NOT 
complex is directed to specific mRNA targets, and to identify proteins that regulate this process. 
The main aim of my doctoral work was to study metazoan-specific aspects in the assembly of the 
CCR4-NOT complex and to understand molecular details of its recruitment to mRNA by 
mRNA-associated proteins. 
The NOT4 E3 ubiquitin ligase is highly conserved in eukaryotes and has been shown to 
associate with the CCR4-NOT complex in budding yeast. Biochemical and structural studies also 
demonstrated that the C-terminal region of yeast NOT4 interacts with the C-terminal part of 
NOT1. In contrast, different studies indicated that NOT4 is not a stable component of the CCR4-
NOT complex in human (Hs) and Drosophila melanogaster (Dm) cells. During my doctoral 
studies, I examined the interactions of human NOT4 with components of the CCR4-NOT 
complex. My studies indicate that NOT4 directly interacts with the NOT1 and CAF40 subunits 
of the deadenylase complex in vitro. The interaction of Hs NOT4 with CAF40 is mediated by a 
conserved CAF40-binding motif (CBM). In addition, Hs NOT4 elicits 5’-to-3’ decay of bound 
mRNAs through its interaction with CCR4-NOT. Importantly, depletion of CAF40 abolishes the 
interaction between NOT4 and the CCR4-NOT complex and impairs the ability of NOT4 to 
elicit decay of bound mRNAs.  
In a collaborative effort among different members of the laboratory, we have also 
identified a CBM in the D. melanogaster protein Bag-of-marbles (Bam). As in the case of 
NOT4, Bam CBM allows the recruitment of the CCR4-NOT complex via CAF40. Thus, in the 
absence of CAF40, Bam does not interact with the CCR4-NOT complex.  
The findings described in this thesis support a model of targeted deadenylation where 
RNA-associated proteins recruit the CCR4-NOT complex to specific mRNAs, resulting in the 
deadenylation, translational repression and degradation of a wide range of transcripts. NOT4 and 
Bam bind to the same surface of CAF40 as a previously characterized RNA-associated protein, 
Roquin, which highlights CAF40 as an important platform for the regulated recruitment of the 
CCR4-NOT complex. 
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2.2 Zusammenfassung 
Der CCR4-NOT Multi-Proteinkomplex ist ein wichtiger Regulationsfaktor der 
Genexpression in Eukaryonten. Aufgrund seiner bedeutenden Rolle als zelluläre mRNA 
Deadenylase ist der enzymatischen Abbau des 3‘-poly(A) Schwanzes von mRNAs durch CCR4-
NOT am besten untersucht; darüber hinaus beeinflusst der Komplex aber auch die meisten 
anderen Bereiche des mRNA Metabolismus. In den vergangenen Jahren wurden einige Studien 
durchgeführt die untersuchten wie der CCR4-NOT Komplex zu bestimmten mRNA Molekülen 
rekrutiert wird und welche Proteine bei der Regulation dieses Prozesses beteiligt sind. Der Fokus 
meiner Doktorarbeit war die Untersuchung der Metazoa-spezifischen Aspekte der 
Zusammensetzung des CCR4-NOT Komplexes in Metazoa, und die Analyse der molekularen 
Zusammenhänge seiner Rekrutierung zu mRNAs durch mRNA-assoziierte Proteine. 
Die E3 Ubiquitin Ligase NOT4 ist in Eukaryonten hochkonserviert und in Bäckerhefe an 
den CCR4-NOT Komplex gebunden. Biochemische und strukturbiologische Untersuchungen 
haben ergeben, dass dabei die C-terminale Region des Hefe NOT4 Proteins mit dem C-Terminus 
von NOT1 interagiert. Im Gegensatz dazu ergaben Studien in humanen (Hs) und Drosophila 
melanogaster (Dm) Zellen, dass NOT4 in diesen Organismen keinen stabilen Bestandteil des 
CCR4-NOT Komplexes bildet. Im Rahmen meiner Doktorarbeit habe ich die Interaktion von 
humanem NOT4 mit Komponenten des CCR4-NOT Komplexes untersucht. Die Ergebnisse 
meiner Arbeit zeigen, dass NOT4 in vitro direkt mit den Untereinheiten NOT1 und CAF40 des 
Deadenylase Komplexes interagiert. Die Bindung von Hs NOT4 an CAF40 erfolgt über ein 
konserviertes CAF40-Bindemotiv (CBM). Des Weiteren induziert Hs NOT4 durch seine 
Interaktion mit dem CCR4-NOT Komplex den 5‘-3‘ Abbau gebundener mRNAs. Eine 
Reduktion der Menge an zellulärem CAF40 blockiert die Bindung von NOT4 an CCR4-NOT 
und vermindert dementsprechend den NOT4-vermittelten Abbau gebundener mRNAs.  
In Zusammenarbeit mit Kollegen gelang es außerdem, auch in dem D. melanogaster 
Protein „Bag-of-marbles“ (Bam) ein CBM zu identifizieren. Wie bei NOT4 ermöglicht das CBM 
in Bam über die Bindung an CAF40 eine Rekrutierung des CCR4-NOT Komplexes. 
Dementsprechend kann Bam in Abwesenheit von CAF40 nicht mit dem CCR4-NOT Komplex 
interagieren.  
Die Ergebnisse meiner Arbeit lassen sich in einem Model zusammenfassen, in dem 
RNA-assoziierte Proteine den CCR4-NOT Komplex zu bestimmten mRNAs rekrutieren und 
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dadurch die Deadenylierung, Translationshemmung und den Abbau zahlreicher Transkripte 
regulieren. Interessanterweise binden NOT4 und Bam an dieselbe Oberfläche von CAF40 wie 
das zuvor untersuchte RNA-assoziierte Protein Roquin, was auf eine wichtige Rolle von CAF40 
bei der geregelten Rekrutierung des CCR4-NOT Komplexes hindeutet. 
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4. Introduction 
 Gene expression in eukaryotes 4.1
In eukaryotic cells, the genetic information encoded in the DNA is tightly packaged in 
the nucleus in chromatin complexes, which mainly consist of histone proteins with the DNA 
strands wound around them. Chromatin structure is established and regulated by many proteins, 
including histones, histone modifying enzymes and chromatin remodeling complexes. The 
information in the DNA is stored or accessed as needed, and these often dynamic changes are 
enabled by epigenetic modifications such as DNA methylation and histone modifications result 
in changes to the chromatin structure, rendering the DNA more accessible or less so for 
enzymes. 
Gene expression is a highly controlled multi-step process (Figure 1). The transcription of 
DNA into messenger RNAs (mRNAs), a mediator molecule for protein production, is carried out 
by RNA polymerase II. The product of transcription is a precursor-mRNA (pre-mRNA), which 
undergoes extensive processing in the nucleus to become mature mRNA (Moore 2005). 
The processing steps that pre-mRNAs undergo can greatly impact the information 
contained in the mRNA molecule. The first step is the co-transcriptional addition of a 7-methyl 
guanosine cap structure to the 5’ end of the emerging pre-mRNA. Proteins of the cap-binding 
complex assemble on the cap and contribute to further processing and nuclear export of the 
mature mRNA. The cap also plays a crucial role for mRNA translation in the cytosol 
(Ramanathan et al. 2016). 
Splicing is another processing event, which removes intronic sequences (noncoding 
intervening sequences in genes) from the pre-mRNA. Alternative splicing mechanisms allow the 
cell to produce several different proteins from the same gene. mRNA splicing is performed by 
the spliceosome, which consists of small nuclear RNAs (snRNAs) and proteins. These snRNAs 
base-pair with consensus RNA sequences to recognize splice sites. After splicing, proteins of the 
exon junction complex (EJC) mark the site of each splicing event (Shi 2017; Baralle and Baralle 
2018). 
As RNA polymerase II reaches the end of a gene, signals marking the 3’ end of the 
emerging pre-mRNA are recognized by RNA-binding proteins and RNA-processing enzymes. 
The RNA molecule is cleaved, and a stretch of approximately 200-250 adenosines is added to the 
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3’ end of the RNA by poly(A) polymerase (PAP) in a template-free manner in higher eukaryotes. 
Exceptions to this are histone mRNAs, which terminate in a highly conserved stem-loop 
structure (Dominski and Marzluff 2007). For polyadenylated mRNAs, despite the higher number 
of initially added adenosines, median tail length in higher eukaryotes is around 50-100 
adenosines due to "pruning" of the poly(A) tail (Chang et al. 2014; Subtelny et al. 2014; Lima et 
al. 2017). The cap structure and the poly(A) tail protect the mRNA from exonucleolytic decay 
and promote mRNA translation. Poly(A)-binding proteins (PABPs) assemble onto the newly 
added poly-A tail, which together with the cap-binding complex and the exon junction 
complexes signal that processing of the mRNA is complete (Moore and Proudfoot 2009). 
Mature mRNAs are exported from the nucleus through channels in the nuclear 
membrane, the nuclear pores. Export of most mRNAs in complex with proteins (messenger 
ribonucleoproteins, mRNPs) requires the binding of the nuclear export receptor NXF1/NXT1, 
which shuttles the mRNA through the nuclear pore via direct interactions with nucleoporins 
(Carmody and Wente 2009). 
Some mRNAs are positioned at intracellular locations to establish spatially restricted 
protein synthesis, which is a key mechanism of post-transcriptional regulation. mRNA 
localization is especially important for some cell types where protein production needs to be 
spatially controlled (e.g. in highly polarized cells such as neurons) (Jansen 2001; Martin and 
Ephrussi 2009). 
Apart from the coding sequences, mRNAs contain 5’ and 3’ untranslated regions (UTRs). 
These UTRs contain sequences with regulatory roles that influence mRNA localization, stability 
and translation efficiency (Fabian et al. 2010; Leppek et al. 2018). 
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Once the mature mRNA is exported to the cytosol, ribosomes decode the mRNA with the 
help of transfer RNAs (tRNAs) in a process called translation. Ribosomes are multiprotein 
complexes that consist of two subunits, the small 40S and the large 60S subunits. Each subunit 
contains ribosomal RNAs (rRNAs) and multiple ribosomal proteins. Ribosomes interact with 
tRNAs that act as adaptors between the mRNA and the amino acids they deliver to synthesize the 
new polypeptide. Initiation of cap-dependent translation and recruitment of the small ribosomal 
subunit requires the assembly of the cap-binding complex eIF4F that consists of eukaryotic 
initiation factors (eIFs): the cap-binding protein eIF4E, the DEAD-box RNA helicase eIF4A, and 
the scaffolding protein eIF4G (Jackson et al. 2010). The eIF4F cap-binding complex recognizes 
the 5’ cap of the mRNA and initiates the assembly of the translation machinery by recruiting the 
43S preinitiation complex (43S PIC) to the mRNA through interactions with the eIF3 complex 
(Wells et al. 1998; Jackson et al. 2010). The 43S PIC contains the 40S ribosomal subunit and 
initiation factors eIF1, eIF1A, eIF5, eIF3, and the eIF2-methionyl-tRNA (tRNAiMet)-GTP ternary 
 
Figure 1. Schematic overview of eukaryotic gene expression. DNA is transcribed in the 
nucleus into pre-mRNA, which undergoes processing and is subsequently exported to the 
cytoplasm. The mRNA is translated by ribosomes into a protein, which is folded and post-
translationally modified (PTM) to be fully functional. The template mRNA is degraded. 
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complex (Hinnebusch 2017). In addition, eIF4G binds to PABP, which was generally thought to 
lead to the formation of a closed-loop, circularized structure that is essential for efficient 
translation. However, recent observations challenge this model, and suggest there may be other 
explanations for the proximity and communication between the 5’ and the 3’ ends of the mRNA 
than the cap-eIF4E-eIF4G-PABP-poly(A) interaction network (Vicens et al. 2018). 
Upon recruitment of the 43S PIC by the eIF4F complex, the 48S ribosomal translation 
initiation complex is formed, and the 5’-UTR is scanned until an AUG translation start codon is 
found. Binding to the start codon triggers the GTP-dependent dissociation of the initiation factors 
and subsequent recruitment of the 60S ribosomal subunit and assembly of the 80S ribosome so 
translation elongation can take place (Bhat et al. 2015). 
During the elongation phase of translation, tRNAs with anticodon complementarity to the 
mRNA codons translocate between the tRNA binding sites on the 80S ribosome, adding an 
amino acid to the nascent polypeptide chain in each cycle (Dever et al. 2018). This phase is 
dependent on eukaryotic elongation factors. The tRNA binding sites are the A (aminoacyl or 
acceptor) site, the P (peptidyl) site and the E (exit) site. The process starts with the initiator 
tRNAiMet bound to the P site of a ribosome positioned at an AUG start codon. Each new peptide 
chain elongation cycle begins with tRNA selection, where an aminoacyl-tRNA harboring the 
anticodon corresponding to the nucleotide triplets of the mRNA binds to the A site on the 
ribosome. Next, peptide-bond formation occurs, the tRNAs are positioned in a ‘hybrid’ state with 
respect to the ribosome subunits, and the growing peptide chain is transferred to the A site tRNA. 
Subsequently, the tRNA is repositioned from the hybrid state to a ‘classical’ state, creating an 
open A site for the next incoming aminoacyl-tRNA (Schuller and Green 2018). Finally, the 
ribosome then translocates to decode the next codon on the mRNA, and the deacylated tRNA 
moves from the P site to the E site (Steitz 2008). Recent findings established that codon 
optimality contributes greatly to translation elongation speed and mRNA stability (Presnyak et 
al. 2015). 
Translation termination occurs when a stop codon is located in the A site of the ribosome, 
resulting in the recruitment of termination factors (eRFs). These factors promote the release of 
the nascent peptide and recycling of the ribosome. The ABC-family ATPase ABCE1 is also 
involved in this process by inducing dissociation of the ribosome into the 60S subunit and the 
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mRNA- and tRNA-bound 40S ribosomal subunit (Pisarev et al. 2010; Pisareva et al. 2011; 
Shoemaker and Green 2011). 
Aberrant mRNA substrates cause problems during translation elongation, resulting in 
translationally stalled ribosomes, which engage the co-translational quality control machinery. 
Ribosome-associated quality control (RQC) mechanisms sense arrested ribosomes, which collide 
on the mRNA substrate, and rescue them by releasing the mRNA and nascent peptide for 
degradation and recycling the ribosomal subunits (Joazeiro 2017). One important effector protein 
of RQC in human cells is the ubiquitin ligase ZNF598 (also known as Hel2 in yeast), which 
serves as a direct sensor of two collided ribosomes by recognizing the 40S di-ribosome interface. 
Ubiquitination of ribosomal proteins by ZNF598 is essential for eliciting quality control 
pathways to terminally arrest the translation of aberrant transcripts, resolve the defective 
translational complexes and recycle or degrade their components (Juszkiewicz et al. 2018).  
Ribosomal stalling leads to the endonucleolytic cleavage and subsequent 5’-to-3’ or 3’-
to-5’ mRNA degradation. There are several pathways for the degradation of defective mRNA: 
nonsense-mediated mRNA decay (NMD) targets mRNAs with premature stop codons, nonstop 
mRNA decay (NSD) degrades mRNAs lacking stop codons, and no-go decay (NGD) acts on 
mRNAs containing secondary structure elements (e.g. stem-loops) or otherwise inhibiting 
efficient elongation. These pathways are conserved in eukaryotes, and they rely on protein 
synthesis and ribosome stalling to reveal mRNA defects (Lykke-Andersen and Bennett 2014). 
 
 mRNA turnover 4.2
mRNA turnover is an important aspect of gene expression control. Measurement of 
mRNA half-lives of almost 20 000 genes in mouse embryonic stem cells indicated that the 
median estimated half-life for all mRNAs was 7.1 hours (Sharov et al. 2008). Stable mRNAs 
with half-lives over 12 hours were coding for proteins involved in metabolism and protein 
biosynthesis, as well as genes encoding for proteins of the extracellular matrix and the 
cytoskeleton. The mRNAs with half-lives shorter than 2 hours code for proteins involved in 
transcriptional regulation (such as transcription factors), cell cycle, apoptosis, signal transduction 
and development. In this study, only 54 mRNAs had half-lives shorter than one hour (Sharov et 
al. 2008). In contrast, the determination of mRNA half-lives in primary human T-lymphocytes 
registered hundreds of mRNAs with half-lives shorter than 30 min (Raghavan et al. 2002). These 
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short-lived transcripts also encode regulatory proteins, including cytokines, cell surface receptors 
and transcription factors, and their rapid degradation may be an important mechanism to control 
levels of the encoded regulatory proteins (Raghavan et al. 2002). 
Measurements of poly(A) tail length using poly(A) tail sequencing (TAIL-seq) in HeLa 
and NIH3T3 cells suggested that the length of the poly(A) tail slightly correlated with mRNA 
half-life, but not with translation efficiency (Chang et al. 2014). Moreover, poly(A)-tail length 
profiling by sequencing (PAL-seq) showed that poly(A) tail length negatively correlated with 
translation rates in yeast and in mouse NIH3T3 cells (Subtelny et al. 2014). In C. elegans, 
abundant transcripts had short poly(A) tails as determined using an adapted TAIL-seq method 
(Lima et al. 2017). These transcripts were also enriched for optimal codons and had high 
ribosome occupancy, indicating higher translational efficiency (Lima et al. 2017). These findings 
challenge the model that longer poly(A) tails promote mRNA stability and translation efficiency, 
which was generally accepted before (Goldstrohm and Wickens 2008; Wahle and Winkler 
2013). 
Two main mRNA decay pathways control eukaryotic mRNA levels: the 5’-to-3’ and the 
3’-to-5’pathway (Figure 2). Both require the shortening of the poly(A) tail, a process known as 
deadenylation. A biphasic model of deadenylation has been proposed, where poly(A) shortening 
is initiated by the PAN2/PAN3 (poly(A)-nuclease 2 / poly(A)-nuclease 3) complex, where PAN2 
is the catalytic subunit. PAN2/PAN3 most likely acts globally on all transcripts, and it has been 
shown to trim long poly(A) tails (>∼150 nucleotides [nt] in HeLa cells). However, depletion of 
PAN2/PAN3 from HeLa cells had little effect on steady-state mRNA levels or on the half-lives 
of individual tested transcripts. Therefore, the PAN2/PAN3 complex seems to have minimal 
impact on mRNA stability in human cells (Yi et al. 2018). After the initial shortening of the 
poly(A) tail, deadenylation is carried out by the CCR4-NOT (carbon catabolite repressor 4 - 
negative on TATA) complex, which is responsible for the shortening of mRNAs with ∼150 nt 
long poly(A) tails (Yi et al. 2018). Depletion of the catalytic subunits of the CCR4-NOT 
complex increased global mRNA level and stabilized all tested transcripts (Yi et al. 2018).  
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Additionally, the 3’-to-5’ exoribonuclease PARN (poly(A)-specific ribonuclease) is 
responsible for the deadenylation of a small subset of mRNAs (Yamashita et al. 2005). 
After deadenylation, the two pathways of mRNA decay diverge: the mRNA either 
undergoes decapping and subsequent degradation from the 5’ end by XRN1 (5’-to-3’ 
exoribonuclease 1), or it is degraded from the 3’end by the exosome complex (3’-to-5’ decay). In 
5’-to-3’ decay, the DCP2 decapping enzyme in complex with activating factors irreversibly 
removes the 5’ cap, exposing the 5’ end to degradation by XRN1 (Fig. 2). 3’-to-5’ decay is 
carried out by the exosome, a conserved multi-subunit protein complex, which plays a role in the 
processing and degradation of almost all RNA classes. The core exosome complex is regulated 
by the SKI complex in the cytoplasm or the TRAMP (Trf4/Air2/Mtr4p polyadenylation) 
complex in the nucleus. The exosome is able to target specific transcripts for degradation, based 
on RNA sequence elements and through cooperation with its cofactors (Zinder and Lima 2017). 
Although the scaling from mRNA to protein levels is not linear, there is a positive 
correlation between them. In Saccharomyces cerevisiae (S. cerevisiae), close to 80% of the 
contribution to the control of protein expression is estimated to come from mRNA abundance (Li 
et al. 2017). Since protein synthesis is a highly energy-consuming process, it is beneficial for 
 
Figure 2. mRNA decay pathways. mRNA degradation starts with the shortening of the 3’ 
poly(A) tail by cytoplasmic deadenylases: the PAN2-PAN3 and the CCR4-NOT complex. 
Next, the deadenylated mRNA undergoes either 5’-to-3’ or 3’-to-5’ decay. In 5’-to-3’ decay, 
the cap structure is removed by the decapping complex, and the mRNA is degraded by 
XRN1. In 3’-to-5’ decay, the mRNA is degraded by the exosome complex. 
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cells to regulate gene expression prior to this step. However, mRNA levels alone are not 
sufficient to predict protein levels under all conditions. Protein levels are also influenced by 
translation rates, protein half-life and protein export (Liu et al. 2016). 
 
 Protein degradation 4.3
The control of protein turnover is essential for maintaining cellular homeostasis. The 
major pathway of regulated protein degradation is through the ubiquitin-proteasome system 
(Metzger et al. 2014). The 26S proteasome is a multi-catalytic ATP-dependent protease complex, 
which consists of two sub-complexes: the 20S core particle, containing the catalytic chamber, 
and the 19S regulatory particle, which (together with other regulators) acts as a gatekeeper for 
substrates entering the proteolytic chamber (Livneh et al. 2016). 
Protein ubiquitination is carried out by several enzymes: an ATP-dependent ubiquitin-
activating enzyme (E1), an ubiquitin-conjugating enzyme (E2), and an ubiquitin protein ligase 
(E3). E3s interact with both E2 enzymes and the substrate, and confer substrate specificity to 
ubiquitination. The human genome encodes more than 600 different RING-type ubiquitin ligases 
(Deshaies and Joazeiro 2009). 
There are two main types of E3 ubiquitin ligases: HECT (Homologous to E6-AP 
Carboxy Terminus)-type and RING (Really Interesting New Gene)-type. In contrast to HECT-
type ubiquitin ligases, RING-type ligases mediate the transfer of ubiquitin directly from E2 to 
the substrate, and do not serve as catalytic intermediates. The RING domain usually coordinates 
two Zn2+ ions in a cross-brace manner. A common feature of RING-type E3s is homo- and 
heterodimerization (Metzger et al. 2014). 
While targeting proteins for degradation is the best-characterized function of ubiquitin, 
this post-translational modification has additional regulatory functions that are independent from 
the proteasome, such as receptor internalization, vesicle sorting, DNA repair and gene silencing 
(Johnson 2002; Sun and Chen 2004). 
 
 The CCR4-NOT complex 4.4
4.4.1 Functions of CCR4-NOT 
The CCR4-NOT complex is a key regulator of eukaryotic gene expression. Its 
importance has been established in most stages of the mRNA lifecycle, from transcription 
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initiation, through nuclear export to translation regulation and mRNA decay (Miller and Reese 
2012; Collart 2016). It has been proposed that the complex is essential for integration of 
environmental information to regulate gene expression (Collart et al. 2013). 
In the nucleus, CCR4-NOT has been shown to impact RNA polymerase (Pol) I and Pol II 
transcription both negatively and positively, through mechanisms that are not clear yet (Chen et 
al. 2018). The association between CCR4-NOT and Pol II is thought to be independent of RNA-
binding (Kruk et al. 2011). Interaction with the exosome complex also links CCR4-NOT to 
nuclear mRNA quality control (Azzouz et al. 2009). In addition, the complex interacts with the 
mRNA nuclear export machinery (Kerr et al. 2011). 
The role of CCR4-NOT as a deadenylase is the most studied cellular function of the 
complex (Wahle and Winkler 2013). Deadenylation is the initial step in mRNA decay and is 
therefore essential for post-transcriptional gene expression control. Recruitment of the 
deadenylase complex may occur through a general mechanism via PABPC1, which interacts 
with both PAN3 (Uchida et al. 2004) and CCR4-NOT associated BTG/TOB (B-cell translocation 
gene/transducer of erbB-2) proteins (Funakoshi et al. 2007; Mauxion et al. 2008) in metazoans. 
The CCR4-NOT complex can also be specifically recruited to mRNAs by RNA-binding proteins 
(Wahle and Winkler 2013). 
It has been demonstrated using reporter mRNAs lacking 3’ poly(A) tails that the CCR4-
NOT complex is able to repress translation in the absence of deadenylation (Cooke et al. 2010; 
Chekulaeva et al. 2011; Bawankar et al. 2013; Zekri et al. 2013). Interaction between NOT1 and 
the translational repressor and decapping activator DDX6 may play a role in this (Chen et al. 
2014b; Mathys et al. 2014), as well as interaction between the 4E-transporter (4ET) and DDX6 
(Kamenska et al. 2016). In addition, the CCR4-NOT complex is involved in the miRNA 
pathway, as it is required for miRNA-mediated mRNA decay (Behm-Ansmant et al. 2006). The 
complex is recruited to miRNA targets via direct interaction with GW182/TNRC6 (Glycine-
tryptophan repeat-containing 182kDa protein/Trinucleotide repeat-containing gene 6) proteins 
(Braun et al. 2011; Chekulaeva et al. 2011; Fabian et al. 2011). 
The CCR4-NOT complex has also been implicated in co-translational quality control 
through the activity of the NOT4 ubiquitin ligase subunit, which will be further discussed in 
chapter 4.5.3 (Dimitrova et al. 2009; Panasenko 2014). 
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4.4.2 Recruitment of CCR4-NOT to mRNA targets 
Cellular mRNA is always bound by multiple proteins, forming messenger 
ribonucleoprotein particles (mRNPs) with dynamically changing protein compositions 
(Hieronymus and Silver 2004). Many RNA-associated proteins have been shown to interact with 
the CCR4-NOT complex, inducing target-specific translational repression and deadenylation. 
These proteins often bind to specific elements in the mRNA 3’-UTRs and control gene 
expression in a wide variety of biological processes (Wahle and Winkler 2013). 
The RNA-binding protein tristetraprolin (TTP) directly interacts with the CCR4-NOT 
complex to induce degradation of mRNAs containing AU-rich elements (AREs) in their 3’-
UTRs (Lykke-Andersen and Wagner 2005; Sandler et al. 2011). Its targets include many 
cytokine-coding mRNAs, the expression levels of which need to be tightly controlled in cells 
during immune response and therefore have a fast turnover rate (Barreau et al. 2005; Fu et al. 
2016). 
Nanos protein, essential in early embryonic development in D. melanogaster, also 
directly associates with CCR4-NOT to regulate mRNA stability. Nanos represses the translation 
of hunchback mRNA specifically at the posterior pole of the embryo to establish an anterior-
posterior gradient of the Hunchback protein, which is essential for head and thorax development 
(Tsuda et al. 2003). In many metazoans, including vertebrates, Nanos proteins are essential for 
germ cell development (Suzuki et al. 2012). The recruitment of the CCR4-NOT complex is 
essential for vertebrate as well as fly Nanos proteins to induce mRNA decay (Bhandari et al. 
2014; Raisch et al. 2016). 
Roquin, an ubiquitin ligase with RNA-binding domains, recognizes stem-loop structures 
in target mRNAs, as shown for the mRNA coding for tumor necrosis factor α (TNF-α). The 
unstructured C-terminal part of the protein can recruit the CCR4-NOT complex to degrade its 
target transcripts (Leppek et al. 2013). 
GW182/TNRC6 proteins are key factors in microRNA (miRNA) mediated gene 
silencing. These proteins interact with the miRNA-induced silencing complex (miRISC) and 
recruit effector complexes, including CCR4-NOT and PAN2-PAN3, to induce translational 
repression and degradation of target mRNAs (Braun et al. 2011; Chekulaeva et al. 2011; Fabian 
et al. 2011). 
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4.4.3 Architecture of the CCR4-NOT complex 
The CCR4-NOT complex is assembled around the NOT1 scaffolding protein, and 
consists of several structurally and functionally distinct modules (Figure 3). The N-terminal part 
of NOT1 binds NOT10 and NOT11 in metazoans and CAF130 (130 kDa CCR4-associated 
factor) in yeast (Bawankar et al. 2013). The precise molecular function of this module is not 
known. 
The MIF4G domain of NOT1 binds the deadenylase module, comprising CAF1 (CCR4-
associated factor 1) and CCR4 (carbon catabolite repressor protein 4), which are both 
polyadenosine-specific exonucleases (Petit et al. 2012). CCR4 belongs to the exonuclease-
endonuclease-phosphatase (EEP) family of enzymes and binds to CAF1 via a leucin-rich repeat 
(LRR) in its N-terminal part. CAF1 is a member of the DEDD nuclease family and binds to the 
MIF4G domain of NOT1 (Petit et al. 2012). In Schizosaccharomyces pombe (S. pombe), CCR4 
acts as the major deadenylase, while CAF1 deadenylates only mRNAs not bound by the poly(A)-
binding protein Pab1 (Webster et al. 2018). Human CAF1 and CCR4 both catalyze 
deadenylation, compensating for each other, but, similar to yeast CAF1, human CAF1 cannot 
deadenylate PABPC1-protected poly(A) tails effectively (Yi et al. 2018).  
The NOT1 MIF4G domain is followed by a helical bundle domain that associates with 
CAF40 (Bawankar et al. 2013; Chen et al. 2014b). This domain of NOT1 is named the CN9BD 
(CAF40/CNOT9 binding domain), and it folds into a defined domain arranged as a three-helix 
bundle that is stabilized by CAF40 binding (Chen et al. 2014b; Mathys et al. 2014). CAF40 is a 
constitutive component of the CCR4-NOT complex (Chen et al. 2001). Hs CAF40 has been 
shown to homodimerize in isolation, however, this is mutually exclusive with binding to NOT1 
(Chen et al. 2014b). CAF40 is a crescent-shaped protein that consists of tandem Armadillo 
repeats formed by alpha helices. The concave, positively charged surface is suggested to be 
important for nucleic acid binding (Garces et al. 2007). The convex surface of the Armadillo 
repeats contains conserved tandem tryptophan (Trp) binding pockets, which serve as a protein 
binding platform, and have been shown to mediate interaction with GW182 and TTP (Chen et al. 
2014b; Mathys et al. 2014). 
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The NOT module consists of the NOT1 C-terminal domain, NOT2 and NOT3 proteins 
(Boland et al. 2013). In yeast, the NOT module includes NOT5 (a NOT3 ortholog), and NOT4 as 
core components (Collart 2016). The NOT module is essential for the activity and stability of the 
CCR4-NOT complex (Boland et al. 2013). In addition, this module provides binding sites for 
many RNA-binding proteins (e.g. Nanos, Roquin and Bicaudal-C) that recruit the CCR4-NOT 
complex to target mRNAs (Chicoine et al. 2007; Leppek et al. 2013; Bhandari et al. 2014; 
Raisch et al. 2016; Sgromo et al. 2017).  
To date, two cryoelectron microscopy structures of the full yeast CCR4-NOT have been 
published, and both show an overall L-shaped complex (Nasertorabi et al. 2011; Ukleja et al. 
2016). However, due to the low resolution (max. 20 Å) of these structures, further studies are 
needed to create a complete structural model of the CCR4-NOT complex. 
 
4.4.3.1 CAF40 
Caf40 was first described in S. pombe as a key factor required for nitrogen starvation-
induced sexual development (Okazaki et al. 1998). In yeast, deletion of caf40 elicited mutant 
phenotypes (such as temperature sensitivity, caffeine sensitivity and sporulation defects) shared 
by defects in other CCR4-NOT genes (Chen et al. 2001). 
 
Figure 3. The metazoan CCR4-NOT complex. The NOT1 protein serves as a binding 
scaffold for the other subunits of the complex. The N-terminal part of NOT1 interacts with 
NOT10 and NOT11. The central MIF4G domain of NOT1 binds CAF1 and CCR4 to form the 
catalytic module of the complex. The MIF4G domain is followed by an α-helical bundle, 
CN9BD, that interacts with CAF40, and a NOT1 superfamily homology domain (SHD) that 
forms the NOT module together with NOT2 and NOT3. NOT4 is not a stable component of 
metazoan CCR4-NOT complex. 
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The physiological importance of CAF40 in higher eukaryotes is not well understood yet, 
but several studies have linked CAF40 to development and oncogenesis. CAF40 is shown to be a 
transcriptional cofactor involved in retinoic-acid induced differentiation of mouse 
teratocarcinoma cells as well as retinoic acid-controlled lung development (Hiroi et al. 2002). In 
addition, CAF40 is frequently upregulated in breast cancer, and it has also been linked to the Akt 
signaling pathway. Phosphorylation of the threonine/serine protein kinase Akt at Ser 473 fully 
activates the Akt protein, promoting cell proliferation and survival (Nicholson and Anderson 
2002). Knockdown of CAF40 reduces Ser 473 phosphorylation of Akt in breast cancer cells. 
This indicates involvement of CAF40 in activating the Akt signaling pathway and suggests that 
CAF40 has oncogenic activity (Ajiro et al. 2009). Whole exome sequencing of 20 metastatic 
melanomas has also revealed a recurrent somatic point mutation at position P131L in the 
RQCD1 gene coding for CAF40, suggesting that this mutation is selected for during tumor 
development (Wong et al. 2014). This residue is located on the concave, predominantly 
hydrophobic surface of the armadillo repeat domain of CAF40, which interacts with the Roquin 
protein (Sgromo et al. 2017). So far, it has not been investigated whether the P131L mutation 
affects the CAF40-Roquin interaction. The importance of this mutation in the development and 
progression of melanoma also requires further studies (Wong et al. 2014). 
GW182 proteins, which interact with AGO (Argonaute) protein and are required for 
miRNA-mediated gene silencing (Fabian and Sonenberg 2012; Braun et al. 2013), bind to 
CAF40 and NOT1 through tryptophan-containing motifs (Braun et al. 2011; Chekulaeva et al. 
2011; Fabian et al. 2011). CAF40 also interacts with the zinc-finger protein tristetraprolin (TTP), 
which recruits the CCR4-NOT complex to degrade inflammatory mRNAs (Bulbrook et al. 
2018). 
 
4.4.3.2 NOT4 as a constitutive or facultative component of CCR4-NOT 
Not4 is a stable component of the CCR4-NOT complex in S. cerevisiae (Chen et al. 
2001). However, it is not an integral subunit of the human and D. melanogaster CCR4-NOT 
complex, as demonstrated by gel filtration and mass spectrometry experiments (Lau et al. 2009; 
Temme et al. 2010). Thus, NOT4 has been proposed to be a non-constitutive subunit of the 
CCR4-NOT complex in higher eukaryotes. 
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It was demonstrated in yeast two hybrid assays that yeast, as well as human NOT1 can 
interact with human NOT4 (Albert et al. 2000). In yeast, the interaction between the C-terminal 
part of yeast Not4 and a C-terminal fragment of Not1 has been characterized by X-ray 
crystallography (Bhaskar et al. 2015). The crystal structure revealed that a low complexity region 
of Not4 is responsible for the binding (labelled as NOT1 binding site in Sc Not4, Figure 4). 
Interestingly, this low complexity region of yeast Not4 can be only partially aligned with 
metazoan NOT4, which could explain the weaker association of NOT4 with the CCR4-NOT 
complex in human and D. melanogaster (Bhaskar et al. 2015).  
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 NOT4 4.5
Similar to most components of the CCR4-NOT complex, NOT4 is a conserved protein 
among eukaryotes (Fig. 4). This is supported by the finding that human NOT4 can complement 
the phenotype of a yeast Not4 knock-out (Albert et al. 2000). The N-terminal part of NOT4 is 
highly conserved from yeast to humans, as opposed to the C-terminal region. 
The N-terminal part of NOT4 contains a RING domain, which confers ubiquitin ligase 
activity to the protein (Albert et al. 2002; Mulder et al. 2007). NOT4 harbors two putative RNA-
binding domains, a C3H1-type Zn-finger, which is generally implicated in binding AU-rich 
elements (AREs) in the mRNA 3’-UTR (Lai et al. 2000; Blackshear 2002; Hudson et al. 2004), 
and an RNA recognition motif (RRM). RRMs are found in over 50% of RNA-binding proteins 
(Lunde et al. 2007). In yeast, it has recently been shown that the RRM and the C3H1-type Zn 
finger domain collaborate with the RING domain to control proteasome activity and global 
proteostasis (Chen et al. 2018). The N-terminal region of NOT4 also contains a positively 
charged region with coiled coil propensity. In metazoan species, however, these domains remain 
rather poorly characterized, and their function, their putative RNA-binding properties or RNA 
targets are currently unknown.  
The C-terminal part of NOT4 is predicted to be mostly unstructured. In S. cerevisiae, this 
region was shown to contain an interaction site with Not1 (Bhaskar et al. 2015). In contrast, it 
has been proposed that NOT4 is a regulatory subunit in metazoans, which is only able to 
associate with the CCR4-NOT complex in specific cells or under specific conditions (Temme et 
al. 2010). 
In yeast, the Not4 deletion strain (not4Δ) displays a slow growth phenotype, as well as 
sensitivity to many environmental stressors, including high temperature (37 °C), hygromycin B 
(which leads to errors during protein synthesis) (Mulder et al. 2007; Halter et al. 2014), and 
hydroxyurea (Lau et al. 2010). The formation of the proteasome is also impaired in not4Δ cells: 
the 19S regulatory particle is defective and unable to deubiquitinate substrates, while the 20S 
core particles show increased catalytic activity (Panasenko and Collart 2011; Halter et al. 2014).  
Heterozygous NOT4+/- mice have defects in vertebrae formation and immunological 
impairments. NOT4 KO mice die after birth during the pre-weaning stage (before approximately 
3-4 weeks of age) (International Mouse Phenotyping Consortium). 
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4.5.1 The role of NOT4 in mRNA deadenylation 
Despite its physical association with the CCR4-NOT complex in yeast and the potential 
to bind RNA via the RRM and C3H1 domains, the role of NOT4 in mRNA deadenylation 
remains unknown. In D. melanogaster, NOT4 is dispensable for general mRNA deadenylation 
(Temme et al. 2010), but the protein has been suggested to play a role in cyclin B mRNA decay 
(Kadyrova et al. 2007). The RNA-associated proteins Nanos and Pumilio are required for 
repression of the maternal cyclin B mRNA in the germline of the fly embryo (Kadyrova et al. 
2007). Interaction screens showed that NOT4 interacts with Nanos, and this interaction was 
proposed to mediate the degradation of cyclin B mRNA via recruitment of the CCR4-NOT 
complex (Kadyrova et al. 2007). However, direct interactions between Nanos and the NOT 
module of the CCR4-NOT complex have since been demonstrated in human and D. 
melanogaster cells (Bhandari et al. 2014; Raisch et al. 2016), therefore it is possible that NOT4 
is dispensable for cyclin B mRNA degradation. 
 
 
Figure 4. Domain composition of NOT4, adapted from Keskeny et al., 2019. The 
conserved N-terminus of NOT4 contains a RING-type ubiquitin ligase domain (RING), a 
positively charged linker with coiled coil propensity (Coiled coil), an RNA-recognition 
motif (RRM) and a C3H1-type zinc finger domain (ZnF). The CAF40-binding motif (CBM) 
is shown in red. The CBM is conserved in metazoan NOT4, but not in yeast. S. cerevisiae 
Not4 contains a previously characterized binding site for S. cerevisiae Not1, shown in 
yellow (Bhaskar et al. 2015). 
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4.5.2 NOT4 as an ubiquitin ligase 
4.5.2.1 The RING domain of NOT4 
Even though several studies have addressed the function of the NOT4 RING domain and 
ubiquitin ligase activity, the significance of such an activity is not quite clear. The NOT4 RING 
domain has been shown in hetero-species complementation experiments performed in yeast to be 
essential for the survival of not4Δ not5Δ on 5-fluoro-orotic acid (FOA) media. In these 
experiments, expression of human NOT4 lacking the conserved N-terminus could not suppress 
synthetic lethality, while expressing full length NOT4 allowed cell survival (Albert et al. 2002). 
On the other hand, the complementation of not4∆ strains with RING-finger mutants in S. 
cerevisiae showed that not all processes involving yeast Not4 require its E3 ligase activity 
(Mulder et al. 2007). 
The highly conserved RING domain of NOT4 is a special C4C4-type (binding two zinc 
atoms using its cysteine residues), as opposed to the more common C3HC4-type (containing 
zinc-coordinating cysteine and histidine residues). Use of nuclear magnetic resonance (NMR) 
spectroscopy to determine the RING domain protein structure of human NOT4 revealed it 
consists of an α-helix and three long loops that are stabilized by the coordination of zinc ions. 
The two zinc ions are bound through cysteine residues in a cross-brace manner, similarly to 
C3HC4 RING domains, and the overall folding also resembles that of the C3HC4 RING fingers, 
suggesting similar function (Hanzawa et al. 2001). 
Yeast two hybrid experiments showed both human and yeast Not4 are able to interact 
through their conserved RING domain with the Ubc ubiquitin conjugating enzymes. In addition, 
direct interaction between human NOT4 and the human E2 enzyme UBCH5B was confirmed by 
GST pull-down assays (Albert et al. 2002). Another study confirmed that the RING domain of 
human NOT4 interacts with UBCH5B, but not with several other ubiquitin conjugases. 
Interestingly, the ubiquitin ligase activity of human NOT4 proved to be dependent on the 
specific and selective interaction with the UBCH5B ubiquitin conjugating enzyme (Winkler et 
al. 2004). UBCH5B has two orthologs in yeast: Ubc4 and Ubc5, which exhibit partially distinct 
functions in vivo (Seufert and Jentsch 1990; Chuang and Madura 2005). 
An NMR structure of the human UBCH5B/NOT4 complex (Dominguez et al. 2004) 
identified amino acids in UBCH5B that are involved in binding to the RING domain of NOT4. It 
was also investigated whether the RRM domain of NOT4 contributes to this interaction, but this 
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was not the case (Dominguez et al. 2004). The structure of the yeast NOT4 RING domain with 
Ubc4 has also been determined, in this case by X-ray crystallography (Bhaskar et al. 2015). This 
structure is very similar to the earlier NMR structures of the human NOT4 ortholog (Hanzawa et 
al. 2001) and of the yeast Ubc4 in isolation (Cook et al. 1993). The yeast Not4 RING contains 
two α-helices and three loop regions, as well as the two zinc ions, which are coordinated in a 
cross-brace fashion by cysteine residues. This structure shows localized differences compared to 
the previously proposed model of human NOT4-UBCH5B (Dominguez et al. 2004; Bhaskar et 
al. 2015). Structural alignment of known yeast E2 proteins with Ubc4 revealed subtle differences 
that explain how the specificity of Not4 is driven toward Ubc4/5 and not toward other Ubc E2 
proteins (Bhaskar et al. 2015). 
 
4.5.2.2 Substrates of the NOT4 ubiquitin ligase 
In yeast and in human cells, NOT4 has been shown to ubiquitinate a wide array of 
substrates that cannot be tied to a single cellular process or pathway. Some substrates are 
polyubiquitinated and degraded by the proteasome, while for others, ubiquitination by NOT4 has 
regulatory consequences. The following examples serve to illustrate the complexity of the 
possible NOT4 functions. 
There are studies indicating that Not4 contributes to transcriptional control. For example, 
yeast Not4 regulates in vivo H3K4 (histone H3 lysine 4) trimethylation levels and, consequently, 
gene expression levels through the polyubiquitination and proteasomal degradation of the Jhd2 
histone demethylase (Laribee et al. 2007; Mersman et al. 2009). Furthermore, human NOT4 
promotes the proteasomal degradation of RNA polymerase II-association factor 1 (PAF1), a 
subunit of the PAF complex that participates in various steps of the transcriptional process (Sun 
et al. 2015). 
There are the several known substrates of Not4 important for oxidative stress response, 
suggesting a role for Not4 in the regulation or coordination of these processes. One such example 
is the Not4-dependent polyubiquitination and degradation of cyclin-C upon H2O2 exposure, 
thereby promoting the expression of genes important for stress response (Cooper et al. 2012). 
Not4 also regulates the levels of the Yap1, a transcription factor that is crucial for oxidative 
stress tolerance. Following its recruitment to target genes, Yap1 is degraded in a Not4-dependent 
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manner. This is proposed to be a mechanism by which some transcription factors are inactivated 
rapidly when their function is no longer necessary (Gulshan et al. 2012). 
It has been recently shown that yeast Not4 plays a role in removing the transcriptionally 
arrested RNA polymerase II (RNAPII) elongation complex and maintaining genomic integrity 
under genotoxic stress conditions. This is achieved by indirectly promoting the ubiquitination 
and proteasome-mediated degradation of the Rbp1 subunit of RNAPII (Jiang et al. 2019). 
Yeast Not4 also plays a role in the functional assembly of the proteasome, specifically in 
the assembly of the 19S regulatory particle (Panasenko and Collart 2011). In addition, Not4 is 
required for the appropriate interaction between the proteasome and Ecm29, a protein that is 
important for proteasome stabilization (Panasenko and Collart 2011; De La Mota-Peynado et al. 
2013).  
 
4.5.3 The role of NOT4 in co-translational quality control 
Several substrates of the NOT4 ubiquitin ligase indicate a role of NOT4 in co-
translational quality control, although the connection is not well understood. For example, S. 
cerevisiae Not4 is involved in the ubiquitination of ribosome-associated substrates (Panasenko et 
al. 2009; Panasenko and Collart 2012). Yeast Not4 has also been suggested to be involved in the 
ubiquitination and subsequent degradation of polybasic-containing proteins derived from non-
stop mRNAs, since protein levels of a non-stop reporter were increased in the absence of Not4 
(Dimitrova et al. 2009). On the other hand, Not4 was found to target polypeptides derived from 
no-go mRNAs containing stalling sequences distant from the 3’-end rather than those derived 
from non-stop mRNAs (Matsuda et al. 2014). Recent studies have however uncovered Ltn1 (E3 
ubiquitin-protein ligase listerin 1) as the main ubiquitin ligase that co-translationally 
ubiquitinates proteins derived from non-stop and no-go mRNAs (Wilson et al. 2007; Bengtson 
and Joazeiro 2010; Shao et al. 2013; Matsuda et al. 2014). Ltn1 forms a complex with the RQC 
factors Tae2, Rqc1 and Cdc48 (Brandman et al. 2012; Defenouillère et al. 2013) and physically 
associates with the targeted polypeptide and with 80S ribosomes or the 60S ribosomal subunit 
(Bengtson and Joazeiro 2010; Brandman et al. 2012). Thus, the function of NOT4 in RQC is 
likely indirect and more complex than ubiquitination of the nascent polypeptide. 
The yeast EGD (enhancer of Gal4p DNA binding) complex (also called nascent 
polypeptide-associated complex, NAC in mammals), which is a ribosome-associated chaperone, 
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is among the substrates of Not4. Ubiquitination of EGD by Not4 supposedly regulates the 
association of EGD with the ribosome and with the proteasome (Panasenko et al. 2009). 
Yeast Not4 may play a role in RQC through the monoubiquitination of small ribosomal 
protein eS7A (also known as Rps7A) (Panasenko and Collart 2012; Ikeuchi et al. 2019). This 
regulatory modification is important for cell viability. Ubiquitinated eS7A associates with 
actively translating ribosomes (Panasenko and Collart 2012). Importantly, the monoubiquitinated 
eS7A is further ubiquitinated by Hel2 (Ikeuchi et al. 2019). Ubiquitination of ribosomal proteins 
by Hel2 (or ZNF598 in humans) is essential for RQC (Juszkiewicz et al. 2018). If Not4 is absent 
and Hel2 is not able to ubiquitinate its other ribosomal substrate, the uS10 ribosomal protein, no-
go decay and RQC are completely inhibited. The molecular details of this process, especially 
regarding the recruitment of different factors, require further studies (Ikeuchi et al. 2019). 
Not4 has been associated with the translational repression of mRNAs undergoing 
transient ribosome stalling under nutrient withdrawal in yeast (Preissler et al. 2015). Stalled 
ribosomes lead to the recruitment of Not4 to polysomes (Halter et al. 2014) but the precise 
mechanism of translational repression remains unclear. Some studies suggest that yeast Not4 can 
regulate the stability and translation of no-go mRNA reporters (Halter et al. 2014; Preissler et al. 
2015; Collart 2016). Whether the destabilization and translational repression of these reporters 
involves the CCR4-NOT-mediated decay or deadenylation-independent translational repression 
is currently unclear. 
Additional roles in co-translational quality control have been proposed for NOT4 in 
higher eukaryotes. In response to mitochondrial damage, NOT4 ubiquitinates the ABCE1 
ribosome-splitting factor (Wu et al. 2018). Polyubiquitinated ABCE1 is recognized by ubiquitin-
binding autophagy receptors and recruited to the mitochondrial outer membrane in order to 
induce mitophagy (Nguyen et al. 2016). As such, NOT4 serves as a molecular signal for 
mitophagy initiation. RQC defects and mitochondrial dysfunction have both been linked to 
neurodegeneration, thus NOT4 may play a role in the pathogenesis of these diseases (Wu et al. 
2018). 
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 Bam (Bag-of-marbles) 4.6
Bam is a fly-specific protein, conserved in D. melanogaster and other dipteran species. It 
contains several predicted alpha-helices (Fig. 5). Bam plays an important role in balancing 
between germline stem cell (GSC) renewal and differentiation in D. melanogaster ovaries (Li et 
al. 2009).  
In females, Bam plays a key role in inducing GCSs differentiation (Chen and McKearin 
2003; Song et al. 2004). In accordance with this, it is exclusively expressed in late cystoblasts 
and 2-, 4-, and 8-cell cysts (McKearin and Ohlstein 1995). Loss of Bam leads to uncontrolled 
stem cell proliferation and germ cell tumors (McKearin and Ohlstein 1995), while ectopic 
expression of Bam results in differentiation and stem cell loss (Ohlstein and McKearin 1997). In 
males, Bam is needed to initiate spermatocyte differentiation and is present only in 4-, 8-, and 
16-cell cysts (Insco et al. 2009). 
Bam physically interacts with and requires the function of Bgcn (benign gonial cell 
neoplasm) and Sxl (Sex-lethal) in GSC differentiation in females (Flores et al. 2015). Bam 
controls GSC differentiation at the post-transcriptional level by repressing nanos and E-cadherin 
mRNAs. This requires the assembly of a complex containing the Bgcn, Tut (tumorous testis), Sxl 
and Mei-P26 (meiotic-P26) proteins (Li et al. 2013; Chen et al. 2014a). The Bam-Bgcn complex 
has been shown to bind to the nanos 3’-UTR, repress its translation and promote cystoblast 
formation (Li et al. 2009). 
 
In addition, Bam acts as a positive regulator of hematopoietic progenitor cell 
maintenance in D. melanogaster (Tokusumi et al. 2011). Bam has also been shown to genetically 
interact with members of the Insulin-like receptor pathway and to positively regulate the 
expression of the Retinoblastoma-family protein Rbf, which is a crucial regulator of cell 
proliferation in the posterior signaling center (a hematopoietic cell population in the larval lymph 
gland) (Tokusumi et al. 2015). In addition, Bam, together with mir-7, genetically interact with 
 
Figure 5. Schematic representation of Bam, adapted from Sgromo et al., 2018. Bam 
contains several predicted alpha-helices (red) and a beta-strand (yellow). The CAF40-binding 
motif is shown in blue. 
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components of the Hedgehog pathway in the maintenance of hematopoietic stem-like progenitors 
(Tokusumi et al. 2018). 
Together with the Dm CCR4 homolog Twin (independently of other CCR4-NOT 
components) and Bgcn, Bam has been shown to promote GSC progeny differentiation (Fu et al. 
2015). The Bam-Bgcn complex also binds to the mei-P26 3’-UTR to repress translation of mei-
P26 mRNA, which leads to terminal differentiation of progenitor cells in males (Insco et al. 
2012). Furthermore, Bam and Bgcn bind the 3’-UTR of E-cadherin in S2 cells to repress its 
translation. Physical interaction between Bam and the translation initiation factor eIF4A 
inactivates Bam function and promotes the self-renewal of GSCs (Shen et al. 2009). 
The ability of Bam to repress its mRNA targets has been linked to its interaction with the 
CCR4 deadenylase (Fu et al. 2015). This interaction was suggested to be independent of the 
CCR4-NOT complex, with CCR4 acting as an isolated deadenylase, since binding to both Bam 
and the CAF1 deadenylase was disrupted by the same mutations in CCR4 (Fu et al. 2015). 
However, since these mutated residues are located in the hydrophobic core of the leucine-rich 
repeat (LRR) domain of CCR4 (Basquin et al. 2012), they may have led to the misfolding of this 
domain and thus might have caused the loss of CCR4-NOT binding non-specifically. Therefore, 
it is not clear whether Bam requires the assembled CCR4-NOT complex or whether the free 
CCR4 deadenylase is sufficient to repress the translation of its mRNA targets. 
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5. Aims and objectives 
The CCR4-NOT complex is the major mRNA deadenylase in eukaryotic cells and 
consequently a central node for mRNA regulation. Many aspects of this regulation are still not 
completely understood. One way to regulate mRNA decay is the active recruitment of the CCR4-
NOT complex to specific mRNA targets (Wahle and Winkler 2013). In this model, RNA-binding 
proteins, which target specific mRNAs, bind the CCR4-NOT complex, bringing it in close 
proximity to the mRNA poly(A) tail and thus inducing deadenylation. The main scientific aim 
and motivation for my doctoral work was to study metazoan-specific aspects in the assembly of 
the CCR4-NOT complex, and to understand molecular details underlying the recruitment of 
CCR4-NOT by mRNA-associated proteins. I studied two RNA-associated proteins, NOT4 and 
Bam, their interactions with the CCR4-NOT complex in higher eukaryotes, and their role in post-
transcriptional regulation. 
NOT4 is a conserved protein with RNA-binding potential that possesses ubiquitin ligase 
activity. This combination highlights NOT4 as one of the proteins that could serve as a bridge 
between the mRNA and protein degradation pathways (Cano et al. 2010). Although the structure 
and function of the NOT4 protein has been studied extensively in yeast, there have been few 
studies on this protein in human cells. When I started my doctoral studies, it was still unclear 
how NOT4 associates with the CCR4-NOT complex in metazoans, but it was clear to be 
different from the interaction in yeast. It was also unknown whether human NOT4 could elicit 
mRNA degradation when tethered to a reporter mRNA and whether the ubiquitin ligase activity 
would play a role downstream of RNA binding. To address these questions, I investigated the 
interaction between NOT4 and CCR4-NOT in human cells and in vitro, using recombinant 
proteins, and I studied the role of NOT4 post-transcriptional regulation using mRNA reporters. 
I was also involved in a collaborative project on the fly-specific Bag-of-marbles (Bam) 
protein. Bam is a germline stem cell differentiation factor that was proposed to interact with the 
CCR4 deadenylase, independently of the CCR4-NOT complex (Fu et al. 2015). To test this 
possibility, I contributed to investigating the interaction of Bam with components of the CCR4-
NOT complex in order to better understand how Bam post-transcriptionally regulates mRNA 
targets.  
Unveiling the network of RNA-associated proteins that bind to different modules of the 
CCR4-NOT complex and deciphering the molecular mechanisms of CCR4-NOT recruitment to 
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specific mRNA targets is key to understanding details of post-transcriptional gene expression 
control. 
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6.1 Synopsis of publication 1 
A conserved CAF40-binding motif in metazoan NOT4 mediates association with the 
CCR4–NOT complex 
Csilla Keskeny, Tobias Raisch, Annamaria Sgromo, Catia Igreja, Dipankar Bhandari, Oliver 
Weichenrieder and Elisa Izaurralde 
Genes Dev. 2019 Feb 1;33(3-4):236-252. doi: 10.1101/gad.320952.118. 
The CCR4-NOT complex is an important post-transcriptional regulator of gene 
expression in eukaryotes. The NOT4 E3 ubiquitin ligase is one of the core subunits of this 
complex in yeast, whereas in human and D. melanogaster cells, NOT4 is not stably associated 
with the complex. In this manuscript, we show that, in vitro, human NOT4 nevertheless directly 
interacts with the NOT1 and CAF40 subunits of the complex in a manner that differs from yeast. 
In particular, we identified a conserved sequence motif in the C-terminal region of human and D. 
melanogaster NOT4 that interacts with CAF40 (CAF40-binding motif [CBM]). Crystal 
structures of the CBM–CAF40 complex show that NOT4 targets the same surface of CAF40 as 
the previously characterized RNA-associated proteins Roquin and Bag-of-marbles, albeit in a 
different orientation. Consequently, CAF40 emerges as an important mediator for the 
recruitment of the CCR4-NOT complex. These data lead us to conclude that, in metazoan cells, 
the interaction between NOT4 and the CCR4-NOT complex is likely a transient and possibly 
regulated event, and we demonstrated that NOT4 is able to induce decay of bound reporter 
mRNAs through the 5’-to-3’ mRNA decay pathway. Depletion of CAF40 from human cells or 
structure-guided mutagenesis to disrupt the NOT4–CAF40 interaction impairs NOT4-mediated 
degradation of reporter mRNAs. In conclusion, our results reveal the molecular details for the 
association of metazoan NOT4 with the CCR4–NOT complex and highlight the NOT4 ubiquitin 
ligase as a conserved but non-constitutive cofactor of the CCR4–NOT complex.  
 
My contribution: I performed and analyzed all of the experiments carried out in human 
cells, and I did the in vitro pull-down experiments in Figure 3. Together with my colleagues, I 
drafted the initial manuscript and took a leading role through all stages of the submission, 
revision and publication process. 
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6.2 Synopsis of publication 2 
Drosophila Bag-of-marbles directly interacts with the CAF40 subunit of the CCR4–NOT 
complex to elicit repression of mRNA targets 
Annamaria Sgromo, Tobias Raisch, Charlotte Backhaus, Csilla Keskeny, Vikram Alva, Oliver 
Weichenrieder and Elisa Izaurralde 
RNA. 2018 Mar;24(3):381-395. doi: 10.1261/rna.064584.117. 
Drosophila melanogaster Bag-of-marbles (Bam) is a key factor that determines germline 
stem cell (GSC) fate. Bam represses the expression of mRNAs encoding stem cell maintenance 
factors, thereby promoting GSC differentiation. Bam was shown to interact with a putative RNA 
helicase Bgcn (Benign gonial cell neoplasm) and with the CCR4 deadenylase, a catalytic subunit 
of the CCR4–NOT complex. Furthermore, Bam was proposed to compete with CAF1 for 
binding to CCR4, and to displace CCR4 from the CCR4–NOT complex. In this manuscript, we 
therefore investigated the interaction between Bam and the CCR4–NOT complex by using 
purified recombinant proteins. We found that Bam does not directly interact with CCR4, but 
rather binds to the CAF40 subunit of the CCR4-NOT complex. This interaction is mediated by a 
conserved N-terminal CAF40-binding motif (CBM) in Bam. The crystal structure of the Bam 
CBM bound to CAF40 shows that the CBM peptide folds into an α-helix when bound to the 
CAF40 armadillo repeats. Previously, the Roquin protein of D. melanogaster had also been 
shown to contain a CBM and to interact with the same concave surface of CAF40, using a 
similar binding mode. The two peptides cannot bind to CAF40 simultaneously, and in vitro 
competition assays suggested they may compete for the binding site on CAF40 if simultaneously 
present in cells. Additionally, we demonstrated that Bam mediates mRNA degradation and 
translational repression when tethered to reporter mRNAs, and this function was dependent on 
Bam's interaction with CAF40. In conclusion, Bam recruits the CCR4-NOT complex through 
direct interaction with CAF40 with the potential to regulate the expression of bound mRNA 
targets. 
 
My contribution: To study the molecular details of the interaction of Bam with the 
CCR4-NOT complex, I generated a CAF40-null human cell line using CRISPR-Cas9 genome 
editing. This cell line was used to demonstrate that Bam is unable to bind to the deadenylase 
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complex in cells depleted of CAF40. The data characterizing the cell line at the genomic and 
protein level was produced by me. I was also involved in correcting the manuscript drafted by 
my colleagues. 
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7. Discussion 
The CCR4-NOT complex is a major regulator of mRNA metabolism in eukaryotes 
(Collart 2016). It affects many stages of the mRNA lifecycle, including transcription, translation 
and mRNA decay (Winkler et al. 2006; Funakoshi et al. 2007; Cooke et al. 2010; Kruk et al. 
2011). As the principal cytoplasmic deadenylase, the CCR4-NOT complex is essential for bulk 
mRNA degradation. In addition, RNA-associated proteins are able to recruit CCR4-NOT for the 
translational repression and degradation of specific subsets of target mRNAs (Wahle and 
Winkler 2013). In this work, I studied two RNA-associated proteins, NOT4 and Bam, that bind 
the CAF40 subunit of the CCR4-NOT complex thereby possibly recruiting the complex to target 
mRNAs. Both factors interact with the same surface as the previously identified CAF40-
interaction partner Roquin (Sgromo et al. 2017). Importantly, I showed that in the absence of 
CAF40 in human cells, the interactions between NOT4 and CCR4-NOT and between Bam and 
CCR4-NOT are abolished. Studying the function of NOT4 in mRNA regulation, I found that 
NOT4 promotes the degradation of an mRNA reporter when tethered to its 3’-UTR. 
Furthermore, I provide evidence that the interaction between human NOT4 and the CCR4-NOT 
complex is likely a regulated event. The work described in this doctoral thesis, together with 
other studies, identifies CAF40 as a binding platform for CCR4-NOT recruitment factors. My 
findings contribute to understanding the molecular and structural details of CCR4-NOT 
recruitment by RNA-associated proteins and clarify the function of the mammalian NOT4 
ubiquitin ligase as a non-constitutive subunit of the CCR4-NOT complex. 
7.1 The transient nature of the interaction between NOT4 and the CCR4-NOT complex 
in human cells 
Using recombinant proteins produced in E. coli, I showed that full-length human NOT4 
as well as its C-terminal fragment directly interact with the CCR4-NOT complex. Co-
immunoprecipitation assays show in human and D. melanogaster S2 (unpublished data) cells, 
however, only the C-terminal fragment of NOT4 displayed a stable interaction with the CCR4-
NOT complex. Full length Hs NOT4 did not efficiently pull down the CCR4-NOT complex in 
cells. As demonstrated using mass spectrometry and size-exclusion chromatography in human 
and D. melanogaster cells (Lau et al. 2009; Temme et al. 2010), metazoan NOT4 does not 
constitutively reside in the CCR4-NOT complex. In contrast, S. cerevisiae and S. pombe NOT4 
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co-purifies with the CCR4-NOT complex, indicating that NOT4 is an integral component of the 
complex in yeast (Chen et al. 2001; Stowell et al. 2016). Binding of the C-terminal fragment of 
NOT4 to the deadenylase complex in not an artefact of unspecific binding due to e.g. 
aggregation, as this fragment was unable to bind other proteins, such as PABP and EDC4. 
These experiments suggest that the interaction between metazoan NOT4 and the CCR4-
NOT complex is transient and possibly regulated by the N-terminal region of NOT4. Control of 
NOT4 association to the deadenylase complex might involve post-translational modifications 
and/or the binding of regulatory proteins to NOT4, two regulatory mechanisms that are absent in 
the in vitro pull-down assays with recombinant proteins expressed in E. coli. 
Further experiments aimed at understanding the regulatory role of individual N-terminal 
domains of Hs NOT4 indicated the RRM domain and the region with coiled coil propensity 
affect the association of Hs NOT4 with the CCR4-NOT complex. Deletion of the RRM and the 
coiled coil domain from the full length protein restored its ability to interact with NOT1 to a 
level comparable to that of the C-terminal fragment. Furthermore, addition of the RRM domain 
to the C-terminal fragment inhibited the interaction between NOT4 and NOT1. 
It is possible that that C-terminal part of NOT4 is released for interaction with the CCR4-
NOT complex as a result of a structural reorganization of the protein. Unless bound to an 
mRNA, the highly positively charged coiled coil linker and the RRM may sequester the 
negatively charged CBM. This could also provide a means for the regulation of the NOT4 
ubiquitin ligase activity based on the availability of the N-terminal domains.  
7.2 The RNA-binding function of NOT4 
Tethered NOT4 induces mRNA decay through the 5’-to-3’ decay pathway, suggesting 
that NOT4 could mediate the recruitment of the CCR4-NOT complex to endogenous mRNAs. 
NOT4 has been shown to be part of the mRNA interactome, as determined in human HeLa and 
HEK (human embryonic kidney) cell lines using photoreactive nucleotide-enhanced or 
conventional UV crosslinking followed by oligo(dT) purification and proteomic analysis (Baltz 
et al. 2012; Castello et al. 2012). However, to date, it remains to be investigated if NOT4 binds 
mRNA in vivo, and if so, which putative RNA-binding domain is responsible for this function, 
and also what subset of mRNAs is recognized by NOT4. So far, it is not clear whether the 
potential mRNA-binding activity of NOT4 has any specificity. In general, the RRM is 
considered as a non-specific RNA-binding domain (Lunde et al. 2007; Lukong et al. 2008), 
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while the C3H1-type zinc finger (for example in TTP or Tis11d proteins) has been shown to bind 
AU-rich elements in the mRNA 3’-UTR (Lai et al. 2000; Blackshear 2002; Hudson et al. 2004). 
Furthermore, the combination of different RNA-binding domains has been suggested to affect 
binding specificity and affinity (Lunde et al. 2007). For example, both Dicer and RNase III 
proteins contain an endonuclease catalytic domain followed by a double-stranded RNA 
(dsRNA)-binding domain. While both proteins recognize dsRNA, Dicer contains additional 
domains that allow it to specifically bind dsRNAs of the RNA interference pathway (Macrae et 
al. 2006; Lunde et al. 2007). 
7.3 NOT4 as an RNA-binding ubiquitin ligase 
The functional relevance of the NOT4 ubiquitin ligase activity in the context of the 
CCR4-NOT complex is currently unknown. My results show that the NOT4 RING domain is 
dispensable for NOT4-mediated decay of a bound reporter mRNA. However, in the past years, 
there has been an increasing interest in studying ubiquitin ligases which, similar to NOT4, 
contain predicted RNA-binding domains. These proteins are suggested to play a role in the 
regulation of mRNA metabolism, even though the importance of the ubiquitin ligase activity in 
this process is not clear in most cases (Cano et al. 2010). In addition to NOT4, there are at least 
14 more ubiquitin ligases with different types of RNA-binding domains in the human proteome, 
including RRMs, KH (heterogeneous nuclear K-homology) domains, PAZ 
(Piwi/Argonaute/Zwille) domains or zinc finger domains (Cano et al. 2010). The first link 
between these features was established when the turnover of cytokine mRNAs containing AU-
rich elements was shown to be dependent on ubiquitination (Laroia et al. 2002). Roquin, an E3 
ligase that contains a RING domain, a unique ROQ domain and a C3H1-type zinc finger domain, 
has been shown to regulate mRNA stability and to interact with the CCR4-NOT complex 
(Vinuesa et al. 2005; Sgromo et al. 2017). It has been suggested that ubiquitin ligases with RNA-
binding ability could serve as a bridge between the mRNA and protein degradation pathways 
(Cano et al. 2010). In the case of Not4, the importance of the ubiquitin ligase activity has been 
demonstrated in no-go decay in yeast (Ikeuchi et al. 2019), but so far this has not been connected 
to the protein’s RNA-binding potential. 
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7.4 Recruitment of the CCR4-NOT complex 
As shown in this work, recruitment of the CCR4-NOT complex via direct interactions 
with CAF40 is required for NOT4 and Bam to degrade reporter mRNAs. A growing number of 
RNA-binding proteins interact with the CCR4-NOT deadenylase complex, which contains 
conserved binding surfaces to interact with different RNA-associated proteins. Known examples 
are TTP (Bulbrook et al. 2018), SMG7 (Loh et al. 2013), or BTG2/TOB (Mauxion et al. 2008). 
These interactions mediate the recruitment of the CCR4-NOT complex to specific mRNAs and 
have the potential to regulate deadenylation. 
Binding of the CCR4-NOT complex is often characterized by functionally relevant 
peptide motifs embedded in low complexity and unstructured regions, known as short linear 
motifs (SLiMs) (Van Roey et al. 2014). SLiMs bind other proteins with high specificity and 
relatively low affinity. Another feature of SLiMs is evolutionary plasticity, meaning that while 
these motifs may diverge in sequence between orthologs, the interactions they perform are 
overall maintained (Tompa 2012; Van Roey et al. 2014). Based on these features, the CAF40-
binding motifs of NOT4, Bam and Roquin can also be regarded as SLiMs. Despite the structural 
and functional similarities of CBMs in NOT4, Bam and Roquin, these three proteins do not share 
sequence identity. Interestingly, structures of the CBMs in complex with CAF40 showed that the 
orientation of the NOT4 CBM is in an inverted position compared to the Bam and Roquin CBMs 
(Figure 7). Taken together, these data suggest the CBMs of NOT4, Bam and Roquin evolved 
independently in order to bind CAF40. 
Even though SLiMs are generally thought not to be conserved across species due to 
evolutionary plasticity of single motif instances (Van Roey et al. 2014), the CBM of NOT4 is 
conserved among metazoans, suggesting the interaction between NOT4 and CAF40 is also 
conserved. 
In many cases, RNA-binding regions and interaction sites for the CCR4-NOT complex 
are spatially separated within the proteins. Nanos, Roquin and NOT4 contain highly conserved 
RNA-binding domains, while the SLiMs responsible for CCR4-NOT binding are located in long 
unstructured regions of these proteins. The long linker regions may allow the proteins to link the 
mRNA to the CCR4-NOT complex or any other interactor. In other cases, different proteins are 
responsible for RNA binding and for CCR4-NOT recruitment. Such is the case of the miRISC, 
where AGO proteins interact with RNA, while GW182 bridges AGO and the mRNA to the 
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CCR4-NOT complex. In the case of Bam, it is not clear yet whether the RNA-binding function 
resides in the protein itself or if Bam associates with additional proteins that mediate mRNA 
binding.  
Importantly, RNA-associated proteins may interact with a single subunit of the CCR4-
NOT complex or with multiple ones. Bam is an example of an RNA-associated protein that uses 
a single subunit, CAF40, to interact with the CCR4-NOT complex. The interaction between Bam 
and CAF40 proved to be necessary and sufficient to recruit the CCR4-NOT complex to a bound 
reporter mRNA. This finding is supported by the fact that single point mutations abolishing the 
interaction between Bam and CAF40, or CAF40 depletion blocked CCR4-NOT mediated mRNA 
degradation upon tethering of Bam. 
In contrast to Bam, and similar to Dm Roquin, Dm Nanos, TTP and GW182, metazoan 
NOT4 contains multiple motifs in its mostly unstructured C-terminal region that provide 
interactions with both NOT1 and CAF40. The loss of CAF40 is sufficient to abolish the 
interaction between NOT4 and the CCR4-NOT complex in co-immunoprecipitation assays. 
NOT4 appears to have multiple NOT1-binding sites in its C-terminal region, however, these 
regions could not be precisely mapped in in vitro using pull-down assays. As a result, the 
individual contribution to the interaction from each subunit could not be clearly dissected. Based 
on my results, I propose a model where CAF40 is the principal mediator for the interaction of 
NOT4 with the CCR4-NOT complex. This differs from what is known about Sc NOT4, where 
NOT1 appears to be the protein’s sole interactor in the CCR4-NOT complex (see comparison of 
proposed binding modes in Fig. 6).  
Sequence alignments of NOT4 proteins revealed that the CBM is conserved in metazoans 
but could not be identified in fungi. Consequently, it is possible that in yeast, the only contact 
between NOT4 and the CCR4-NOT complex is the known interaction (Bhaskar et al. 2015) 
between NOT4 and NOT1. In human and D. melanogaster, binding to CAF40 through the NOT4 
CBM is essential for a functional interaction between NOT4 and the complex. Furthermore, 
human NOT4 can also directly interact with NOT1, as demonstrated in vitro using pull-down 
assays with recombinant proteins. Therefore, the binding mode between metazoan NOT4 and 
CCR4-NOT differs from yeast, as it involves two components of the deadenylase complex: 
CAF40 and NOT1. This functional difference in the binding mode of NOT4 to the CCR4-NOT 
complex in metazoans may also contribute to the fact that NOT4 is not a constitutive 
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deadenylase complex subunit. As mentioned above, the negatively charged CBM in metazoans 
may also interact with the positively charged coiled coil linker in the N-terminus of NOT4, 
which could prevent and thus regulate interaction with the CCR4-NOT complex. The stable 
interaction and absence of a CBM in yeast could support this theory of structural reorganization 
as a means of regulating binding of NOT4 to CCR4-NOT in higher eukaryotes. 
 
7.5 CAF40 is a binding platform for RNA-associated proteins 
The results provided in my thesis show that NOT4 and Bam are RNA-associated proteins 
that recruit the CCR4-NOT complex to mediate degradation and translational repression of 
reporter mRNAs.  
The convex and concave surfaces of CAF40 both provide binding sites for RNA-
associated proteins like Roquin, TTP and GW182. Interestingly, NOT4 and Bam both bind to the 
 
Figure 6. CAF40 mediates association of metazoan NOT4 and Bam with the CCR4-NOT 
complex. In yeast, Not4 has been shown to bind the C-terminal SHD domain of NOT1. In 
metazoans, NOT4 associates with the CCR4-NOT complex via binding to both NOT1 and 
CAF40, a previously unknown interaction partner. NOT4 binds to CAF40 through its CBM in 
the C-terminal, mainly unstructured part of the protein. D. melanogaster Bam also interacts 
with the CAF40 subunit of the CCR4-NOT complex. NOT4 and Bam both bind to the same 
surface of CAF40 as Roquin (Sgromo et al. 2017). 
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same concave surface of the armadillo-repeat domains of CAF40 as Roquin (Fig. 7). This 
indicates that binding of NOT4, Bam and Roquin to CAF40 is mutually exclusive, hence there 
might be competition for binding, provided the proteins are all present in the same cells under 
the same physiological conditions. Protein abundance, localization, additional binding partners 
and post-translational modifications may also affect competition for CAF40 binding. ITC 
(isothermal titration calorimetry) experiments to measure binding affinities of the Roquin and 
Bam CBMs to CAF40 showed that Bam has a much stronger affinity for binding to CAF40 
compared to Roquin, which was also supported by in vitro competition assays. These results 
suggest Bam has a competitive advantage over Roquin for binding to CAF40, despite their 
highly similar binding modes. Bam is a fly-specific protein, and NOT4 and Roquin have D. 
melanogaster orthologs, so competition for binding CAF40 is, in theory, possible between these 
three proteins in flies. In human cells, NOT4 and Roquin may compete for binding to CAF40, 
depending on their expression under the same conditions. However, it is not clear whether these 
proteins are expressed in the same cell types in vivo, and whether they compete with each other 
and with additional, so far unknown interactors of CAF40 under physiological conditions. 
Therefore, the functional relevance of the shared interaction site on CAF40 requires further 
studies. 
CAF40 and its CBM-binding surface are highly conserved, which suggests there could be 
more CBM-containing proteins that interact with CAF40. An in silico search based on the Bam 
and Dm Roquin CBM profile identified several proteins with potential CBMs, however, testing 
these proteins for interaction with CAF40 in vitro yielded no positive results. This indicates that 
if there are CBMs in other proteins, they evolved independently from Bam and Roquin, and thus 
have no sequence conservation. 
Apart from Roquin, NOT4 and Bam, CAF40 has been shown to interact with other RNA-
associated proteins, such as GW182 and TTP, through surfaces that are distinct from the CBM-
binding surface. It is tempting to speculate that GW182/TTP – CAF40 – Bam/NOT4 may form a 
larger complex together with CCR4-NOT. This could be important for example to regulate 
degradation of specific mRNA targets. Identifying transcripts regulated by CAF40, and how 
these targets are affected by the presence or absence of different mRNA-associated proteins that 
bind to CAF40 would be interesting to explore in the future. 
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7.6 Conclusion 
My doctoral work contributed to the field of post-transcriptional control, and specifically 
mRNA decay, by shedding light on mechanisms of recruitment of the CCR4-NOT complex 
through its CAF40 subunit. The data shown here fit a model of targeted deadenylation where the 
non-enzymatic subunits of the CCR4-NOT complex serve as binding sites for RNA-associated 
proteins that recruit the complex to specific mRNA targets, leading to the deadenylation, 
translational repression and eventual degradation of these mRNAs. These RNA-associated 
proteins typically contain one or several conserved RNA-binding domains, and spatially 
separated interaction sites for the CCR4-NOT complex. The binding of NOT4, Bam and Roquin 
to CAF40 is the first known example of a binding surface on the CCR4-NOT complex which is 
shared by several proteins with a similar binding mode. It is tempting to speculate that 
competition for binding CAF40 may be a new regulatory mechanism of CCR4-NOT recruitment, 
which requires further studies. The interaction network of the CCR4-NOT complex and 
associated decay factors, as well as interplay between the complex and the downstream mRNA 
decay machinery are important directions for future research. 
 
Figure 7. Crystal structure of CBMs bound to CAF40. Surface representation of Hs CAF40 
in complex with the CBMs of Dm NOT4 (Keskeny et al. 2019, Protein Data Bank (PDB) ID: 
6hon), Dm Roquin (Sgromo et al. 2017, PDB ID: 5lsw) and Dm Bam (Sgromo et al. 2018, PDB 
ID: 5onb).The CBMs are shown in cartoon representation, excluding structurally variable 
flanks. Interacting residues of CAF40 are colored in yellow. The N- and C-terminal ends of the 
CBMs are marked. Note the inverted orientation of the NOT4 CBM vs. Roquin and Bam. 
Adapted from Keskeny et al, 2019. 
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A conserved CAF40-binding motif
in metazoan NOT4 mediates association
with the CCR4–NOT complex
Csilla Keskeny, Tobias Raisch,1 Annamaria Sgromo,2 Cátia Igreja, Dipankar Bhandari,
Oliver Weichenrieder, and Elisa Izaurralde3
Department of Biochemistry, Max Planck Institute for Developmental Biology, D-72076 Tübingen, Germany
The multisubunit CCR4–NOT mRNA deadenylase complex plays important roles in the posttranscriptional regu-
lation of gene expression. The NOT4 E3 ubiquitin ligase is a stable component of the CCR4–NOT complex in yeast
but does not copurify with the human or Drosophila melanogaster complex. Here we show that the C-terminal
regions of human and D. melanogaster NOT4 contain a conserved sequence motif that directly binds the CAF40
subunit of the CCR4–NOT complex (CAF40-binding motif [CBM]). In addition, nonconserved sequences flanking
the CBM also contact other subunits of the complex. Crystal structures of the CBM–CAF40 complex reveal a
mutually exclusive binding surface for NOT4 and Roquin or Bag of marbles mRNA regulatory proteins. Further-
more, CAF40 depletion or structure-guidedmutagenesis to disrupt theNOT4–CAF40 interaction impairs the ability
of NOT4 to elicit decay of tethered reportermRNAs in cells. Togetherwith additional sequence analyses, our results
reveal the molecular basis for the association of metazoan NOT4 with the CCR4–NOT complex and show that it
deviates substantially from yeast. They mark the NOT4 ubiquitin ligase as an ancient but nonconstitutive cofactor
of the CCR4–NOT deadenylase with potential recruitment and/or effector functions.
[Keywords: deadenylation; mRNA decay; translational repression; ubiquitination]
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The CCR4–NOT complex plays a central role in the post-
transcriptional regulation of gene expression by catalyz-
ing the removal of the mRNA poly(A) tail, thereby
repressing translation and promoting mRNA degradation
(Wahle and Winkler 2013; Collart 2016). In addition, the
CCR4–NOTcomplex has the ability to repress translation
independently of deadenylation (Cooke et al. 2010;
Chekulaeva et al. 2011; Bawankar et al. 2013).
The CCR4–NOT complex (Fig. 1A) is a multisubunit
complex (Chen et al. 2001; Lau et al. 2009; Temme et al.
2010) that assembles on theNOT1 scaffold protein, which
consists of several α-helical domains that serve to dock the
other subunits of the complex (Bawankar et al. 2013).
Deadenylation is carried out by two interacting deadeny-
lases; namely, CCR4 and CAF1. They dock onto a central
α-helical domain in NOT1 (labeled “MIF4G”), forming
the “catalytic module” of the complex (Basquin et al.
2012; Petit et al. 2012). The C-terminal end of NOT1 con-
tains the NOT1 superfamily homology domain (SHD),
which is another α-helical domain that interacts with the
NOT2–NOT3 heterodimer to form the “NOT module”
of the complex (Bhaskar et al. 2013; Boland et al. 2013).
The catalytic module and theNOTmodule are connected
by the CAF40-binding domain of NOT1 (labeled
“CN9BD”) and a connector domain (labeled “MIF4G-C”)
of unknown function (Chen et al. 2014; Mathys et al.
2014; Raisch et al. 2018). Both the NOT module and the
CAF40 subunit of the CCR4–NOT complex have been re-
ported as important peptide-docking sites for the recruit-
ment of the complex by mRNA-associated proteins. The
NOTmodule provides binding sites for Bicaudal-C (Chic-
oine et al. 2007), Nanos (Bhandari et al. 2014; Raisch
et al. 2016), and Roquin (Sgromo et al. 2017). CAF40 is
known to be contacted by Roquin (Sgromo et al. 2017),
Bag of marbles (Bam) (Sgromo et al. 2018), and TTP (Bul-
brook et al. 2018) as well as the GW182/TNRC6 family
of proteins that mediates microRNA-mediatedmRNA re-
pression and decay (Chen et al. 2014; Mathys et al. 2014).
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The N-terminal portion of NOT1 is less well conserved
than itsC-terminal portion (Basquin et al. 2012) and serves
to dock NOT10 and NOT11 as additional subunits of
the complex in metazoan species (Bawankar et al. 2013;
Mauxion et al. 2013). The CCR4–NOT complexes of Sac-
charomyces cerevisiae (Sc) and Schizosaccharomyces
pombe lack NOT10 and NOT11 proteins. Furthermore,
these CCR4–NOT complexes are special because they
contain NOT4 as an integral component (Bai et al. 1999;
Chen et al. 2001; Nasertorabi et al. 2011; Stowell et al.
2016; Ukleja et al. 2016).
NOT4 (Fig. 1B) is an evolutionarily conserved E3ubiqui-
tin ligase that contains a RING domain, a linker region
with coiled-coil propensity (CC), an RNA recognition
motif (RRM) domain, and aC3H1-type zinc finger domain
(ZNF). Together, they define the conservedN-terminal re-
gion of NOT4 (NOT4-N) (Fig. 1B). The C-terminal region
of NOT4 (NOT4-C) (Fig. 1B) is predicted to be unstruc-
tured, and its sequence and length are not conserved
among NOT4 proteins (The UniProt Consortium 2018).
NOT4 causes the ubiquitination of diverse proteins in
yeast andalsohumancells, targeting themfor proteasomal
degradation or resulting in regulatory changes. Ubiquiti-
nation targets include the nascent polypeptide-associated
complex NAC (Panasenko et al. 2006), the histone de-
methylase JHD2 (Mersman et al. 2009), the transcription
factor YAP1 (Gulshan et al. 2012), the master regulator of
meiosis Mei2 (Simonetti et al. 2017), the cyclin C subunit
of the Mediator complex (Cooper et al. 2012), the small
ribosomal protein RPS7A (Panasenko and Collart 2012),
and the cotranslational quality control factor ABCE1
(Wu et al. 2018). NOT4 has been implicated in cotransla-
tional mRNA quality control and translational repression
in the context of stalled ribosomes, suchas in the“No-Go”
A
CB
Figure 1. HumanNOT4 interacts with theCCR4–NOT complex. (A) Composition of the humanCCR4–NOT complex. TheNOT1 scaf-
fold protein containsN-terminal α-helical domains (classified asHEAT repeat domains) that interact withNOT10 andNOT11 to form the
NOT1–10–11 module. NOT1 furthermore contains a central HEAT repeat domain (MIF4G) that binds CAF1 and CCR4 to form the cat-
alytic module, an α-helical bundle that interacts with CAF40 (CN9BD), a connector domain (MIF4G-C), and a NOT1 SHD that forms the
NOT module together with NOT2 and NOT3. A “pentameric” complex lacking CCR4 and the NOT1–10–11 module can be assembled
from recombinant human CCR4–NOT proteins (Sgromo et al. 2017). (B) Domain composition of NOT4 proteins. The conserved N-ter-
minal region of NOT4 (NOT4-N) comprises a RING-type E3 ubiquitin ligase domain (RING), a positively charged linker with coiled-
coil propensity (CC), an RNA recognitionmotif (RRM) domain, and a C3H1-type zinc finger domain (ZNF). The nonconservedC-terminal
region of NOT4 (NOT4-C) was found to interact with the CCR4–NOT complex. To map the interactions, Homo sapiens (Hs) NOT4-C
was subdivided into three regions: C1 (residues P275–S376), C2 (residues E377–Q428), and C3 (residues P429–A575). A CAF40-binding
motif (CBM) was identified in the C2 region. The CBM is conserved in metazoan NOT4, including Dm NOT4, but is not conserved in
yeasts. Instead, Sc Not4-C harbors a previously characterized binding site for Sc Not1 (N1BS) (Bhaskar et al. 2015). (C ) SBP pull-down
of endogenous human NOT proteins with V5-SBP-MBP (V5-streptavidin-binding peptide-maltose-binding protein)-tagged Hs NOT4
fromHEK293T cell lysates. V5-SBP-GFP-MBP served as negative control. Input samples correspond to 3% of the total lysate for V5-tagged
proteins and 2% of the total lysate for NOT proteins. Pull-down samples correspond to 3% of the total pull-down for V5-tagged proteins
and 35% of the total pull-down for NOT proteins. The mRNA decapping factor EDC4 and the poly(A)-binding protein PABP served as
negative controls.
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mRNA decay pathway (Dimitrova et al. 2009; Matsuda
et al. 2014; Panasenko 2014; Preissler et al. 2015; Wu
et al. 2018).
A crystal structure demonstrated how ScNot4 interacts
with the SHD of Sc Not1 via an elongated polypeptide
from the C-terminal region of Sc Not4 (Bhaskar et al.
2015). Using yeast two-hybrid assays, the human NOT4
and NOT1 proteins (Homo sapiens [Hs] NOT4 and Hs
NOT1)were also shown to interact via theC-terminal por-
tion of Hs NOT1 (Albert et al. 2002). However, the Sc
Not1-binding sequence of Sc Not4 is only partially con-
served, at best (Bhaskar et al. 2015), andNOT4was not de-
tected inmass spectrometric analyses of the native human
andDrosophilamelanogaster (Dm) CCR4–NOTcomplex-
es (Lau et al. 2009; Temme et al. 2010). This raised the
question ofwhetherNOT4 should be regarded as a compo-
nent or cofactor of theCCR4–NOTcomplex inmetazoans
and how it would be recruited to the complex in species
other than S. cerevisiae.
We therefore performed pull-down experiments from
human cell extracts and with purified bacterially ex-
pressed proteins to identify and map interactions of hu-
man NOT4 with the CCR4–NOT complex. Assisted by
alignments of metazoan NOT4 proteins, we uncovered a
23-amino-acid peptide motif in NOT4-C that binds to
theCAF40 subunit of theCCR4–NOTcomplex and hence
was termed the NOT4 CAF40-binding motif (CBM).
Crystal structures of the CBM–CAF40 complex identified
critical contacts required in human andDm S2 cells for an
efficient recruitment of NOT4 to the CCR4–NOT com-
plexandforNOT4-mediatedmRNAdeadenylationandde-
cay via the CCR4–NOT complex. Consequently, NOT4
emerges as a nonconstitutive cofactor of the CCR4–NOT
complex in metazoans with a conserved mode of interac-
tion via the CAF40 subunit.
Results
Hs NOT4-C shows a stable interaction with the CCR4–
NOT complex
To investigate whether and how HsNOT4 interacts with
the CCR4–NOT complex inHEK293T cells, we expressed
Hs NOT4 with a V5-SBP-MBP (V5-streptavidin-binding
peptide-maltose-binding protein) tag in HEK293T cells
and performed SBP pull-down assays. In agreement with
previous reports (Lau et al. 2009; Temme et al. 2010),
full-length Hs NOT4 failed to pull down the endogenous
CCR4–NOT complex efficiently (Fig. 1C, lane 6).
Hs NOT4-C, however, showed a stable interaction with
the CCR4–NOT complex, as indicated by the detection
of endogenous NOT1, NOT2, and NOT3 subunits in the
pull-down fraction (Fig. 1C, lane 8). This is consistent
with previous yeast two-hybrid experiments (Albert
et al. 2002). In contrast, Hs NOT4-N did not interact
with the CCR4–NOT complex (Fig. 1C, lane 7). The
lack of an efficient interactionwith the full-length protein
remains unexplained but hints at a possible regulation of
NOT4-C binding by NOT4-N. Additional SBP pull-
down experiments showed that it is the presence of the
positively charged CC linker and of the RRM domain in
NOT4-N that prevents NOT4-C from interacting with
the CCR4–NOT complex (Supplemental Fig. S1A,B).
Tethered Hs NOT4 causes deadenylation-dependent
mRNA decay
To address the relevance of an interaction betweenNOT4
and the CCR4–NOT complex with a functional assay, we
investigated the molecular consequences resulting from
the presence of NOT4 in the context of an mRNA. Usual-
ly, the recruitment of the CCR4–NOT complex to an
mRNA target promotes its deadenylation-dependent de-
cay (Wahle and Winkler 2013). It is unknown, however,
whether NOT4 can bind to an mRNA despite the pres-
ence of putative and conserved RNA-binding domains in
NOT4-N (CC-RRM-ZNF) (Fig. 1B). In the absence of
knownmRNA targets, we therefore used a tethering assay
to directNOT4 toward the 3′ untranslated region (UTR) of
defined reporter mRNAs and tested them for NOT4-de-
pendent deadenylation and decay.
In a first series of experiments, we tethered MS2-tagged
Hs NOT4 to a β-globin mRNA reporter containing six
MS2-binding sites in the 3′ UTR (β-globin-6xMS2bs)
(Lykke-Andersen et al. 2000). Even though full-length Hs
NOT4 did not associate with the CCR4–NOT complex
in SBP pull-down assays (Fig. 1C, lane 6), we found that
tethered MS2-HA-Hs NOT4 caused a substantial reduc-
tion of the β-globin-6xMS2bs mRNA level compared
with the negative control MS2-HA (Fig. 2A,B). Tethering
HsNOT4-Calso reducedmRNA levels,whereas tethering
Hs NOT4-N had no effect (Fig. 2A,B). All Hs NOT4 frag-
ments were expressed at comparable levels (Fig. 2C), and
none of them affected the expression of the control β-glo-
bin mRNA lacking MS2-binding sites (Fig. 2B). Regarding
full-length Hs NOT4, the discrepancy with the SBP pull-
down assay (Fig. 1C)might be rationalized by a higher sen-
sitivity of the tethering assay for weak and possibly tran-
sient interactions or, alternatively, by conformational
changes ofHsNOT4 in the presence of RNA that promote
the availability of NOT4-C to the deadenylase complex.
In a second series of experiments, we also tetheredMS2-
taggedHsNOT4 to another reporter mRNA that encoded
Renilla luciferase (R-Luc-6xMS2bs) instead of β-globin, al-
lowing for the quantification of protein abundance in ad-
dition to mRNA levels. In agreement with the β-globin
mRNA reporter, we observed a clear reduction of both
Renilla luciferase mRNA and Renilla luciferase protein
levels in the case of tethered Hs NOT4 or Hs NOT4-C
(Supplemental Fig. S2A,B). By comparison, a Renilla lucif-
erase mRNA lacking MS2-binding sites was not affected
by the expression of MS2-tagged full-length Hs NOT4 or
its fragments (Supplemental Fig. S2C,D).
To verify whether the reduction of reporter mRNA lev-
els upon tetheringHsNOT4 orHsNOT4-C resulted from
deadenylation-dependent decay, we overexpressed a GFP-
tagged catalytically inactivemutant of the humanmRNA
decapping enzyme DCP2 (GFP-DCP2 mut; E148Q). The
presence of this mutant is known to impair mRNA
decapping in a dominant-negative manner and hence
Keskeny et al.
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5′-to-3′ mRNA decay by XRN1 (Loh et al. 2013; Bhandari
et al. 2014; Chang et al. 2014; Kuzuog˘lu-Öztürk et al.
2016; Sgromo et al. 2017). Indeed, we observed the accu-
mulation of a shorter deadenylated decay intermediate
of the β-globin-6xMS2bs reporter mRNA upon tethering
Hs NOT4 or upon tethering the Hs Nanos2 mRNA-
binding protein (Bhandari et al. 2014), which served as a
positive control (Supplemental Fig. S3A–C). We therefore
attributed reporter mRNA decay to the recruitment of
theCCR4–NOTcomplex, althoughwe could not formally
exclude contributions from other deadenylases at this
stage.
The capacity of NOT4-C to mediate tethered mRNA
decay is conserved in metazoans
The C-terminal region of NOT4 is not conserved in se-
quence and length (Fig. 1B). We therefore investigated
the functionality of DmNOT4 as an example from an in-
vertebrate species and to allow more general conclusions
on NOT4 recruitment to the CCR4–NOT complex in
metazoans. ForDmNOT4, we used a λN-based tethering
assay inDm S2 cells with an F-Luc-5BoxB reportermRNA
(Behm-Ansmant et al. 2006). Similar to HsNOT4 and de-
spite highly divergent sequences of NOT4-C, tethered
DmNOT4 andDmNOT4-C efficientlymediated reporter
mRNA decay (Fig. 2D,E). Dm NOT4 and its fragments
were expressed at equal levels (Fig. 2F), and none of
them affected the expression of an F-Luc reporter lacking
the BoxB sites (Supplemental Fig. S2E,F).
Again, reportermRNAdecaywas deadenylation-depen-
dent. Deadenylated F-Luc-5BoxB reporter mRNAwas sta-
bilized in the presence of tethered Dm NOT4, when a
GFP-tagged Dm DCP1 mutant (GFP-DCP1 mut; R70G,
L71S, N72S, and T73G) known to prevent mRNA decapp-
ing in a dominant-negative manner (Chang et al. 2014;
Kuzuog˘lu-Öztürk et al. 2016) was overexpressed (Supple-
mental Fig. S3D–F). Tethered GW182 protein was used
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Figure 2. Metazoan NOT4 induces degradation of teth-
ered mRNA reporters. (A–C ) Tethering assay with Hs
NOT4 and a β-globin mRNA reporter in HEK293T cells.
Hs NOT4 or its fragments carried an N-terminal MS2-
HA tag. β-Globin mRNA served as a reporter and con-
tained six binding sites for the MS2 protein (6xMS2bs).
β-Globin-GAPDH mRNA served as a reference and
transfection control (control). (A) mRNA levels of the
β-globin-6xMS2bsmRNA reporter normalized to the ref-
erence and plotted with respect to the values obtained
from the expression of MS2-HA alone (set to 100). Error
bars correspond to standard deviations. n= 3. (B) North-
ern blot of representative RNA samples. (C ) Western
blot demonstrating equal expression of MS2-HA-tagged
proteins with F-Luc-GFP as a transfection control. (D–
F ) Tethering assay with Dm NOT4 and a luciferase re-
porter inDm S2 cells.DmNOT4 or its fragments carried
an N-terminal λN-HA tag. Firefly luciferase mRNA
served as a reporter and contained five BoxB binding sites
for the λN peptide (F-Luc-5BoxB). Renilla luciferase
mRNA served as a reference and transfection control
(R-Luc). (D) F-Luc activity (white bars) andmRNA levels
(black bars) normalized to the reference and plotted with
respect to the values obtained from the expression of λN-
HA alone (set to 100). Error bars correspond to standard
deviations. n =3. (E) Northern blot. (F ) Western blot
with R-Luc-V5 as a transfection control. (G–I ) Tethering
assay with fragments of Hs NOT4-C and the β-globin
mRNA reporter. (G) Relative mRNA levels, with error
bars corresponding to standard deviations.n =3. For addi-
tional details, see A. (H) Northern blot. (I ) Western blot.
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as a positive control (Kuzuog˘lu-Öztürk et al. 2016). To-
gether, our results indicate that the interaction of
NOT4-C with the CCR4–NOT complex is conserved be-
tween humans and flies.
Hs NOT4 directly interacts with the NOT1 and CAF40
subunits of the CCR4–NOT complex
To testwhether the interaction betweenHsNOT4and the
CCR4–NOT complex is direct, we expressed MBP-tagged
Hs NOT4, Hs NOT4-N, and Hs NOT4-C in Escherichia
coli and performed pull-down experiments with a recon-
stituted and purified subcomplex of human CCR4–NOT
components that we had described previously (Sgromo
et al. 2017) and that we here call the “pentameric” com-
plex (Figs. 1A, 3A). This subcomplex comprises the C-ter-
minal portion of NOT1 together with the CAF1 and
CAF40 subunits and the C-terminal fragments of NOT2
and NOT3. Indeed, we observed a direct interaction with
the pentameric complex. In contrast to the result from
the SBP pull-down experiment in HEK293T cells (Fig.
1C, lane 6), the interaction occurred even with the full-
length Hs NOT4 (Fig. 3A, lane 7). Furthermore, Hs
NOT4-C interacted with the pentameric complex as effi-
ciently as the recombinant full-length protein (Fig. 3A,
lane 9), whereas recombinantHsNOT4-N did not interact
(Fig. 3A, lane 8).
Tomap the interactions to individual components of the
CCR4–NOT complex, we also used previously described
smaller subassemblies of the complex (Petit et al. 2012;
Boland et al. 2013; Chen et al. 2014; Sgromo et al. 2017)
in MBP pull-down experiments (Figs. 1A, 3B). These
were the NOT1–NOT10–NOT11 module (comprising
the N-terminal region of NOT1 and NOT10 and the C-
terminal half of NOT11), CAF1 bound to the central α-he-
lical domain inNOT1 (labeled“MIF4G”), CAF40bound to
the CAF40-binding domain of NOT1 (labeled “CN9BD”),
the NOT1 connector domain (labeled “MIF4G-C”), and
the NOT module (comprising the C-terminal regions of
NOT1, NOT2, and NOT3). We detected interactions of
Hs NOT4 with both the CAF40-containing subcomplex
and the NOT module (Fig. 3B, lanes 13,17), pointing to
multiple NOT4-binding sites within the CCR4–NOT
complex. Finally, we narrowed down these interactions
even further, primarily to the NOT1-SHD (Fig. 3C, lane
7) andCAF40 alone (Fig. 3C, lane 11),with onlyminor con-
tributions from the NOT2–NOT3 heterodimer (Fig. 3C,
lane 9).
The central C2 region of Hs NOT4-C is sufficient to
contact CCR4–NOT and trigger decay of tetheredmRNA
It is not uncommon for the long unstructured portions of
regulatorymRNA-associated proteins (such as inGW182/
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Figure 3. Hs NOT4 directly interacts with the NOT1-SHD and CAF40. (A–D) MBP pull-down assays with MBP-tagged Hs NOT4 and
purified components of the human CCR4–NOT complex. MBP-tagged NOT4 or NOT4 fragments were used to pull down potential in-
teraction partners. MBP alone served as a control. The respective starting materials (“input”) and pull-down samples were analyzed by
SDS-PAGE and Coomassie blue staining. Potential interaction partners included a pentameric assembly of recombinant human
CCR4–NOT proteins (A), various subassemblies of the CCR4–NOT proteins (B), and individual proteins (C ). (D) To further confine indi-
vidual interactions, Hs NOT4-C was subdivided into the C1, C2, and C3 regions. See Figure 1B for details. MBP-tagged constructs are
labeled in gray.
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TNRC6, Nanos, or Roquin) to showmultiple interactions
with the CCR4–NOT complex, targeting several of its
subunits (Jonas and Izaurralde 2015; Raisch et al. 2016;
Sgromo et al. 2017). In order to map the interactions
with theNOTmodule andCAF40more precisely, we sub-
divided Hs NOT4-C into three regions (C1, C2, and C3)
based on initial secondary structure and disorder predic-
tion and tested them individually in MBP pull-down ex-
periments with the NOT module or CAF40. These
experiments identified the central C2 region (residues
E377–Q428) (Fig. 1B) as a major interaction site for both
the NOT module and CAF40 (Fig. 3D, lanes 11,16), al-
though the interactions were weaker than with the entire
NOT4-C region (Fig. 3D, lanes 9,14). The NOT module
also interacted very weakly with the C3 region of Hs
NOT4 (Fig. 3D, lane 12), whereas CAF40 showed no addi-
tional interactions in this context.
Considering the importance of theC2 region in the pull-
down experiments, we also tested it in a tethering assay
using the β-globin-6xMS2bs mRNA reporter. Strikingly,
the C2 region was sufficient and highly efficient to trigger
reporter mRNA decay. In contrast, the C1 or C3 region
failed to elicit mRNA decay when tethered to the reporter
(Fig. 2G,H). All tested fragments were expressed at compa-
rable levels (Fig. 2I).
Alignments of NOT4 proteins reveal highly conserved
sequence motifs in NOT4-C
To identify a potential sequence motif that could be re-
sponsible for the interaction of the C2 region with the
NOTmodule and CAF40, we generated and analyzed sep-
arate alignments of NOT4 proteins from metazoans,
plants, and yeasts. These alignments revealed locally con-
served sequences at different positions in the C-terminal
regions of NOT4 (Fig. 1B; Supplemental Figs. S4, S5A;
Supplemental Alignment Files SF1–SF3).
Most striking is the conservationof a 23-amino-acidmo-
tif with α-helical propensity in the C2 region ofHsNOT4,
which is present throughout all metazoans (Fig. 1B; Sup-
plemental Fig. S4). A similar sequence also exists in plants
but is not found in fungi. Conversely, the NOT1-binding
motif of ScNot4 (Bhaskar et al. 2015) is conserved in yeast
but cannot be identified in plants and metazoans (Supple-
mental Fig. S5A; Supplemental Alignment Files SF1–SF3).
Beside the 23-amino-acidmotif, the alignments also un-
covered the presence of a proline-rich PPPGΦmotif (Φ= F,
L, or I) at least once in each of the NOT4 sequences from
metazoans, plants, and yeasts. The position of the PPPGΦ
motif within NOT4-C varies with the phylogeny and can
be found before or after the 23-amino-acid motif with the
potential formisaligning distantly related sequences (Sup-
plemental Figs. S4, S5A; Supplemental Alignment Files
SF1–SF3). PPPGΦ motifs are known to be recognized by
proteins containing proline-binding GYF domains (Kofler
and Freund 2006).
The 23-amino-acid motif (residues E400–E422) occu-
pies the second half of the C2 region (Supplemental Fig.
S5B).We therefore again performedMBP pull-down exper-
iments with the NOT module and CAF40, where either
the first half (C2a) or the second half (C2b) of theC2 region
or the entire C2 region was deleted from Hs NOT4-C.
These deletions did not detectably affect the interaction
with the NOT module, indicating that the C1 and C3 re-
gions of Hs NOT4-C together are still sufficient to pull
down the NOT module (Supplemental Fig. S5C, lanes
9–12). However, the interaction with CAF40 was clearly
diminished by deleting the second half of the C2 region
(Supplemental Fig. S5C, lanes 15,17). This observation
suggests that the 23-amino-acid motif acts as a conserved
CBM. This assumption was confirmed in the following
by X-ray crystallography. The motif is hence called the
NOT4 CBM.
Crystal structure of the CBM of Dm NOT4 in complex
with Hs CAF40
To understand in molecular detail how NOT4 interacts
with the CCR4–NOT complex, we used peptides corre-
sponding to the putative CBM of Hs NOT4 or Dm
NOT4 to set up cocrystallization trials with Hs CAF40.
We obtained crystals—but only of a heterologous complex
consisting of Hs CAF40 and the CBM of Dm NOT4. We
obtained two distinct crystal forms, eachwith two crystal-
lographically independent complexes per asymmetric
unit and diffracting X-rays to a maximum resolution of
2.1 Å (Table 1). CBM binding is highly similar among
the four CAF40–CBM complexes, and therefore only
one of them (polypeptide chains A and B from space group
P212121) is described (Fig. 4A–C; Supplemental Figs. S5D,
E, S6).
From Dm NOT4 L816 to E835 (see Fig. 4D for human
sequence numbers), the Dm CBM adopts a common con-
formation in all of the available structures, with Dm
NOT4 P820 to E835 folding into four turns of an amphi-
pathic α helix that is bent between turns two and three to-
ward the surface of Hs CAF40. Only the very N-
terminal and very C-terminal residues of the crystallized
peptide show differing orientations in the four available
complexes, probably due to crystal-packing interactions
and indicating structural flexibility (Supplemental Fig.
S5E). Hs CAF40 adopts its rigid and previously described
crescent-like shape, made from six armadillo repeats. De-
spite its highly negative overall charge (pI = 3.6), the Dm
CBM interacts withHs CAF40 primarily via hydrophobic
contacts. It engages the concave surface ofHsCAF40, con-
tacting residues from three parallel α helices (α5, α8, and
α11) and burying a surface on Hs CAF40 of 842 Å2 (Fig.
4A–C).
Importantly, the very same surface of CAF40 was de-
scribed previously to be engaged also by the CBMs of
Roquin and Bam (Fig. 4E,F; Sgromo et al. 2017, 2018).
These CBMs also fold into amphipathic helices, covering
surface areas of 841 Å2 and 748 Å2, respectively, and ex-
cluding any simultaneous associations of multiple
CBMs with CAF40. Strikingly, however, whereas the
CBMs of Roquin and Bam run in parallel to the α helices
α5, α8, and α11, the CBM of NOT4 runs in an antiparallel
fashion and hence is structurally and evolutionarily unre-
lated to the other two CBMs.
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Details of the interaction between the CBM ofDmNOT4
and Hs CAF40
The amphipathic α helix of theDmNOT4CBM is preced-
ed by an “LGFDP” sequence motif that is invariant in our
alignment of metazoan species (Fig. 4D). This sequence
motif by itself forms a characteristic structure that helps
to pin down the N-terminal half of the α helix (Fig. 4G,
H). Probably due to the backbone flexibility provided by
Dm NOT4 G817, the side chains of Dm NOT4 L816,
F818, and P820 can join to form a small hydrophobic clus-
ter, which is centrally contacted and completed by V181
from the αhelix α11 ofHsCAF40. Furthermore,V181 is as-
sistedbyF184 to fixDmNOT4L816andbyL177 to fixDm
NOT4 F818, allowing DmNOT4 L816 and F818 to inter-
calate between the side chains on the α helix α11 of Hs
CAF40. Dm NOT4 P820 also initiates the α helix of
NOT4 and is assisted by Dm NOT4 D819, which caps
thehelix andcompensates for thepositive chargeof thehe-
lix dipole.Moreover, P820 is positioned straight overG141
in the α helix α8 of Hs CAF40 and would be spatially in-
compatible with any other residue at this position apart
from a glycine.
Following P820, the hydrophobic surface of theNOT4 α
helix probes the groove between α helices α8 and α5 of Hs
CAF40 (Fig. 4D,H,I) using side chains of DmNOT4 F821,
T824, L828, and L831. These side chains are lined by res-
idues from α helices α8 (Hs CAF40 T138, L137, Y134, and
P131) and α5 (Hs CAF40 A95, N92, C91, N88, S87, H85,
and A84), all of which are within van der Waals distance
and frequently contribute to the interactions with the al-
iphatic portions of their side chains. At the C-terminal
end of the CBM (Fig. 4D,H,I), the invariant Dm NOT4
E835 pins down the C-terminal half of the NOT4 α helix,
using two hydrogen bonds to coordinate the free main
chain nitrogens of Hs CAF40 A84 and H85 at the begin-
ning of αhelix α5 and compensating for the positive charge
of the helix dipole. As a consequence of this interaction,
the side chain of A84 gets completely surrounded by resi-
dues from NOT4 (Dm NOT4 L828, L831, M832, and
E835), tolerating no side chains at this position that are
larger than alanine. Additional specificity arises from an
H bond between the side chains of Dm NOT4 T824 and
Hs CAF40 T138 on α helix α8, which is deeply buried in
the interface (Fig. 4D,H). Finally, it is important for Hs
CAF40Y134 on α helix α8 to rotate away from its preferred
Table 1. Data collection and refinement statistics for the Hs CAF40–Dm NOT4 CBM complex
Crystal form 1 Crystal form 2
Space group P 21 21 2 I 21 21 21
Unit cell
Dimensions a, b, c 83.9 Å, 109.6 Å, 69.7 Å 85.6 Å, 90.3 Å, 197.0 Å
Angles α, β, γ 90.0°, 90.0°, 90.0° 90.0°, 90.0°, 90.0°
Data Collectiona
Wavelength 1.0000 Å 1.0000 Å
Resolution range 50 Å–2.1 Å (2.14 Å–2.10 Å) 50 Å–2.2 Å (2.25 Å–2.20 Å)
Rsym 7.0% (91.4%) 6.5% (157.3%)
Completeness 99.6% (99.8%) 99.9% (99.8%)
Mean I/σ(I) 12.2 (1.5) 16.6 (1.6)
CC 1/2 99.0 (55.6) 100.0 (89.9)
Unique reflections 38,143 (2780) 39,129 (2831)
Multiplicity 4.0 (4.2) 8.9 (9.0)
Refinement
Rwork 19.1% 19.3%
Rfree 22.2% 23.0%
Number of atoms
All atoms 4971 4805
Protein 4760 4738
Ligands 34 3
Water 177 64
Average B factor
All atoms 52.7 Å2 81.0 Å2
Protein 52.3 Å2 81.1 Å2
Ligands 95.5 Å2 93.7 Å2
Water 53.7 Å2 66.9 Å2
Ramachandran plot
Favored regions 99.2% 98.3%
Disallowed regions 0.0% 0.0%
RMSD from ideal geometry
Bond lengths 0.002 Å 0.010 Å
Bond angles 0.426° 1.040°
aValues in parentheses are for the highest-resolution shell.
(RMSD) Root mean square deviation.
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rotamer position that is observed in free CAF40 (Garces
et al. 2007; Chen et al. 2014; Mathys et al. 2014) and in
the complexes with Roquin (Sgromo et al. 2017) and
Bam (Sgromo et al. 2018). Hence, the orientation of Hs
CAF40Y134 could help to discriminate between the three
binding partners, liberating access for T824 and L828 from
the DmNOT4 α helix to the groove between α helices α5
and α8 (Fig. 4D,H,I). As a result, the CBM and CAF40 in-
teract via highly complementary shapes with a hydropho-
bic interface that excludes any water molecule and by
exposing polar residues (Dm NOT4 K826, E830, E833,
and N834) to the solvent on the hydrophilic side of the
Dm NOT4 α helix (Fig. 4D,H).
Validation of the binding interface
To validate the specificity of the interface observed in the
crystal structure, we generated mutations in the CBM of
Dm NOT4 and in Hs CAF40 and tested them in MBP
pull-down assays. First, we demonstrated that the CBM
ofDmNOT4 indeed also interacts with Hs CAF40 in sol-
ution (Fig. 5A, lane 14), confirming that it is a bona fide
CBM. We disrupted the interaction from the side of
CAF40 using either a single point mutation targeted at
the “LGFDP”motif (Hs CAF40 V181E) (Fig. 4G) or a dou-
ble point mutation targeted at the α-helical part of the
CBM (Hs CAF40 2x mut; Y134D and G141W) (Fig. 4G,I).
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Figure 4. Crystal structure of the NOT4 CBM bound to CAF40. (A) Complex of theDmNOT4 CBM peptide (blue, shown in ribbon rep-
resentation) bound toHsCAF40 (gray). The α helices of CAF40 are numbered and depicted as cylinders. The orange semicircle marks the
predominantly hydrophobic interface between the CBM peptide and CAF40. The structurally variable flanks of the CBM peptide are ex-
cluded. (B) Rotated view of the CBM–CAF40 complex in cartoon representation marking the three central α helices of the concave CBM-
binding surface. (C ) Top view of CAF40 in surface representation, with the CBM of NOT4 as a cartoon. Interacting residues are colored in
yellow. (D) Sequence alignment of metazoanNOT4CBMs excluding the structurally variable flanks. TheN-terminal portion of the CBM
contains an extended LGFDP motif, and the C-terminal portion of the CBM consists of a bent α helix. Residues that directly contact
CAF40 are shaded in blue, and residues that were mutated in this study are marked by orange asterisks. (E,F ) Complexes of Hs CAF40
with the CBMs of Dm Roquin (E; Protein Data Bank [PDB] ID 5lsw) (Sgromo et al. 2017) and Dm Bam (F; PDB ID 5onb) (Sgromo et al.
2018), shown in the same style and orientation as in C and excluding structurally variable flanks of the CBMs. Note the inverted orien-
tation of theCBMs. (G–I ) Close-up views of the interface betweenDmNOT4 andHsCAF40. Selected side chains of NOT4 andCAF40 are
shown as blue and orange sticks, respectively, with nitrogens in dark blue and oxygens in red. Hydrogen bonds are indicated by red dashed
lines. Residues mutated in this study are underlined. (I ) Rotamers of CAF40 Y134 as found in the complexes of CAF40 with the CBMs of
Dm Roquin (yellow) and Dm Bam (lime).
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Bothmutations had been used previously to disrupt the in-
teractions of CAF40 with the CBMs of Roquin and Bam
(Sgromo et al. 2017, 2018); in the present structural con-
text, they abolished the interaction with the Dm NOT4
CBM (Fig. 5A, lanes 15,16). Conversely, single substitu-
tions in the Dm NOT4 CBM (F821D or L828E) (Fig. 4D,
H) were sufficient to abrogate the interaction with Hs
CAF40 (Fig. 5B, lanes 14,16).
Furthermore, the His6-NusA-tagged Dm NOT4 CBM
and the His6-NusA-tagged Dm Bam CBM competed
with the MBP-tagged Dm NOT4 CBM for binding to Hs
CAF40, confirming that they target overlapping binding
surfaces on Hs CAF40 (Supplemental Fig. S5F). As in the
case of theDmRoquinCBM (Sgromoet al. 2018), we could
not determine a precise dissociation constant for the Dm
NOT4CBMbecause it aggregated at concentrations need-
ed to perform isothermal titration calorimetry and micro-
scale thermophoresis experiments.
Finally, we also tested the interaction of the Hs NOT4
CBM with Hs CAF40. Similar to the results obtained
with theDmNOT4CBM, the singleHsCAF40V181Emu-
tation (Fig. 4G) was sufficient to abolish the interaction
with theHsNOT4CBM (Fig. 5C, lane 15 vs. 14). The dou-
ble point mutation (Hs CAF40 2x mut) (Fig. 4G,I) also
reduced the interaction but was not sufficient to abolish
it, indicating species-specific adaptations in themolecular
details of the coevolved interface of the human proteins
(Fig. 5C, lane 16 vs. 14). Together, the results confirm
that the interactions observed in the crystal structure
also occur in solution.
The CBM is essential for the interaction of NOT4 with
the human CCR4–NOT complex
To investigate the significance of the CBM–CAF40 inter-
action in cells and in the context of the entire CCR4–
NOT complex, we repeated SBP pull-down assays with
HsNOT4-Cwhere either the CBM (ΔC2b), the C2a region
(ΔC2a), or the entire C2 region (ΔC2) were deleted from
the construct (see Supplemental Fig. S5B for boundaries).
We found that the presence of the CBM is required to pull
down the CCR4–NOT complex (Fig. 6A, lane 7), as de-
tected by the absence of NOT1, NOT2, NOT3, and
CAF40 in the pull-down fraction when the C2b region
was deleted (Fig. 6A, lane 10). Consistently, the deletion
of the entire C2 region as well disrupted the interaction
(Fig. 6A, lane 8). Surprisingly however, the presence of
the C2a region was also required for an efficient pull-
down of the CCR4–NOT complex (Fig. 6A, lane 9). The
C2a region could simply act as a spacer to allow for a
proper interaction of the CBM with CAF40. More likely,
however, its requirement reflects and underlines the im-
portance of auxiliary and possibly species-specific interac-
tions of NOT4-C with other parts of the CCR4–NOT
complex, such as the NOT module. In line with these re-
sults, the deletion of the entire C2 region strongly dimin-
ished the NOT4-mediated degradation of the β-globin-
6xMS2bs reporter mRNA in HEK293T cells (Fig. 6B,C).
The separate deletion of the C2a region (ΔC2a) or
the CBM (ΔC2b) did so as well but to a lesser degree. All
tethered proteins were expressed at a similar level
(Fig. 6D).
To probe more directly for the interface observed in the
crystal structure, we engineered a quadruple pointmutant
of theHsNOT4CBM (4xmut; F405D, F408A, T411E, and
L415E) (Fig. 4D) affecting both the LGFDP motif and the
hydrophobic surface of the α helix. Thismutation strongly
reduced the interaction with the CCR4–NOT complex in
the SBP pull-down assay (NOT4-C 4x mut) (Fig. 6E),
whereas individual point mutations were not as effective
(Supplemental Fig. S7A). Also in the tethering assay, the
quadruple point mutation (NOT4 4x mut) impaired the
ability of NOT4 to degrade the β-globin-6xMS2bs reporter
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mRNA to a degree that is comparable with the deletion of
the entireCBM (Fig. 6, F,G vs. B,C). All of the tethered pro-
teins were equally expressed (Fig. 6H). These findings
demonstrate the importance of the CBM for the function
of NOT4 and indicate that this is a major site of interac-
tion with the CCR4–NOT complex.
CAF40 plays a crucial and conserved role
for the recruitment of NOT4 to the CCR4–NOT
complex in metazoans
The present crystal structures show how the CBM inter-
acts with CAF40, but our previous experiments did not
formally exclude that the CBM makes similarly impor-
tant contacts with other subunits of the CCR4–NOT
complex. Therefore, we took advantage of HEK293T cells
in which CAF40 had been knocked out by CRISPR–Cas9
genome editing (CAF40 knockout cells) (Fig. 7A–D; Sup-
plemental Fig. S7B–D; Sgromo et al. 2018). In this cell
line, the levels of endogenous NOT1, NOT2, and NOT3
proteins were not altered (Fig. 7B), but the NOT4-mediat-
ed decay of the tethered R-Luc-6xMS2bs mRNA reporter
(Fig. 7A,D) or of the tethered β-globin-6xMS2bsmRNA re-
porter (Supplemental Fig. S7B,C) was impaired. This ob-
servation underlines the importance of CAF40 for the
efficient recruitment of the CCR4–NOT complex.
To test whether the remaining mRNA repression in
CAF40 knockout cells (Fig. 7A; Supplemental Fig. S7B,C)
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was due to the CCR4–NOT complex, we additionally
disrupted and depleted the remainder of the complex
by a shRNA-mediated knockdown of NOT1 (Fig. 7C;
Supplemental Fig. S7D; Boland et al. 2013). Under these
conditions, tethering ofNOT4 left reportermRNAexpres-
sion almost unaffected (CAF40 knockout +NOT1 knock-
down) (Fig. 7A; Supplemental Fig. S7B,C). Consequently,
the remaining subunits of the complex in CAF40 knock-
out cells still interact with tethered NOT4, which seems
to act exclusively via the CCR4–NOT complex.
Finally, there was only a small difference between teth-
ering the quadruple point mutation of NOT4 (NOT4 4x
mut) and tethering wild-type NOT4 in CAF40 knockout
cells, whereas this difference was considerable in wild-
type cells (Fig. 7D). This result confirms CAF40 as the pri-
mary interaction partner of the NOT4 CBM in human
cells.
The conservation of the CBM suggests that the interac-
tion of NOT4 with CAF40 is preserved in metazoans, al-
beit modulated by additional contacts, such as with the
NOT1-SHD (Fig. 3C). Likely due to such taxon-specific
or species-specific modulation, it was therefore possible
in Dm S2 cells to obtain a dominant-negative effect on
CCR4–NOT recruitment by overexpressing a V186E mu-
tant of GFP-tagged Dm CAF40 (Fig. 7E–G). This mutant
(corresponding toHsCAF40V181E)was also shown previ-
ously to impair CCR4–NOT recruitment by the CBM of
Bam (Sgromo et al. 2018). Apparently, in this case, the
overexpression of GFP-tagged CAF40 can functionally re-
place the endogenous protein, and a single pointmutation
is then sufficient to disrupt the interaction with NOT4.
Again, these observations demonstrate the central and
conserved role of the CBM for the recruitment of NOT4
to the CCR4–NOT complex.
Discussion
The present work demonstrates that metazoan NOT4
contains a conserved CBM in its variable C-terminal tail
and elucidates the molecular details of the CBM–CAF40
complex. The CBM is required in cells for an efficient re-
cruitment of NOT4 to the CCR4–NOT complex or a re-
cruitment of the complex to NOT4-mediated cellular
processes. The interaction of the CBM is assisted by aux-
iliary flanking sequences in NOT4-C that vary between
metazoan species. These sequences also contact other
subunits of the CCR4–NOT complex, such as the SHD
of NOT1. From an evolutionary point of view, the CBM
therefore appears to represent the ancestral mode of cou-
pling the NOT4-dependent E3 ubiquitin ligase activity
with the CCR4- and CAF1-dependent deadenylation ac-
tivity of the CCR4–NOT complex. In yeast, however,
the CBM seems to have become dispensable, possibly
because the contacts with NOT1 are sufficient to main-
tain the interaction (Bhaskar et al. 2015). The conserva-
tion of the CBM marks NOT4 as a ubiquitous but
apparently facultative cofactor of the metazoan CCR4–
NOT complex that likely has important functions in a
subset of CCR4–NOT-dependent cellular processes.
Facultative and regulated interaction of the CCR4–NOT
complex with metazoan NOT4
In S. cerevisiae and S. pombe, NOT4 copurifies with the
CCR4–NOT complex (Chen et al. 2001; Stowell et al.
2016), suggesting that it is an integral component of
the complex. In metazoan species, however, NOT4 is ap-
parently not generally available to interact with the
CCR4–NOT complex in a constitutive manner. This is
indicated by the fact that endogenous Hs NOT4 or Dm
NOT4 do not copurify with the core of the complex
(Lau et al. 2009; Temme et al. 2010) and by our observa-
tion that full-length Hs NOT4 does not pull down the
CCR4–NOT complex from HEK293T cell extracts, in
contrast to Hs NOT4-C. However, full-length Hs
NOT4 that was expressed in bacteria does interact with
a reconstituted subassembly of the human CCR4–NOT
complex.
We therefore speculate that metazoan NOT4-N some-
how prevents NOT4-C from interacting with the CCR4–
NOT complex, with possible assistance from posttransla-
tional modifications or additional binding partners. For
example, it is conceivable that a structural reorganization
ofNOT4 is required in eukaryotic cells to release theCBM
for an interaction with CCR4–NOT and/or that the nega-
tively chargedCBM (pI = 4.0 inHsNOT4) gets sequestered
by the highly positively charged coiled-coil linker and
RRM domains of NOT4-N (pI = 10.2 in Hs NOT4) when
NOT4 is not bound to an mRNA. In this way, it would
be possible to regulate the availability of the NOT4 ubiq-
uitin ligase activity to only a subset of the CCR4–NOT-
mediated cellular processes, but whether such regulation
indeed exists and how it might be achieved in detail re-
mains to be investigated.
Mutual corecruitment of NOT4 and the CCR4–NOT
complex
The widespread conservation of the CBM in NOT4
proteins reveals NOT4 as an ancient cofactor of the
CCR4–NOT complex. Furthermore, we show that NOT4
is able to cause CCR4–NOT-mediated mRNA decay if
tethered to anmRNA target. However, it remains unclear
from these experimentswhethermetazoanNOT4 is need-
edprimarily as anupstream recruitment factor that directs
the CCR4–NOT complex to selective mRNA targets or
rather as a downstream effector that recruits additional
proteins to the CCR4–NOTcomplex and/or ubiquitinates
nearby protein targets; e.g., to mark them for proteasomal
degradation. In contrast to selective mRNA-binding pro-
teins such as TTP, Nanos, or Roquin (Newman et al.
2016), there are currently no known RNA targets for the
coiled-coil linker, RRM, or ZNF domains of NOT4; i.e.,
for its putativeRNA-binding domains. This argues against
an RNA-specific recruitment function.
In the context of cotranslationalmRNAquality control,
however, NOT4 could act as both an upstream recruit-
ment factor of the CCR4–NOT complex to mRNAs with
stalled ribosomes and a downstream effector for the ubiq-
uitination and degradation of protein targets (Panasenko
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2014). Additional protein-binding partners may modulate
or stabilize the interactions in this case.
Finally, it is worthwhile to follow up also on the PPPGΦ
motifs that we found to be highly conserved in the NOT4
proteins from metazoans, plants, and yeasts. PPPGΦmo-
tifs tend to interact with GYF domain proteins (Kofler and
Freund 2006), such as the GIGYF1/2 translational repres-
sors (Kryszke et al. 2016; Peter et al. 2017; AmayaRamirez
et al. 2018) that were described to bind CAF40 in human
cancer cells (Ajiro et al. 2009). Quite likely, therefore,
the CCR4–NOT complex and NOT4 frequently support
each other in a mutual corecruitment that is difficult to
disentangle experimentally.
Competition of mRNA-associated proteins for the CBM-
binding site of CAF40
In most of the known cases where CCR4–NOT gets re-
cruited to an mRNA target, the CBM-binding surface on
CAF40 appears to remain available for a simultaneous re-
cruitment of NOT4. This is, for example, the case for the
TNRC6/GW182-mediated microRNA-dependent mRNA
regulation, where tryptophans of TNRC6/GW182 bind
to the convex side of CAF40 (Chen et al. 2014; Mathys
et al. 2014). Similarly, mRNA-specific CCR4–NOT re-
cruitment proteins such as TTP or Nanos apparently do
not structurally interfere with NOT4 binding to the con-
cave surface of CAF40 (Fabian et al. 2013; Bhandari et al.
2014; Bulbrook et al. 2018), allowing for a combinatorial
mRNA regulation.
In contrast, the CBMs of Roquin and Bam were shown
to target the exact same binding surface on CAF40 as
the CBM of NOT4 (Sgromo et al. 2017, 2018), making
their binding mutually exclusive. It is therefore possible
that Roquin proteins have evolved to displace NOT4
in a context-specific manner, since they bring along
their own E3 ubiquitin ligase domain. Conversely, in the
case of Bam, the CBM might serve to prevent NOT4-me-
diated and ubiquitination-dependent processes down-
stream from CCR4–NOT recruitment in the germline of
D. melanogaster. Future work will show whether such
competition indeed occurs in vivo and whether there are
additional CBM-containing mRNA-binding proteins in
fungi, plants, or metazoans that operate in a similar
manner.
Clearly, however, the present identification of a con-
served CBM in the NOT4 protein underlines the role of
CAF40 as a hub for peptide-mediated interactions and
adds to the ever more complex regulation of mRNA ex-
pression in eukaryotic cells.
Materials and methods
DNA plasmid constructs
For bacterial expression of recombinant Hs NOT4 constructs in
E. coli, cDNA sequences were inserted between the XhoI and
NheI restriction sites of the pnEA-pMplasmid, resulting in fusion
proteins carrying N-terminal MBP tags cleavable by the human
rhinovirus 3C (HRV3C) protease and, in addition, C-terminal
GB1 and hexahistidine tags. For bacterial expression of recombi-
nant Dm NOT4 constructs, cDNA sequences were inserted be-
tween the XhoI and BamHI restriction sites of the pnYC-vM
plasmid, resulting in tobacco etch virus (TEV) protease-cleavable
MBP fusion proteins. For the expression of Hs NOT4 constructs
in human (HEK293T) cells, cDNA sequences were inserted into
the pCIneo-V5-SBP-MBP plasmid or the pcDNA3.1-MS2-HA
plasmid using the XhoI and NotI restriction sites. For the expres-
sion of Dm NOT4 constructs in Dm S2 cells, cDNA sequences
were inserted into the pAc5.1B-λN-HA plasmid using the NotI
and BstBI restriction sites. All of the plasmid constructs generated
in this study, including backbone references, are listed in Supple-
mental Table S1.
MBP pull-down assays with bacterially expressed proteins
For initial pull-down assays with full-length Hs NOT4 and its
fragments, the proteins were expressed in E. coli BL21 (DE3)
Star cells (Invitrogen) overnight in LB medium at 20°C. Cells
were homogenized in lysis buffer (50 mM Na/HEPES at pH 7.5,
300 mM NaCl, 5 µg/mL DNaseI, 1 mg/mL lysozyme, Roche
“Complete” EDTA-free protease inhibitors) supplemented with
20 mM imidazole and 2 mM β-mercaptoethanol. The proteins
were immobilized and isolated from the lysate on Ni-NTA resin
(Qiagen) followed by elution in lysis buffer supplemented with
500mM imidazole. They were then immobilized on 50 µL of am-
ylose resin and incubated with an excess of purified CCR4–NOT
proteins for 1 h in 500 µL of binding buffer (50 mMNa/HEPES at
pH 7.5, 300 mM NaCl, 2 mM β-mercaptoethanol). Finally, the
amylose beads were washed five times with binding buffer, and
the proteins were eluted in 50 µL of binding buffer supplemented
with 25 mM D(+)-maltose.
For pull-down assays withHs andDmNOT4 CBM constructs,
proteins were purified from cells homogenized in lysis buffer sup-
plemented with 2 mMDTT. Proteins were immobilized and iso-
lated from the lysate on an amylose resin (New England Biolabs)
followed by anion exchange chromatography over aHiTrapQ col-
umn (GE Healthcare) and size exclusion chromatography over a
Superdex 200 26/600 column (GEHealthcare) in a buffer contain-
ing 10 mM Na/HEPES (pH 7.5), 200 mM NaCl, and 2 mM DTT.
Forty micrograms of purified MBP-tagged NOT4 fragments or 20
µg of MBP were then incubated with approximately equimolar
amounts of the respective purified CCR4–NOT proteins and 50
µL of amylose resin in 500µL of binding buffer (50mMNa/HEPES
at pH 7.5, 200 mM NaCl, 2 mM DTT). After the incubation and
washing steps, the proteinswere eluted in 200µLof binding buffer
supplemented with 25 mM D(+)-maltose and precipitated with
trichloroacetic acid.
The purifications of other human CCR4–NOT proteins, in-
cluding Hs CAF40 for crystallization, were described previously
(Petit et al. 2012; Boland et al. 2013; Bhandari et al. 2014; Chen
et al. 2014; Raisch et al. 2016; Sgromo et al. 2017, 2018). The pro-
tein samples were resolved and analyzed by SDS-PAGE.
Crystallization
Hs CAF40 (GPHMLE-R19–E285) (Chen et al. 2014) was mixed
with a twofold molar excess of the Dm NOT4 CBM peptide
(D813–Q838, chemically synthesized and purchased from EMC
Microcollections) in 10 mM Na/HEPES (pH 7.5), 200 mM
NaCl, and 2 mM DTT. Initial screens were carried out in sitting
drops at 22°C by mixing 200 nL of sample solution (6 mg/mL
CAF40, 1.2 mg/mL NOT4) with 200 nL of reservoir solution.
Crystals appearedwithin 1 d inmany conditions. Crystals of crys-
tal form 1 appeared in the initial screen over a reservoir
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containing 0.2 M ammonium sulfate, 0.1 M Bis-Tris/Cl (pH 5.5),
and 25% (w/v) PEG 3350. The crystals were cryoprotected in res-
ervoir solution supplementedwith 25% glycerol and flash-cooled
in liquid nitrogen.Optimized crystals of crystal form2 grewat 18°
C in hanging dropsmixing 1 µL of sample solution and 1 µL of res-
ervoir solution containing 0.9 M K2HPO4 and 0.3 M NaH2PO4.
Crystals were cryoprotected in 4.0 M sodium formate and flash-
cooled in liquid nitrogen.
Data collection and structure determination
X-ray diffraction data were collected at a wavelength of 1.0000 Å
on a Pilatus 6M detector (Dectris) at the PXII beamline of the
Swiss Light Source (Villigen) and processed using XDS and
XSCALE (Kabsch 2010). Crystal form 1 (space group P21212) dif-
fracted X-rays to a resolution of 2.1 Å, whereas crystal form 2
(space group I212121) diffracted X-rays to a comparable resolution
of 2.2Åbutwith an increasedBWilson (56.7Å
2 vs. 39.2Å2). For each
crystal form, we identified two copies ofHsCAF40 per asymmet-
ric unit by molecular replacement using PHASER (McCoy et al.
2007) from the CCP4 package (Winn et al. 2011) and using chain
A of Protein Data Bank (PDB) ID 2fv2 (Garces et al. 2007) as a
search model. Initial models were improved and completed by it-
erative cycles ofmodel building in COOT (Emsley et al. 2010) and
refinement using PHENIX (Afonine et al. 2012). The NOT4 CBM
peptides were then built manually into the remaining electron
density and improved by additional building and refinement cy-
cles. For crystal form 1, final refinement rounds were done using
PHENIXwith one TLS group per polypeptide chain and including
small molecule ligands (one molecule each of Tris and glycerol
plus four sulfate ions) in addition to 177watermolecules. This re-
sulted in an Rwork of 19.0% and anRfree of 21.8%. For crystal form
2, final refinement rounds were done using BUSTER (https://
www.globalphasing.com/buster), also with one TLS group per
polypeptide chain but in addition to small molecule ligands (one
sodiumand two chloride ions) and 64watermolecules, also autor-
efining NCS restraints. This resulted in an Rwork of 19.3% and an
Rfree of 23.0% (Table 1). Illustrations were prepared in PyMOL
(http://www.pymol.org).
SBP pull-down assays from HEK293T cells
HEK293T cellswere seeded in 10-cmdishes (4 × 106 cells per plate
and experiment) and transfected with pCIneo-V5-SBP-MBP plas-
mids after 1 d using Turbofect (Thermo Scientific) according to
the manufacturer’s protocol. Two days after transfection, the
cells were lysed on ice in 1 mL of NET lysis buffer (50 mM
Tris/Cl at pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 1 mM
EDTA, 10% glycerol) supplemented with protease inhibitors
(Roche). After 15 min, lysates were centrifuged at 20,000g for
15 min at 4°C. The cleared lysate was then treated with
200 µg/mL RNase A (Qiagen) for 30 min at 4°C and centrifuged
again as before, resulting in the input fraction for the experiment
(1 mL=100%). The input fraction was then incubated for 1 h at
4°C with 50 µL of streptavidin sepharose resin (GE Healthcare).
The beads were washed three times with NET buffer and finally
resuspended in protein sample buffer, resulting in the pull-
down fraction (100 µL=100%). The samples were analyzed by
Western blot (for antibodies, see Supplemental Table S2) using
the ECL Western blotting detection system (GE Healthcare).
Tethering assays in HEK293T cells
ForMS2-dependent tethering assays with the β-globin mRNA re-
porter (Lykke-Andersen et al. 2000), HEK293T cells were seeded
in six-well plates (0.7 × 106 cells per well) and transfected on the
following day using Lipofectamine 2000 (Invitrogen). The trans-
fectionmixtures contained 0.5 μg of the β-globin reporter plasmid
encoding six MS2-binding sites (β-globin-6xMS2bs); 0.5 μg of the
β-globin reference and transfection control plasmid lacking
MS2-binding sites and containing a partial sequence of GAPDH
(control; β-globin-GAPDH) (Lykke-Andersen et al. 2000); and var-
iable amounts (0.05–0.75 μg) of pcDNA3.1-MS2-HA plasmids
(Supplemental Table S1) to achieve equivalent expression of
MS2-HA fusion proteins. The cells were harvested 2 d after trans-
fection. The total RNAwas isolated using the peqGOLD TriFast
reagent (Peqlab) and analyzed byNorthern blot as described previ-
ously (Behm-Ansmant et al. 2006). Equivalent expression ofMS2-
HA-tagged proteins was tested in parallel by Western blot, ex-
pressing F-Luc-GFP (Kuzuog˘lu-Öztürk et al. 2016) as a transfec-
tion control.
For the experiment shown in Supplemental Figure S3, A–C,
cells were additionally cotransfected with 0.5 µg of a plasmid ex-
pressing either wild-type Hs DCP2 (GFP-DCP2 wild-type) or the
Hs DCP2 mutant (GFP-DCP2 mut; E148Q) (Loh et al. 2013).
Equivalent expression of the GFP-tagged proteins was tested in
parallel by Western blot, expressing V5-SBP-MBP as a transfec-
tion control.
ForMS2-dependent tethering assays with the luciferase report-
er system (Kuzuog˘lu-Öztürk et al. 2016), the transfection mix-
tures contained 0.2 µg of reporter plasmid containing or lacking
six MS2-binding sites (R-Luc-6xMS2bs or R-Luc), 0.2 µg of refer-
ence and transfection control plasmid lacking six MS2-binding
sites (F-Luc-GFP), and variable amounts of pcDNA3.1-MS2-HA
plasmids (0.1–1.5 μg) (Supplemental Table S1). The cells were har-
vested 2 d after transfection, mRNA levels were determined by
Northern blot, and R-Luc and F-Luc activities were measured us-
ing a “dual-luciferase reporter assay” system (Promega).
Tethering assays in HEK293T cells with knockdown of NOT1
The shRNA-mediated depletion of NOT1 has been described pre-
viously (Boland et al. 2013) using shRNA (HsNOT1 target: ATT
CAACATTCCCTTATA) and control shRNA (scr, control target:
ATTCTCCGAACGTGTCACG). For tethering assays in cells de-
pleted of NOT1, wild-type HEK293T cells or HEK293T CAF40
knockout cells (Sgromo et al. 2018) were transfected twice. For
the first transfection, cells were seeded in six-well plates (0.7 ×
106 cells per well) and transfected on the following day with mix-
tures containing 4 μg of plasmid expressing the respective
shRNA. After 1 d, cells were selected for 24 h in DMEM supple-
mented with 1.5 µg/mL puromycin and subsequently seeded in
six-well plates in medium without puromycin (0.7 × 106 cells
per well). The following day, cells were transfected again with
mixtures containing 2 µg of the respective shRNA plasmids but
also containing the reporter and reference/transfection control
plasmids (0.2 μg of R-Luc-6xMS2bs and 0.2 μg of F-Luc-GFP)
and 0.125–0.25 μg of pcDNA3.1-MS2-HA plasmids (Supplemen-
tal Table S1). After 1 d, cells were selected for 48 h inDMEM (sup-
plemented with 1.5 µg/mL puromycin) and analyzed as before.
Tethering assays in Dm S2 cells
For the λN-dependent tethering assay (Behm-Ansmant et al.
2006) with the luciferase reporter system in Dm S2 cells, cells
were seeded in six-well plates (2.5 × 106 cells per well) and trans-
fected just thereafter using Effectene (Qiagen). The transfection
mixtures contained 0.1 μg of the F-Luc-5BoxB reporter plasmid,
0.4 μg of an R-Luc reference and transfection control plasmid en-
coding a deadenylation-resistant mRNA lacking BoxB sequences
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(R-Luc; R-Luc-A90-HhR) (Raisch et al. 2016), and variable
amounts (0.01–0.08 μg) of pAC5.1B-λN-HAplasmids (Supplemen-
tal Table S1) to achieve equivalent expression of λN-HA-fusion
proteins. The cells were harvested 3 d after transfection and ana-
lyzed as described.
For the experiments in Supplemental Figure S3, D–F, Dm S2
cells were additionally cotransfected with 1 µg of a plasmid ex-
pressing either wild-type Dm DCP1 (GFP-DCP1 wild-type) or
the Dm DCP1 mutant (GFP-DCP1 mut; R70G, L71S, N72S,
and T73G) (Kuzuog˘lu-Öztürk et al. 2016), and, for the experi-
ments in Figure 7, E–G, cells were cotransfected with 1.5 µg of
a plasmid expressing either wild-type Dm CAF40 (GFP-CAF40
wild-type) or the Dm CAF40 mutant (GFP-CAF40 V186E)
(Sgromo et al. 2018).
Accession numbers
Atomic coordinates and structure factors for the reported crystal
structures have been deposited with the PDB under accession
number 6hom for space group P21212 and 6hon for space group
I212121.
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Supplemental Figure S1. The presence of the positively charged CC linker and RRM 
domain prevents NOT4-C from interacting with the CCR4-NOT complex 
 
(A) SBP pulldown of endogenous human NOT1 from HEK293T cell lysates with V5-SBP-MBP-tagged deletion 
variants of Hs NOT4. V5-SBP-GFP-MBP served as negative control. Input samples correspond to 3 % of the total 
lysate for V5-tagged proteins and to 2 % for NOT1. Pulldown samples correspond to 7 % of the total pulldown 
for V5-tagged proteins and to 35 % for NOT1. For abbreviations and construct details see Figure 1B and 
Supplemental Table S1. 
 
(B) SBP pulldown of endogenous human NOT1 from HEK293T cell lysates with V5-SBP-MBP-tagged fragments 
of Hs NOT4-N fused to Hs NOT4-C. CC-C: Putative coiled coil region fused to NOT4-C; RRM-C: RRM domain 
fused to NOT4-C; ZNF-C: zinc-finger domain fused to NOT4-C. 
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Supplemental Figure S2. Metazoan NOT4 induces degradation of tethered mRNA 
reporters 
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Supplemental Figure S2. Metazoan NOT4 induces degradation of tethered mRNA 
reporters 
 
(A, B) Tethering assay with Hs NOT4 and a luciferase reporter in HEK293T cells. Hs NOT4 or its fragments 
carried an N-terminal MS2-HA tag. Renilla luciferase mRNA served as a reporter and contained six binding sites 
for the MS2 protein (R-Luc-6xMS2bs). Firefly luciferase mRNA served as a reference and transfection control 
(F-Luc). (A) R-Luc activity (white bars) and mRNA levels (black bars) normalized to the reference and plotted 
with respect to the values obtained from the expression of MS2-HA alone (set to 100). Error bars correspond to 
standard deviations (n=3). (B) Representative Northern blot. 
 
(C, D) Control experiment for the tethering assay in panels (A, B). Renilla luciferase mRNA without binding sites 
for the MS2 protein (R-Luc) served as a tethering control. (C) Relative protein and mRNA levels analyzed as 
described in (A). (D) Northern blot.  
 
(E, F) Control experiment for the tethering assay in Figure 2D, E with Dm NOT4 and a luciferase reporter in Dm 
S2 cells. Firefly luciferase mRNA without BoxB binding sites (F-Luc-V5) served as a tethering control. (E) 
Relative protein and mRNA levels analyzed as described in Figure 2D. (F) Northern blot. 
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Supplemental Figure S3. Tethered NOT4 causes reporter mRNA degradation via the 5’-
to-3’ decay pathway 
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Supplemental Figure S3. Tethered NOT4 causes reporter mRNA degradation via the 5’-
to-3’ decay pathway 
 
(A–C) Tethering assay with Hs NOT4 and the β-globin mRNA reporter in HEK293T cells overexpressing a DCP2 
catalytically inactive mutant. Experiments were done and analyzed as described in Figure 2A, but cells were 
additionally overexpressing either wildtype Hs DCP2 (GFP-DCP2 WT) or the Hs DCP2 mutant (GFP-DCP2 mut; 
E148Q). MS2-HA-tagged Hs Nanos2 was overexpressed as a positive control for a protein eliciting 5’-to-3’ 
mRNA decay (Bhandari et al. 2014). (A) Relative mRNA levels with error bars corresponding to standard 
deviations (n=3). (B) Northern blot demonstrating the accumulation of deadenylated mRNA degradation 
intermediates (A0) as compared to polyadenylated mRNA (An). (C) Western blot demonstrating equivalent 
expression of GFP-tagged DCP2 proteins with V5-SBP-MBP as a transfection control. 
 
(D–F) Tethering assay with Dm NOT4 in Dm S2 cells overexpressing a DCP1 mutant. Experiments were done 
and analyzed as described in Figure 2D, but cells were additionally overexpressing either wildtype Dm DCP1 
(GFP-DCP1 WT) or the Dm DCP1 mutant (GFP-DCP1 mut; R70G, L71S, N72S, T73G). λN-HA-tagged GW182 
was overexpressed as a positive control for a protein eliciting 5’-to-3’ mRNA decay (Kuzuoğlu-Öztürk et al. 2016). 
(D) Relative mRNA levels with error bars corresponding to standard deviations (n=3). (E) Northern blot 
demonstrating the accumulation of deadenylated mRNA degradation intermediates (A0) as compared to 
polyadenylated mRNA (An). (F) Western blot demonstrating equivalent expression of GFP-tagged DCP1 proteins 
and λN-HA-tagged proteins (NOT4 and GW182), with F-Luc-V5 as a transfection control. 
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Supplemental Figure S4. Sequence alignment of metazoan NOT4 
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Supplemental Figure S4, continued. Sequence alignment of metazoan NOT4 
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Supplemental Figure S4, continued. Sequence alignment of metazoan NOT4 
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Supplemental Figure S4, continued. Sequence alignment of metazoan NOT4 
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Supplemental Figure S4. Sequence alignment of metazoan NOT4 
 
Sequences cover the following phyla. Chordata: Hs, Homo sapiens; Gg, Gallus gallus; Ac, Anolis carolinensis; 
Xl, Xenopus laevis; Dr, Danio rerio. Echinodermata: Ap, Acanthaster planci. Hemichordata: Sk, Saccoglossus 
kowalevskii. Arthropoda: Dm, Drosophila melanogaster; Lp, Limulus polyphemus; Dam, Daphnia magna. 
Nematoda: Ce, Caenorhabditis elegans. Mollusca: Ob, Octopus bimaculoides; Bg, Biomphalaria glabrata; My, 
Mizuhopecten yessoensis. Annelida: Hr, Helobdella robusta. Uniprot or NCBI accession numbers are provided in 
the Supplemental alignment file SF1. Sequences were aligned using MAFFT (Katoh et al. 2002) as implemented 
in the MPI Bioinformatics Toolkit (Zimmermann et al. 2018). Structural domains in the conserved N-terminal 
region of NOT4 are marked below the alignment. Similarly, the presently identified CBM and PPPGF motifs are 
marked in the non-conserved C-terminal region of NOT4 and respectively shaded in blue and gray. Conserved 
residues are shaded in red, and residues with >70% similarity are shaded in yellow, with conservation scores 
calculated using the SCORECONS webserver (Valdar 2002). Secondary structure elements are indicated above 
the alignment and taken from the previously reported NMR structures of the RING and RRM domains (PDB-ID 
1ur6, Dominguez et al. 2004, and PDB-ID 2cpi), from our presently determined crystal structure of the CBM, or 
from PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) secondary structure prediction. 
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Supplemental Figure S5. Identification and analysis of the NOT4 CBM 
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Supplemental Figure S5. Identification and analysis of the NOT4 CBM 
 
(A) Domain composition of selected NOT4 proteins from Homo sapiens, Drosophila melanogaster, Arabidopsis 
thaliana and Saccharomyces cerevisiae, indicating the relative positions of conserved sequence motifs in NOT4-
C. The sequences corresponding to the 23 amino acid motif are labelled ‘CBM’ or ‘CBM-like’ in Arabidopsis 
thaliana, and the sequences corresponding to the PPPGF motifs are listed as PPPGL, PPPGF or PPPGI. For 
alignments see Supplemental alignment files SF1–SF3. 
 
(B) Sequence logo (Waterhouse et al. 2009) of the NOT4 C2 region as derived from the alignment in Supplemental 
Figure S4. The consensus sequence is indicated below the logo, along with residue numbers corresponding to the 
human sequence. The separately deleted C2a and C2b regions are indicated as well as the 23 amino acid motif 
which is labelled as ‘CBM’. 
 
(C) MBP pulldown assay with MBP-tagged deletion variants of Hs NOT4-C and purified recombinant NOT 
module or CAF40. Experiments were done as described in Figure 3A–D, identifying the 23 amino acid motif as a 
CAF40 binding motif (CBM). NOT4-C DC2 lacks residues E377–S424. NOT4-C DC2a lacks residues E377–
D402. NOT4-DC2b lacks residues E400–Q428 including the CBM (E400–E422). 
 
(D) Composite omit maps for the NOT4 CBM peptide. 2FO-FC type electron density surrounding the CBM peptide 
is contoured at 1.0 s. The maps were generated with phenix.composite_omit_map (Afonine et al. 2012) using the 
final refined models, respectively. Top panel: space group P21212. Bottom panel: space group I212121. 
 
(E) Superposition of the four crystallographically independent complexes of CAF40 with the NOT4 CBM. The 
structurally variable and non-conserved flanks of the CBM are shown in magenta. The C-terminal flanks of the 
Dm NOT4 CBM (V836–Q838) mediate crystal contacts and differ from the Hs NOT4 CBM (L423–V425), 
possibly explaining why the Hs NOT4 CBM did not crystallize. 
 
(F) Competition assay. Hs CAF40 was incubated with equimolar amounts of MBP-tagged Dm NOT4 CBM and 
increasing amounts of His6-NusA-tagged Dm NOT4 CBM (HN-NOT4 CBM) or His6-NusA-tagged Dm Bam 
CBM (HN-Bam CBM). His6-NusA (HN) was used as a negative control. The amount of Hs CAF40 pulled down 
with the MBP-tagged Dm NOT4 CBM was analyzed by SDS-PAGE and subsequent Coomassie staining. Molar 
equivalents (1x, 2x, 5x) are relative to the MBP-tagged Dm NOT4 CBM. MBP-tagged constructs are labelled in 
gray. See Sgromo et al. (2018) for additional experimental details. 
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Supplemental Figure S6. Difference electron density for the CBM peptide 
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Supplemental Figure S6. Difference electron density for the CBM peptide 
 
Classic FO-FC type difference electron density for the CBM peptide was calculated using the final refined models, 
respectively, but with the CBM peptide, ligands and water molecules omitted. The maps are contoured at 2.5 s. 
The difference density is rather poor for the N-terminal and C-terminal residues of the modeled peptide and for 
the solvent-exposed side chains of K826, E830, E833 and N834. These residues were nevertheless modeled 
without truncating their side chains. The structurally conserved part of the CBM peptide as shown in Figure 4 
ranges from L816 to E835. Top panel: space group P21212. Bottom panel: space group I212121. 
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Supplemental Figure S7. Importance of the NOT4 CBM and of the CCR4-NOT 
deadenylase for the degradation of tethered mRNA 
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Supplemental Figure S7. Importance of the NOT4 CBM and of the CCR4-NOT 
deadenylase for the degradation of tethered mRNA 
 
(A) SBP pulldown of endogenous Hs NOT1 and Hs CAF40 proteins with V5-SBP-MBP-tagged CBM mutation 
variants of Hs NOT4-C. The CBM contained single or multiple point mutations. 4x mut; F405D, F408A, T411E, 
L415E. For additional details see Figure 6E. 
 
(B–D) Tethering assay with Hs NOT4 and the β-globin mRNA reporter in HEK293T cells lacking CAF40 (CAF40 
KO) (Sgromo et al. 2018). Efficiency of CRISPR-Cas9-mediated gene editing of CAF40 is shown in Figure 7B. 
Experiments were done and analyzed as described in Figure 2A. (B) Relative mRNA levels with error bars 
corresponding to standard deviations (n=3). The shRNA-mediated depletion of the CCR4-NOT complex is 
indicated by white bars (sh-NOT1 RNA, NOT1 KD) as compared to black bars (sh-scr RNA, control). WT: 
wildtype, KO: knockout, KD: knockdown. (C) Northern blot. (D) Efficiency of shRNA-mediated depletion of 
NOT1. The Western blot shows HEK293T cells expressing sh-NOT1 RNA in comparison to a dilution series of 
HEK293T cells expressing sh-scr RNA using PABP as a loading control. 
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Supplemental Table S1. Generated plasmid constructs 
 
Plasmids expressing Hs NOT4 protein and Hs NOT4 fragments (Uniprot-ID O95628-1) 
 
Name Construct details Plasmid backbone * 
Hs NOT4 MS2-HA-Hs NOT4 pcDNA3.1-MS2-HA 
V5-SBP-MBP-Hs NOT4 pCIneo-V5-SBP-MBP 
MBP-Hs NOT4-GB1-6xHis pnEA-pM, GB1 
Hs NOT4-N MS2-HA-Hs NOT4_1–274 pcDNA3.1-MS2-HA 
V5-SBP-MBP-Hs NOT4_1–274 pCIneo-V5-SBP-MBP 
MBP-Hs NOT4_1–274-GB1-6xHis pnEA-pM, GB1 
Hs NOT4-C MS2-HA-Hs NOT4_275–575 pcDNA3.1-MS2-HA 
V5-SBP-MBP-Hs NOT4_275–575 pCIneo-V5-SBP-MBP 
MBP-Hs NOT4_275–575-GB1-6xHis pnEA-pM, GB1 
Hs NOT4 ΔRING V5-SBP-MBP-Hs NOT4 (Δ1–63) pCIneo-V5-SBP-MBP 
Hs NOT4 ΔCC V5-SBP-MBP-Hs NOT4 (Δ64–104) pCIneo-V5-SBP-MBP 
Hs NOT4 ΔRRM V5-SBP-MBP-Hs NOT4 (Δ109–189) pCIneo-V5-SBP-MBP 
Hs NOT4 ΔCC-RRM V5-SBP-MBP-Hs NOT4 (Δ64–189) pCIneo-V5-SBP-MBP 
Hs NOT4 ΔZNF V5-SBP-MBP-Hs NOT4 (Δ190–274) pCIneo-V5-SBP-MBP 
Hs NOT4-CC-C V5-SBP-MBP-Hs NOT4_64–104_GSSG_275–
575 
pCIneo-V5-SBP-MBP 
Hs NOT4-RRM-C V5-SBP-MBP-Hs NOT4_109–189_GSSG_275–
575 
pCIneo-V5-SBP-MBP 
Hs NOT4-ZNF-C V5-SBP-MBP-Hs NOT4_190–575 pCIneo-V5-SBP-MBP 
Hs NOT4-C1 MS2-HA-Hs NOT4_275–376 pcDNA3.1-MS2-HA 
MBP-Hs NOT4_275–376-GB1-6xHis pnEA-pM, GB1 
Hs NOT4-C2 MS2-HA-Hs NOT4_377–428 pcDNA3.1-MS2-HA 
MBP-Hs NOT4_377–428-GB1-6xHis pnEA-pM, GB1 
Hs NOT4-C3 MS2-HA-Hs NOT4_429–575 pcDNA3.1-MS2-HA 
MBP-Hs NOT4_429–575-GB1-6xHis pnEA-pM, GB1 
Hs NOT4 ΔC2 MS2-HA-Hs NOT4 (Δ377–424) pcDNA3.1-MS2-HA 
Hs NOT4-C ΔC2 V5-SBP-MBP-Hs NOT4_275–575 (Δ377–424) pCIneo-V5-SBP-MBP 
MBP-Hs NOT4_275–575-GB1-6xHis (Δ377–
424) 
pnEA-pM, GB1 
Hs NOT4 ΔC2a MS2-HA-Hs NOT4 (Δ377–402) pcDNA3.1-MS2-HA 
Hs NOT4-C ΔC2a V5-SBP-MBP-Hs NOT4_275–575 (Δ377–402) pCIneo-V5-SBP-MBP 
MBP-Hs NOT4_275–575-GB1-6xHis (Δ377–
402) 
pnEA-pM, GB1 
Hs NOT4 ΔC2b MS2-HA-Hs NOT4 (Δ400–428) pcDNA3.1-MS2-HA 
Hs NOT4-C ΔC2b V5-SBP-MBP-Hs NOT4_275–575 (Δ400–428) pCIneo-V5-SBP-MBP 
MBP-Hs NOT4_275–575-GB1-6xHis (Δ400–
428) 
pnEA-pM, GB1 
Hs NOT4-CBM MBP-Hs NOT4_400–427 pnEA-pM 
* Plasmid backbones are described in Jonas et al. (2013) for pcDNA3.1-MS2-HA and pCIneo-V5-SBP-MBP, in 
Diebold et al. (2011) for pnEA-pM and in Cheng and Patel (2004) for GB1. 
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Supplemental Table S1, continued. Generated plasmid constructs 
 
Plasmids expressing Hs NOT4 point mutations (Uniprot-ID O95628-1) 
 
Name Construct details Plasmid backbone * 
Hs NOT4 4x mut MS2-HA-Hs NOT4 (F405D, F408A, T411E, 
L415E) 
pcDNA3.1-MS2-HA 
Hs NOT4-C 4x mut V5-SBP-MBP-Hs NOT4_275–575 (F405D, 
F408A, T411E, L415E) 
pCIneo-V5-SBP-MBP 
Hs NOT4-C 2x mut V5-SBP-MBP-Hs NOT4_275–575 (T411E, 
L415E) 
pCIneo-V5-SBP-MBP 
Hs NOT4-C F405D V5-SBP-MBP-Hs NOT4_275–575 (F405D) pCIneo-V5-SBP-MBP 
Hs NOT4-C F408A V5-SBP-MBP-Hs NOT4_275–575 (F408A) pCIneo-V5-SBP-MBP 
Hs NOT4-C T411E V5-SBP-MBP-Hs NOT4_275–575 (T411E) pCIneo-V5-SBP-MBP 
Hs NOT4-C L415E V5-SBP-MBP-Hs NOT4_275–575 (L415E) pCIneo-V5-SBP-MBP 
* Plasmid backbones are described in Jonas et al. (2013). 
 
 
Plasmids expressing Dm NOT4 proteins (Uniprot-ID M9PCL9) 
 
Name Construct details Plasmid backbone * 
Dm NOT4 λN-HA-Dm NOT4 pAc5.1B-λN-HA 
Dm NOT4-N λN-HA-Dm NOT4_1–249 pAc5.1B-λN-HA 
Dm NOT4-C λN-HA-Dm NOT4_248–1050 pAc5.1B-λN-HA 
Dm NOT4-CBM MBP-Dm NOT4_813–836 pnYC-vM 
His6-NusA-Dm NOT4_813–836 pnYC-vHN 
Dm NOT4-CBM F821D MBP-Dm NOT4_813–836 (F821D) pnYC-vM 
Dm NOT4-CBM L828E MBP-Dm NOT4_813–836 (L828E) pnYC-vM  
* Plasmid backbones are described in Rehwinkel et al. (2005) for pAc5.1B-λN-HA and in Diebold et al. (2011) 
for pnYC-vM. 
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Supplemental Table S2. Antibodies 
 
Antibody Source Catalog number Dilution Monoclonal/polyclonal 
Anti-NOT1 In house - 1:1000 Rabbit polyclonal 
Anti-NOT2 Bethyl A302-562A 1:2000 Rabbit polyclonal 
Anti-NOT3 Abcam ab55681 1:2000 Mouse monoclonal 
Anti-CAF40 Proteintech 22503-1-AP 1:1000 Rabbit polyclonal 
Anti-EDC4 Santa Cruz Biotech SC-8418 1:1000 Mouse monoclonal 
Anti-PABP Abcam ab21060 1:10000 Rabbit polyclonal 
Anti-tubulin Sigma T6199 1:5000 Mouse monoclonal 
Anti-V5 LSBio LS-C57305 1:5000 Mouse monoclonal 
Anti-GFP Roche 11 814 460 001 1:2000 Mouse monoclonal 
Anti-HA-HRP Roche 12 013 819 001 1:5000 Rat monoclonal 
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Supplemental alignment files 
Supplemental alignment files contain CLUSTAL-formatted text files with sub-alignments of 
NOT4 proteins and their Uniprot or NCBI accession codes. 
SF1: SF1_metazoan_NOT4_alg.rtf 
SF2: SF2_plant_NOT4_alg.rtf 
SF3: SF3_yeast_NOT4_alg.rtf 
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Drosophila Bag-of-marbles directly interacts with the
CAF40 subunit of the CCR4–NOT complex to elicit
repression of mRNA targets
ANNAMARIA SGROMO,1,3 TOBIAS RAISCH,1,3 CHARLOTTE BACKHAUS,1 CSILLA KESKENY,1 VIKRAM ALVA,2
OLIVER WEICHENRIEDER,1 and ELISA IZAURRALDE1
1Department of Biochemistry, Max Planck Institute for Developmental Biology, Tübingen, D-72076, Germany
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ABSTRACT
Drosophila melanogaster Bag-of-marbles (Bam) promotes germline stem cell (GSC) differentiation by repressing the expression of
mRNAs encoding stem cell maintenance factors. Bam interacts with Benign gonial cell neoplasm (Bgcn) and the CCR4
deadenylase, a catalytic subunit of the CCR4–NOT complex. Bam has been proposed to bind CCR4 and displace it from the
CCR4–NOT complex. Here, we investigated the interaction of Bam with the CCR4–NOT complex by using purified
recombinant proteins. Unexpectedly, we found that Bam does not interact with CCR4 directly but instead binds to the CAF40
subunit of the complex in a manner mediated by a conserved N-terminal CAF40-binding motif (CBM). The crystal structure of
the Bam CBM bound to CAF40 reveals that the CBM peptide adopts an α-helical conformation after binding to the concave
surface of the crescent-shaped CAF40 protein. We further show that Bam-mediated mRNA decay and translational repression
depend entirely on Bam’s interaction with CAF40. Thus, Bam regulates the expression of its mRNA targets by recruiting the
CCR4–NOT complex through interaction with CAF40.
Keywords: deadenylation; mRNA decay; translational repression; germ cell differentiation
INTRODUCTION
The CCR4–NOT deadenylase complex is a major down-
stream effector complex in post-transcriptional mRNA regu-
lation in eukaryotes (Wahle and Winkler 2013). Beyond its
role in global mRNA degradation, the complex regulates
the expression of a large number of specific mRNAs, to which
it is recruited via interactions with RNA-associated proteins.
These proteins include the GW182 family, which is involved
in miRNA-mediated gene silencing in animals (Chen et al.
2014a; Mathys et al. 2014); tristetraprolin (TTP), a protein
required for the degradation of mRNAs containing AU-rich
elements (Fabian et al. 2013); the germline determinant
Nanos (Suzuki et al. 2012; Bhandari et al. 2014; Raisch et
al. 2016); and human (Hs) and Drosophila melanogaster
(Dm) Roquin proteins (Leppek et al. 2013; Sgromo et al.
2017).
In metazoans, the CCR4–NOT complex comprises a core
of seven proteins, which bind to independently folding α-he-
lical domains in the central NOT1 scaffold subunit, forming
four subcomplexes or modules: the catalytic module, the
CAF40 module, the NOT module, and the NOT10-NOT11
module (Wahle and Winkler 2013). The catalytic module
comprises two deadenylases, namely CAF1 or its paralog
POP2 (also known as CNOT7 and CNOT8, respectively, in
humans), and CCR4a or its paralog CCR4b (also known as
CNOT6 and CNOT6L, respectively, in humans). CAF1 (or
POP2) binds to a central domain of NOT1 that is structurally
related to the middle portion of eIF4G (termed the NOT1
MIF4G domain) (Basquin et al. 2012; Petit et al. 2012).
CAF1 or POP2 also bind to a leucine-rich repeat domain
(LRR) in CCR4a/b, thus bridging the interaction of CCR4
paralogs with NOT1, and consequently with the assembled
CCR4–NOT complex (Draper et al. 1994, 1995; Dupressoir
et al. 2001; Basquin et al. 2012; Petit et al. 2012; Bawankar
et al. 2013). The NOT1MIF4G domain also serves as a bind-
ing platform for the DEAD-box protein DDX6 (also known
as RCK), which functions as a translational repressor and
decapping activator (Chen et al. 2014a; Mathys et al. 2014).
The CAF40 module consists of the highly conserved CAF40
subunit (also known as NOT9) bound to the NOT1
CAF40/NOT9-binding domain (CN9BD), which is located
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C-terminal to the MIF4G domain (Chen et al. 2014a; Mathys
et al. 2014). The NOT module consists of the NOT2–NOT3
heterodimer bound to the C-terminal NOT1 superfamily ho-
mology domain SHD (Bhaskar et al. 2013; Boland et al.
2013), whereas the NOT10 and NOT11 subunits bind to
the N-terminal end of NOT1 (Bawankar et al. 2013;
Mauxion et al. 2013).
Bag-of-marbles (Bam) is a key differentiation factor that
determines the fate of germline stem cells (GSCs) (Cooley
et al. 1988; McKearin and Spradling 1990; Carreira and
Buszczak 2014). Loss of Bam results in uncontrolled stem
cell proliferation, thus giving rise to germ cell tumors that
characterize the mutant phenotype (McKearin and
Ohlstein 1995). In contrast, ectopic Bam expression causes
stem cell loss (Ohlstein and McKearin 1997). Bam is con-
served in Drosophila and other dipteran species and contains
several predicted α-helices (Fig. 1A), thus suggesting that it is
mainly a folded protein. However, Bam does not display
detectable similarity to other known proteins or domains.
Bam controls GSC differentiation by post-transcriptionally
repressing the expression of nanos and E-cadherinmRNAs (Li
et al. 2009). Bam function requires the assembly of a protein
complex, which includes Benign gonial cell neoplasm (Bgcn),
a putative DEXH RNA helicase protein, and additional pro-
teins such as Tumorous testis (Tut) (Chen et al. 2014b),
Sex-lethal (Sxl) (Chau et al. 2012) and Mei-P26 (Neumüller
et al. 2008; Li et al. 2013). All of these proteins have been im-
plicated in germ cell differentiation in Dm, but their individ-
ual contributions to mRNA binding and repression, as well as
their interactionmodes are not well understood. Bamhas also
been shown to interact with the translation initiation factor
eIF4A and to antagonize its role in translation initiation
(Shen et al. 2009).
Although the mechanism through
which Bam-containing complexes re-
press the expression of specific mRNA
targets has not been fully elucidated, it
apparently involves interaction with the
CCR4 deadenylase subunit of the
CCR4–NOT complex (Fu et al. 2015).
Bam has been proposed to compete
with CAF1/POP2 for direct binding to
the CCR4 LRR domain, thereby displac-
ing CCR4 from the CCR4–NOT com-
plex. In this model, CCR4 participates
in Bam-mediated repression as an isolat-
ed deadenylase and not as an integral
component of the CCR4–NOT complex.
The model was proposed on the basis of
the observation that mutations in the
CCR4 LRR domain disrupt binding to
both Bam and CAF1/POP2 (Fu et al.
2015). However, the mutated residues
are located in the hydrophobic core of
the LRR domain (Basquin et al. 2012)
and most probably destabilize the
domain fold. Therefore, it remains un-
clear whether free CCR4 or the assem-
bled CCR4–NOT complex is required
for Bam-mediated repression.
In the present study, we investigated
the role of the CCR4–NOT complex in
Bam-mediated mRNA regulation. We
found that Bam promotes translational
repression and degradation of bound
mRNAs and that these activities depend
on the N-terminal region of Bam, which
does not contain the previously identified
Bgcn-binding region and putative CCR4-
binding site (Supplemental Fig. S1; Pan
et al. 2014; Fu et al. 2015). We further
FIGURE 1. Bam induces degradation of bound mRNAs through its N-terminal region. (A)
Bam consists of several predicted α-helices (shown in yellow) and a β-strand (shown in cyan).
The position of the CAF40-binding motif (CBM, in red) as well as the boundaries of the Bam-
N and Bam-C fragments are indicated. (B) Tethering assay using the F-Luc-5BoxB reporter
and λN-HA-tagged Bam (full-length or the indicated fragments) in Dm S2 cells. A plasmid ex-
pressing R-Luc mRNA served as a transfection control. For each experiment, F-Luc activity
and mRNA levels were normalized to those of the R-Luc transfection control and set to 100%
in cells expressing the λN-HA peptide. (C) Northern blot of representative RNA samples shown
in B. (D) Western blot analysis showing the equivalent expression of the λN-HA-tagged proteins
used in the tethering assays shown in B and C. Protein size markers (kDa) are shown on the right
of the panel. Full-length Bam and Bam-N display an aberrant mobility in SDS–PAGE, thus result-
ing in a higher apparent molecular weight. (E,F) Tethering assay using the F-Luc-5BoxB-A95-C7-
HhR reporter and λN-HA-tagged Bam (full-length or the indicated fragments) in Dm S2 cells.
The samples were analyzed as described in B and C. In B and E, bars represent mean values
and error bars represent standard deviations from at least three independent experiments.
Sgromo et al.
382 RNA, Vol. 24, No. 3
show that this N-terminal region contains a CAF40-binding
motif (CBM) that interacts directly with CAF40. A crystal
structure of the Bam CBM peptide bound to CAF40 reveals
a binding mode similar to that observed for the Dm
Roquin CBM (Sgromo et al. 2017). However, in contrast to
Dm Roquin, which recruits the CCR4–NOT complex
through multiple redundant binding sites, Bam relies entirely
on the interaction with CAF40. Disruption of the Bam–
CAF40 interaction also disrupts the interaction with CCR4
and the additional subunits of the CCR4–NOT complex
and abolishes Bam activity. Thus, Bam recruits the assembled
CCR4–NOT deadenylase complex through a direct interac-
tion with CAF40 and this interaction is essential for Bam to
repress bound mRNAs.
RESULTS
The Bam N-terminal region mediates translational
repression and degradation of mRNA targets
Bam promotes stem cell differentiation by repressing the ex-
pression of specific mRNA targets through a mechanism that
involves interaction with the CCR4 deadenylase (Fu et al.
2015). To obtain detailed mechanistic insights into this re-
pressive mechanism and more precisely define the Bam se-
quences responsible for its repressive activity, we used a
λN-based tethering assay in Drosophila melanogaster S2 cells
(Behm-Ansmant et al. 2006). On the basis of sequence align-
ments, we designed Bam N- and C-terminal fragments for
tethering assays (Fig. 1A; Supplemental Fig. S1; Supplemental
Table S1). Full-length Bam and the Bam-N and Bam-C frag-
ments were expressed with λN-HA tags that bind to a coex-
pressed firefly luciferase mRNA reporter containing five
λN-binding sites (BoxB hairpins) in the 3′ UTR (F-Luc-
5BoxB mRNA). An mRNA encoding Renilla luciferase (R-
Luc) served as a transfection control.
λN-HA-tagged Bam decreased the F-Luc expression level
to 10% relative to the λN-HA fusion protein, which was
used as a negative control (Fig. 1B). The decrease in F-Luc ac-
tivity was predominantly explained by a corresponding
decrease in the mRNA abundance (Fig. 1B,C) and a shorten-
ing of themRNA half-life (Supplemental Fig. S2A,B), thus in-
dicating that Bam induces mRNA degradation in S2 cells.
Furthermore, the Bam-N fragment retained the activity of
the full-length protein, whereas the activity of the Bam-C frag-
ment was strongly impaired (Fig. 1B,C). All proteins were ex-
pressed at comparable levels (Fig. 1D), and none of the
proteins affected the expression of an F-Luc reporter lacking
the BoxB hairpins (Supplemental Fig. S2C,D), thus confirm-
ing that Bam must bind to the mRNA to induce degradation.
To determine whether Bam might repress translation in-
dependently of mRNA degradation, we used an mRNA re-
porter containing a 3′ end generated by a self-cleaving
hammerhead ribozyme (HhR) that consequently lacks a
poly(A) tail (F-Luc-5BoxB-A95C7-HhR) (Zekri et al. 2013).
Additionally, the reporter contains an internal, DNA-encod-
ed, oligo(A) stretch of 95 nucleotides and a 3′ oligo(C) stretch
of seven nucleotides upstream of the ribozyme cleavage site.
This reporter is resistant to deadenylation and subsequent
degradation and is efficiently translated in S2 cells (Zekri et
al. 2013). Full-length Bam and the Bam-N fragment re-
pressed the expression of this reporter in S2 cells (Fig. 1E,
F). This repression occurred mainly at the translational level,
because mRNA levels were not decreased to a similar extent
as with the polyadenylated reporter. Together, our results in-
dicated that Bam promotes the degradation of polyadenyl-
ated mRNAs and also represses translation independently
of mRNA degradation when deadenylation is blocked.
Furthermore, the Bam activity resides primarily in the
Bam-N fragment, which does not contain the putative
CCR4-binding region (Supplemental Fig. S1; Fu et al. 2015).
Bam directs bound mRNAs to the 5′-to-3′ decay
pathway
We next investigated whether Bam elicits mRNA degradation
via the 5′-to-3′ decay pathway. In this pathway, deadenylation
is followed by decapping and 5′-to-3′ exonucleolytic degrada-
tion of the mRNA body. We therefore performed tethering
assays in S2 cells depleted of the decapping enzyme DCP2
and overexpressing a catalytically inactive DCP2 mutant
(DCP2 E361Q), which inhibits decapping in a dominant
negative manner (Chang et al. 2014). In these cells, degrada-
tion of the F-Luc-5BoxBmRNA by tethered Bam or the Bam-
N fragment was impaired (Fig. 2A). The F-Luc-5BoxB
mRNA accumulated as a fast-migrating form corresponding
to a deadenylated decay intermediate (A0; Fig. 2B, lanes 5 and
6). Despite the restoration of mRNA levels, F-Luc activity was
not restored (Supplemental Fig. S2E), most likely because
deadenylated transcripts are translated less efficiently. The
expression of the tethered proteins was not affected by coex-
pression of the DCP2 mutant (Fig. 2C). Together, these re-
sults indicated that Bam directs mRNA targets to the 5′-to-
3′ decay pathway.
Bam recruits the CCR4–NOT complex to induce
mRNA degradation
Our results indicated that Bam promotes deadenylation-de-
pendent decapping. To determine whether Bam-mediated
deadenylation requires the assembled CCR4–NOT complex
or, alternatively, whether only the CCR4 subunit acts in iso-
lation, as suggested previously (Fu et al. 2015), we disrupted
CCR4–NOT complex assembly by depleting NOT1, the scaf-
fold subunit of the complex (Wahle and Winkler 2013).
NOT1 depletion partially suppressed degradation of F-Luc-
5BoxB mRNA mediated by Bam and Bam-N (Fig. 2D,E;
Supplemental Fig. S2F), thus suggesting that the assembled
CCR4–NOT complex is required for Bam’s repressive activ-
ity. Furthermore, NOT1 depletion also suppressed Bam-
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mediated translational repression of the reporter that was re-
sistant to deadenylation and decay (F-Luc-5BoxB-A95C7-
HhR; Fig. 2F,G; Supplemental Fig. S2G). Western blot
analysis indicated that NOT1 levels were indeed decreased
to <25% of the control levels in the knockdown cells
(Supplemental Fig. S2H).
Because Bam activity depends on the integrity of the
CCR4–NOT complex and it resides in the N-terminal frag-
ment, which does not contain the putative CCR4-binding re-
gion (Fu et al. 2015), we re-examined Bam interactions with
subunits of the CCR4–NOT complex. We expressed Bam
with an HA tag in S2 cells and tested for interactions with
GFP-tagged subunits of the CCR4–NOT complex in coim-
munoprecipitation assays. Bam interacted with NOT1,
NOT2, NOT3, CCR4, and CAF40 (Supplemental Fig. S3A–
E), thus suggesting that it interacts with the assembled
CCR4–NOT complex. All of these interactions were observed
in the presence of RNaseA. Together, our results indicated
that the CCR4–NOT complex is an important downstream
effector of Bam-mediated mRNA regulation.
FIGURE 2. Bam degrades mRNAs through the 5′-to-3′ mRNA decay pathway. (A) Tethering assay using the F-Luc-5BoxB reporter was performed
in control S2 cells or cells depleted of the decapping enzyme DCP2 (DCP2 KD). The transfectionmixture included plasmids expressing either GFP-V5
or a GFP-tagged catalytically inactive DCP2 mutant (DCP2∗; E361Q). The F-Luc-5BoxB mRNA levels were normalized to those of the R-Luc trans-
fection control and set to 100% in control and knockdown cells expressing the λN-HA peptide. The gray bars represent the normalized F-Luc-5BoxB
mRNA values in control cells expressing GFP-V5. The black bars represent the normalized F-Luc-5BoxB mRNA values in DCP2-depleted cells ex-
pressing GFP-DCP2∗-V5. (B) Northern blot of representative RNA samples shown in A. The positions of the polyadenylated (An) and deadenylated
(A0, dashed red line) mRNA reporter are indicated on the right of the panel. (C) Western blot analysis showing equivalent expression of λN-HA-
tagged proteins in the experiments shown in A and B. (KD) Knockdown. (D,E) Tethering assay using the F-Luc-5BoxB reporter in control S2 cells
or in NOT1-depleted cells. Samples were analyzed as described in Figure 1B–D. (F,G) Tethering assay using the F-Luc-5BoxB-A95-C7-HhR reporter in
control cells and inNOT1-depleted cells. Samples were analyzed as described in Figure 1B–D. InA,D, and F, bars represent mean values and error bars
represent standard deviations from at least three independent experiments. (H) Western blot analysis showing the efficiency of NOT1 depletion in the
experiments shown inD–G. Dilutions of control cell lysates were loaded in lanes 1–4. PABP served as a loading control. Protein size markers (kDa) are
shown on the right in each panel.
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Bam interacts with the CAF40 subunit
of the CCR4–NOT complex
To discriminate between direct and indi-
rect interactions between Bam and the
subunits of the CCR4–NOT complex,
we performed pull-down assays in vitro,
using purified recombinant proteins ex-
pressed in Escherichia coli. Because some
Dm NOT1 domains are not expressed in
a soluble form in bacteria, we first tested
whether Bam could also interact with
the human CCR4–NOT complex. To
this end, we expressed Bam with a V5-
SBP tag in human HEK293T cells and
tested for interactions with endogenous
subunits of the CCR4–NOT complex in
pull-down assays. Bam pulled down all
of the tested subunits of the endogenous
CCR4–NOT complex (NOT1, NOT2,
NOT3 and CAF40; Fig. 3A, lane 4) as
well as HA-tagged CCR4 (Fig. 3B, lane
4) in the presence of RNaseA, thereby in-
dicating that the Bam-binding surface on
the CCR4–NOT complex is conserved.
This result allowed us to test for inter-
actions with individual purified human
CCR4–NOT subcomplexes in vitro, in-
cluding the NOT1-10-11 module, the
catalytic module comprising the NOT1
MIF4G domain bound to CAF1 and
CCR4a, the NOT1 CN9BD domain
bound to CAF40, a C-terminal connector
domain of unknown function (CD), the
NOT module comprising the NOT1
SHD and the C-terminal regions of
NOT2 and NOT3, and an N-terminal
coiled coil domain of NOT3 (Supple-
mental Fig. S3F).MBP-tagged Bam inter-
acted only with the CN9BD–CAF40
module but not with any other subcom-
plex (Supplemental Fig. S3G, lane 25).
The CN9BD–CAF40 module is highly
conserved between Hs and Dm (CN9BD
and CAF40 display 50% and 75% se-
quence identity, respectively). Accord-
ingly, Bam also interacted with the Dm
CN9BD–CAF40module in pull-downas-
says (Fig. 3C, lane 12).
The CAF40-binding motif (CBM) is
required for Bam repressive activity
To more precisely define the region of
Bam that interacts with the CAF40
FIGURE 3. Bam binds directly to CAF40 by using an N-terminal CAF40-binding motif
(CBM). (A) SBP pull-down assay in HEK293T cells expressing V5-SBP-tagged full-length
Bam. V5-SBP-tagged MBP served as negative control. Input (1.5% for the V5-SBP tagged pro-
teins and 1% for endogenous CCR4–NOT subunits) and bound fractions (10% for the V5-
SBP tagged proteins and 30% for the CCR4–NOT subunits) were analyzed by western blotting
using the indicated antibodies. (B) SBP pull-down assay in HEK293T cells expressing V5-SBP-
tagged full-length Bam and HA-CCR4. V5-SBP-tagged MBP served as negative control.
Samples were analyzed as described in A. (C) MBP pull-down assay testing the interaction of
MBP-tagged full-length Bam, the CBM or Bam ΔCBM with the Dm CN9BD–CAF40 complex.
MBP served as a negative control. The inputs (10%) and bound fractions (50%) were analyzed
by SDS–PAGE and subsequent Coomassie staining. (D) MBP pull-down assay showing the inter-
action of MBP-tagged Bam CBM with the Dm and Hs CN9BD–CAF40 complex and Hs CAF40.
Samples were analyzed as in C. (E) Tethering assay using the F-Luc-5BoxB reporter and λN-HA-
tagged Bam (full-length or the indicated fragments) in S2 cells. The samples were analyzed as de-
scribed in Figure 1B–D. The mean values ±SD from three independent experiments are shown.
(F) Northern blot of representative RNA samples shown in E. (G) Western blot showing the
equivalent expression of λN-HA-tagged proteins used in E and F. Protein size markers (kDa)
are shown on the right in each panel.
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module, we performed a series of pull-down assays using var-
ious Bam fragments, which led to the identification of a
CAF40-binding motif (CBM, residues D13–E36) within the
Bam N-terminal fragment. The Bam CBM was sufficient
for binding to the Dm and human CN9BD–CAF40 modules
in pull-down assays (Fig. 3C, lane 14 and Fig. 3D, lanes 14
and 15). Furthermore, the CBM interacted directly with the
isolated Hs CAF40 subunit in the absence of the NOT1
CN9BD (Fig. 3D, lane 16). Importantly, deletion of the
CBM in the context of full-length Bam abolished the interac-
tion with the Dm CN9BD–CAF40 module in vitro (Fig. 3C,
lane 16), thereby indicating that the CBM is the principal
CAF40-binding site in Bam.
To determine the contribution of the CBM to Bam’s re-
pressive activity, we performed tethering assays in S2 cells.
Remarkably, the CBM alone (fragment D13–E36 fused to
GST) was sufficient to induce the repression and degradation
of the F-Luc-5BoxB mRNA to a similar extent as full-length
Bam (Fig. 3E,F). Furthermore, deletion of the CBM was suf-
ficient to abolish the repressive activity of Bam in tethering
assays (Fig. 3E,F). All proteins were expressed at comparable
levels (Fig. 3G) and did not affect the expression of an F-Luc
reporter lacking the BoxB hairpins (Supplemental Fig. S4A,
B). We therefore concluded that the CBM is essential for
Bam’s repressive activity.
Crystal structure of the Bam CBM bound to CAF40
To elucidate the molecular principles underlying the interac-
tion of Bam with the CAF40module, we sought to determine
the crystal structure of the CBM peptide (residues D13–E36)
bound to the Dm and Hs CAF40 armadillo (ARM) domain
(Dm CAF40 E25–G291 and Hs CAF40 R19–E285) as well
as to the CAF40 modules containing the NOT1 CN9BD (res-
idues Dm NOT1 Y1468–T1719 and Hs NOT1 V1351–
L1588). However, only the complexes containing the human
proteins yielded well-diffracting crystals. We solved the struc-
tures of the Bam CBM peptide bound to CAF40 and to the
CN9BD–CAF40 complex and refined them to 3.0 Å and
2.7 Å resolution, respectively (Table 1; Fig. 4A–C).
The asymmetric unit of the CAF40-CBM crystal contained
four complexes that were highly similar to each other
TABLE 1. Data collection and refinement statistics
CAF40–Bam NOT1–CAF40–Bam
Space group P 21 21 2 P 32 2 1
Unit cell
Dimensions a, b, c (Å) 105.6, 200.9, 59.6 106.6, 106.6, 263.4
Angles α, β, γ (°) 90.0, 90.0, 90.0 90.0, 90.0, 120.0
Data collectiona
Wavelength (Å) 1.0396 1.0000
Resolution range (Å) 50.–3.0 (3.08–3.00) 50–2.7 (2.77–2.70)
Rsym (%) 9.5 (100.8) 11.4 (222.4)
Completeness (%) 99.5 (98.8) 99.9 (99.5)
Mean (I/σI ) 13.2 (1.7) 15.5 (1.2)
Unique reflections 26,082 (1852) 48,613 (3529)
Multiplicity 5.5 (5.7) 11.0 (10.7)
CC(1/2) 1.00 (0.65) 1.00 (0.70)
Refinement
Rwork (%) 21.6 20.9
Rfree (%) 26.8 23.7
Number of atoms
All atoms 9358 8481
Protein 9352 8424
Ordered solvent 6 57
Average B factor (Å2)
All atoms 100.8 97.9
Protein 100.7 97.5
Ordered solvent 103.7 149.3
Ramachandran plot
Favored regions (%) 96.4 98.9
Disallowed regions (%) 0.2 0.0
RMSD from ideal geometry
Bond lengths (Å) 0.010 0.002
Bond angles (°) 1.080 0.437
aValues in parentheses are for highest-resolution shell.
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(RMSDs between 0.31 and 0.75 Å; over 237–278 Cα atoms)
and that were arranged as two pairs of dimers (Supplemental
Fig. S5A,B). The dimer interface corresponds to the one pre-
viously observed in the structure of free CAF40 (Supplemen-
tal Fig. S5C; Garces et al. 2007). The asymmetric unit of the
CN9BD–CAF40-CBM crystals contained two almost identi-
cal complexes (RMSD of 0.28 Å over 457 Cα atoms; Supple-
mental Fig. S5D,E). In all complexes, the interaction of the
CBM peptide with the CAF40 concave surface was found to
be almost identical (Fig. 4B,C; Supplemental Fig. S5F), and
the CBM does not contact the NOT1 CN9BD (Fig. 4A–C),
thus confirming that the CBM interacts exclusively with
CAF40. Superposition of the CAF40 dimer bound to the
CBM with the previously determined ligand-free CAF40
dimer (Supplemental Fig. S5C; RMSD of 0.90 Å over 509
Cα atoms; Garces et al. 2007) or with CAF40 bound to the
NOT1 CN9BD (Supplemental Fig. S5G; RMSD of 0.94 Å
over 416 Cα atoms; Chen et al. 2014a), indicated that binding
of the CBM peptide does not induce any major conforma-
tional changes in the CAF40 ARM domain.
The CBM peptide folds into an amphipathic α-helix that is
bound centrally across the concave surface of the crescent-
shaped CAF40 ARM domain, which consists of 17 α-helices
arranged into six armadillo (ARM) repeats (Fig. 4A–C;
Supplemental Fig. S6A,B; Garces et al. 2007; Chen et al.
2014a; Mathys et al. 2014). The α-helix binds to a conserved
hydrophobic patch close to the previously proposed nucleic
acid-binding groove (Garces et al. 2007). In the structure of
the Bam CBM bound to the CAF40 module, the NOT1
CN9BD binds to the convex surface of CAF40 and prevents
CAF40 dimerization, as previously observed (Chen et al.
2014a; Mathys et al. 2014). Importantly however, the
NOT1 CN9BD does not interfere with Bam CBM binding
on the concave surface of CAF40, thus indicating that Bam
can interact with CAF40 also in the context of the fully as-
sembled CCR4–NOT complex (Fig. 4C).
The Bam CBM competes with the Roquin CBM
for binding to CAF40
Remarkably, the BamCBMoccupies the same binding surface
as the previously described CBM of Dm Roquin (Roq)
(Sgromo et al. 2017) and binds CAF40 in a similar manner
(Fig. 4D). The two CBM peptides fold into amphipathic heli-
ces that bind via their hydrophobic sides along a groove on the
concave face of CAF40. Consequently, the two peptides
FIGURE 4. Structure of the Bam CBM bound to CAF40 and to the NOT1 CN9BD–CAF40 module. (A) The Bam CBM peptide (red, backbone
shown in ribbon representation) bound toHsCAF40 (gray). CAF40 helices are depicted as tubes and numbered in black. The orange semicircle marks
the predominantly hydrophobic interface between the CBM peptide and CAF40. (B) Cartoon representation of the Bam CBM peptide bound to Hs
CAF40. Selected CAF40 secondary structure elements are labeled in black. (C) Structure of the CBM peptide bound to the NOT1 CN9BD–CAF40
complex. (D) Superposition of the CAF40–BamCBM structure with the structure of CAF40 bound to the Roq CBM (PDB 5LSW; Sgromo et al. 2017).
The Roq CBM is shown in yellow and CAF40 from the Roq complex in blue. (E) In vitro competition assay. GST-taggedHsCAF40 was incubated with
equimolar amounts of MBP-tagged Bam or Roq CBMs and increasing amounts of His6-NusA-tagged Bam CBM. His6-NusA was used as a negative
control. Proteins bound to GST-CAF40 were pulled down and analyzed by SDS-PAGE and subsequent Coomassie staining. Molar equivalents (eq) are
relative to GST-CAF40.
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cannot bind CAF40 simultaneously and compete for binding
to CAF40 when tested in vitro in a competition assay. In this
assay, GST-tagged CAF40 was incubated with equimolar
amounts of MBP-tagged Bam or Roq CBMs and increasing
concentrations ofHis6-NusA-tagged BamCBM.The peptides
bound to CAF40 were pulled down by using glutathione-aga-
rose beads. Increasing concentrations of the His6-NusA-Bam
CBM competed with the two MBP-tagged CBMs for CAF40
binding (Fig. 4E). Interestingly, the Roquin CBM was com-
peted out more efficiently than the Bam CBM (Fig. 4E, e.g.,
lane 12 versus 17), thus suggesting that Bam has a competitive
advantage.
To obtain information on the affinities of the CBM pep-
tides for CAF40, we performed isothermal titration calorim-
etry (ITC) experiments. The Bam CBM bound to the Dm
CN9BD–CAF40 complex with a dissociation constant (KD)
in the nanomolar range (183 ± 44 nM; Supplemental Fig.
S7A). In contrast, the affinity of the Roq CBM was too low
to be measured by ITC (i.e., the necessary peptide concentra-
tions for measurement could not be reached), thereby ex-
plaining why the Roq CBM competed rather poorly with
the Bam CBM.
The Bam and Roquin CBMs use similar binding modes
The Bam CBM forms a single amphipathic α-helix extending
through residues D13–E33 and the hydrophobic face of this
helix binds in a groove formed by helices α5, α8 and α11 on
the CAF40 concave surface (Fig. 5A,B). The interaction bur-
ies a total surface area of 1638 Å2 and involves the side chains
of Bam residues L17, F21, M24, L28, M31 and V32, which
engage the hydrophobic CAF40-binding surface consisting
of residue A84 in helix α5, residues R130, Y134, L137,
T138, G141 and G144 in helix α8, and residues L177,
T180, V181 and F184 in helix α11 on the CAF40 side (Fig.
5A,B). In addition, the N and C termini of the CBM helix
contact the CAF40 surface through hydrogen bonds between
Bam N20 and CAF40 N88, and Bam E33 and CAF40 K230,
respectively (Fig. 5B). However, these interactions were not
observed in all six complexes, thus indicating some degree
of flexibility of the helix ends.
In the Roq CBM, the N-terminal portion (residues E790–
M797) is no longer α-helical, owing to the insertion of a gly-
cine (G796), which is conserved among Roq proteins from
different Drosophila species (Fig. 5C,D). Instead, the residues
form an extended “hook” that is stabilized by internal hydro-
gen bonds. In contrast, the Bam N-terminal residues (D13–
N20) extend the amphipathic α-helix by another two turns.
Despite this structural difference, Bam residue L17 engages
the same binding pocket as Roq residue I793. Thus, critical
contacts are preserved in both peptides despite the fact that
Roq is no longer helical (Fig. 5C,D). Overall, the all α-helical
conformation of the Bam CBM is likely to be more stable on
its own than the more extended conformation of the Roq
CBM, which probably does not form in the absence of
CAF40. The resulting difference in the binding entropy could
contribute to the higher affinity of the Bam CBM for CAF40
and to its competitive advantage over the Roquin CBM.
Alternatively, differences in the hydrophobic interface resi-
dues may also potentially explain the observed differences
in affinity and competition between the two CBMs, e.g.,
the side chain of residue F21 in the center of the Bam CBM
establishes a more extensive network of hydrophobic interac-
tions along the interface than the side chain of residue M798
at the same structural position in the Roq CBM.
The interaction of Bam with CAF40 is required
for mRNA repression
To assess the importance of the interactions observed in the
crystal structure, we substituted Bam residues L17 or M24
with glutamic acid. These substitutions abolished the interac-
tion of the MBP-tagged Bam with the Dm CAF40 module in
pull-down assays (Fig. 5E; Supplemental Table S1), thus indi-
cating that the CBM is the only CAF40-binding site in Bam.
We also analyzed the effects of amino acid substitutions in
the CAF40 interface on complex formation. A single V186E
substitution or the double Y139D, G146W substitution
(2xMut) inDm CAF40 (corresponding toHs CAF40 residues
V181, Y134 and G141) were sufficient to disrupt the interac-
tion with Bam in vitro (Fig. 5F; Supplemental Table S1). The
equivalent substitutions in Hs CAF40 were also sufficient to
disrupt binding to the Roq CBM (Sgromo et al. 2017), thus
further confirming the similarity in the CBM-bindingmodes.
Next, we assessed the relevance of the interface in S2 cells.
The single amino acid substitution in Dm CAF40 (V186E)
was sufficient to abolish binding to full-length Bam in cell ly-
sates (Supplemental Fig. S3E, lane 6). Conversely, substitu-
tions of CBM residues (4xMut, Supplemental Table S1) in
the context of full-length Bam abolished binding to Dm
CAF40 (Supplemental Fig. S7B).
To assess the functional relevance of the CAF40-Bam in-
teraction in mRNA target repression, we performed tethering
assays in S2 and human cells. Single amino acid substitutions
in the Bam CBM abolished Bam activity in tethering assays in
S2 cells (Fig. 6A,B) a result indicating that the CBM provides
a major contribution to Bam’s repressive activity. All mutants
were expressed at comparable levels (Fig. 6C) and did not af-
fect the expression of a F-Luc mRNA lacking the BoxB hair-
pins (Supplemental Fig. S7C,D).
In human cells, we tethered MS2-HA-tagged full-length
Bam (wild-type or the 4xMut) to a β-globin reporter contain-
ing six binding sites for the MS2 protein in the 3′ UTR. As
observed in Dm cells, wild-type Bam caused degradation of
the β-globin-6xMS2bs reporter, whereas the Bam 4xMut
was inactive (Supplemental Fig. S7E–G). Furthermore, the
CBM alone fused to MBP was as active as full-length Bam
(Supplemental Fig. S7E–G). Thus, Bam depends on the in-
tegrity of the CBM to repress mRNA expression both in hu-
man and S2 cells.
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Bam interaction with CCR4 is indirect and mediated
by CAF40
In the pull-down assays using recombinant proteins, we did
not observe a direct interaction between Bam and the catalyt-
ic module (containing Hs CCR4a, which is 57% identical to
Dm CCR4; Supplemental Fig. S3G). Furthermore, Bam did
not competitively displace the CAF1-NOT1 subcomplex
from CCR4a (Supplemental Fig. S3G, lane 24), as has previ-
ously been suggested (Fu et al. 2015). To determine whether
Bam interaction with CCR4 was direct or mediated by
CAF40, we used CRISPR-Cas9 gene editing to generate a
FIGURE 5. The Bam and Roq CBMs use a similar CAF40-binding mode. (A,B) Close-up views of the CAF40-Bam CBM-binding interface in two
orientations. Selected residues of CAF40 and Bam are shown as orange and red sticks, respectively. Hydrogen bonds are indicated by red dashed lines.
Residues mutated in this study are underlined. (C) Close-up view of the structural superposition of the CAF40-Bam CBM structure with the structure
of the Roq CBMbound to CAF40. The Bam and Roq CBMs are shown in red and yellow, respectively. (D) (Upper panel) Superposition of the Bam and
Roq CBM peptides bound to CAF40. The backbones are shown in ribbon representation, and side chains are shown as sticks. CAF40 is indicated as a
thick gray line. (Lower panel) Sequence alignment of the Bam and Roq CBMs from the indicatedDrosophila species. Hydrophobic residues interacting
with CAF40 are highlighted by a light green background. Gray letters indicate residues that were not included in the crystallization setup. (E) MBP
pull-down assay testing the interaction of MBP-tagged Bam (wild-type or mutants L17E and M24E) with the Dm NOT1-CN9BD–CAF40 complex.
MBP served as a negative control. (F) MBP pull-down assay testing the interaction of MBP-tagged Bam with Dm NOT1-CN9BD–CAF40 complex
(containing CAF40 wild-type or the indicated mutants). MBP served as a negative control.
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CAF40-null HEK293T human cell line in which the CAF40
levels were decreased below detectable levels (Fig. 6D, lanes
3 and 4 versus 1 and 2 and Supplemental Fig. S7H), whereas
the expression of the additional subunits
of the CCR4–NOT complex was not af-
fected (Fig. 6D, lane 3 and 4 versus 1
and 2). In this cell line, Bam did not in-
teract with endogenous NOT1, NOT2
and NOT3 (Fig. 6D, lane 8 versus 6) or
with HA-tagged CCR4 (Fig. 6E, lane 8
versus 6), thus indicating that the interac-
tion of Bam with the subunits of the
CCR4–NOT complex is indeed mediated
by CAF40. Similarly, the combined qua-
druple substitutions in the Bam CBM
(4xMut) abrogated the interaction with
the endogenous subunits of the CCR4–
NOT complex in human cells (Fig. 6F,
lane 8 versus 6) as well as the interaction
with HA-tagged CCR4 (Fig. 6G, lane 8
versus 6). Similarly, the Bam 4xMut did
not interact with CCR4 or NOT2 in S2
cells (Supplemental Fig. S7I,J). Together,
our results indicated that the previously
reported interaction of Bam with CCR4
(Fu et al. 2015), is most likely indirect
and mediated by CAF40 in the context
of the fully assembled CCR4–NOT
complex.
CAF40 is the only Bam-binding
site within the CCR4–NOT
complex
To further validate the relevance of Bam
interaction with CAF40 for the recruit-
ment of the CCR4–NOT complex, we
performed tethering assays inDm S2 cells
overexpressing CAF40 wild-type or the
CAF40V186Emutant,which does not in-
teract with Bam and was thus expected to
suppress Bam activity in a dominant neg-
ative manner. Accordingly, Bam activity
in tethering assays was suppressed in cells
overexpressing the CAF40 V186Emutant
but not when CAF40 wild-type was over-
expressed (Fig. 7A,B). For a control, we
tethered Dm Roq, which in addition to
theCBMcontains additional binding sites
for the CCR4–NOT complex (Sgromo et
al. 2017). Consequently, Roq activity
was only slightly affected in cells overex-
pressing the CAF40 mutant (Fig. 7A,B,
lane 9). Overexpression of CAF40 did
not affect the Bam and Roq expression
levels (Fig. 7C). The differential effect of the CAF40 mutant
onBamandRoqactivities further confirmed thatBam, in con-
trast toRoq, depends entirelyon its interactionwithCAF40 for
FIGURE 6. The CBM is necessary for Bam-mediated mRNA repression. (A) Tethering assay
using the F-Luc-5BoxB reporter and λN-HA-tagged Bam (wild-type or the indicated mutants) in
S2 cells. The samples were analyzed as described in Figure 1B. (B) Northern blot of representative
RNA samples shown in A. (C) Western blot showing the equivalent expression of λN-HA-tagged
proteins used in A and B. (D) SBP pull-down assay in control and CAF40-null HEK293T cells
expressing V5-SBP-tagged full-length Bam. V5-SBP-tagged MBP served as a negative control.
Input (1.5% for the V5-SBP tagged proteins and 1% for endogenous CCR4–NOT subunits)
and bound fractions (10% for the V5-SBP tagged proteins and 30% for the CCR4–NOT subunits)
were analyzed by western blotting using the indicated antibodies. (KO) Knockout. (E) SBP pull-
down assay in control and CAF40-null HEK293T cells expressing V5-SBP-tagged full-length Bam
and HA-CCR4. Samples were analyzed as in D. (F) SBP pull-down assay in HEK293T cells ex-
pressing V5-SBP-tagged full-length Bam or the 4xMut. V5-SBP-tagged MBP served as a negative
control. Input (1.5% for the V5-SBP tagged proteins and 1% for CCR4–NOT subunits) and the
bound fractions (10% for the V5-SBP tagged proteins and 30% for CCR4–NOT subunits) were
analyzed by western blotting using the indicated antibodies. (G) SBP pull-down assay in
HEK293T cells expressing V5-SBP-tagged full-length Bam or the 4xMut and HA-tagged CCR4.
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repression, whereas Roq can recruit the CCR4–NOTcomplex
through additional binding sites.
In an independent approach, we tethered Bam in S2 cells
depleted of CAF40 in which CAF40 levels were decreased
to∼10% of the control levels (Fig. 7D). CAF40 depletion par-
tially suppressed Bam activity in tethering assays in S2 cells
(Fig. 7E,F). The Bam-mediated repression was restored by
transient expression of wild-type CAF40 but not by expres-
sion of the CAF40 V186E mutant, which does not interact
with Bam (Fig. 7E,F), despite comparable expression levels
(Fig. 7G). Thus, Bam requires interactions with CAF40 for
full repressive activity.
DISCUSSION
In this study, we showed that Bam represses the translation
and promotes the degradation of bound mRNAs by directly
recruiting the CCR4–NOT deadenylase complex through
an interaction with CAF40. This interaction is mediated by
a short CAF40-binding motif (CBM) that is necessary and
FIGURE 7. Bam depends on CCR4–NOT complex recruitment to induce mRNA decay. (A) Tethering assay using the F-Luc-5BoxB reporter and
λN-HA-tagged Bam and Roq in S2 cells. The transfection mixtures also contained plasmids for expression of GFP (control) or GFP-CAF40 (wild-type
or the V186Emutant) as indicated. The samples were analyzed as described in Figure 1B. (B) Northern blot of representative RNA samples shown inA.
(C) Western blot showing the equivalent expression of the λN-HA-tagged proteins in cells expressing GFP or GFP-CAF40 (either wild-type or the
V186E mutant) used in A and B. (D) Western blot showing the efficiency of the CAF40 depletion in Dm S2 cells. Dilutions of control cell lysates were
loaded in lanes 1–4 to estimate the efficacy of the depletion. PABP served as a loading control. (KD) Knockdown. (E) Complementation assay using
the F-Luc-5BoxB reporter and λN-HA-tagged Bam in S2 cells depleted of CAF40 (CAF40 KD) or in control cells (control). Samples were analyzed as
described in Figure 1B. (F) Northern blot of representative RNA samples shown in E. (G) Western blot showing the equivalent expression of the λN-
HA-tagged Bam constructs used in E and F.
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sufficient for Bam’s repressive activity. We further elucidated
the structural basis of the interaction of the Bam CBM with
CAF40 and identified the concave surface of CAF40 as a
binding site for amphipathic helices in RNA-associated pro-
teins that recruit the CCR4–NOT complex.
CCR4–NOT complex recruitment is required
for Bam repressive activity
The recruitment of the CCR4–NOT complex via the CAF40-
CBM interaction is required for Bam to repress the transla-
tion of mRNA targets. Unlike other proteins, such as
GW182, TTP, Roq and Dm Nanos, that use multiple redun-
dant motifs to recruit the CCR4–NOT complex (Fabian et al.
2013; Chen et al. 2014a; Mathys et al. 2014; Raisch et al. 2016;
Sgromo et al. 2017), Bam depends entirely on the interaction
between the CBM and CAF40. Indeed, single point muta-
tions in the CBM that abolished the interaction with
CAF40 also disrupted the interaction with CCR4 and addi-
tional subunits of the CCR4–NOT complex and abrogated
Bam’s repressive activity. Similar results were obtained in
cells depleted of CAF40, thus indicating that the previously
reported interaction between Bam and CCR4 is indirect
and is mediated by CAF40 in the context of the assembled
CCR4–NOT complex. These results also indicated that the
CCR4–NOT complex is the main downstream effector com-
plex in Bam-mediated mRNA regulation.
CAF40 serves as a binding platform
of the CCR4–NOT complex
Bam adds to the growing number of examples of RNA-asso-
ciated proteins that directly recruit the CCR4–NOT complex
via short linear motifs to down-regulate mRNA targets.
To date, the motifs that have been characterized have been
found to bind non-overlapping surfaces on the CCR4–
NOT complex. For example, vertebrate and Dm Nanos and
Saccharomyces cerevisiae (Sc) NOT4 bind to non-overlapping
surfaces on the NOT module (Bhandari et al. 2014; Bhaskar
et al. 2015; Raisch et al. 2016). The CAF40 subunit also pro-
vides interaction sites for RNA-associated proteins within the
CCR4–NOT complex. The convex surface of the CAF40 ar-
madillo-repeat domain features two tryptophan-binding sites
that are used by proteins of the GW182 protein family, which
recruit the CCR4–NOT complex to miRNA targets (Chen et
al. 2014a; Mathys et al. 2014). The CAF40 concave surface
provides binding sites for the CBM in the Dm Roq protein
(Sgromo et al. 2017). Here, we found that this surface also
binds to the Bam CBM, thus indicating that Bam and Roq
binding to CAF40 is mutually exclusive. However, the Bam
and Roq proteins share no apparent sequence similarity
and thus their CBMs may have evolved independently to
bind to the same surface of CAF40. The functional relevance
of this competitive binding remains unclear, because it is not
known whether the two proteins are expressed in the same
cell type under the same physiological conditions.
The high conservation of CAF40 (75% sequence identity
between the Hs and Dm proteins, and 57% identity between
Hs and Sc), particularly of the CBM-binding surface, suggests
the existence of additional CBM-containing proteins in eu-
karyotes. Through an in silico search using a consensus pat-
tern derived from the Bam and Dm Roq CBM sequences, we
could indeed identify several potential CBMs in other pro-
teins (Supplemental Fig. S8). However, none of the tested se-
quences interacted with Hs CAF40 in vitro in pull-down
assays (data not shown), thus indicating that the tested frag-
ments are not bona fide CBMs and that the rules guiding
CAF40 binding are still incompletely understood. From
what we know, it is possible and quite likely indeed that if
CBMs exist in other proteins, they do not share an evolution-
ary origin with Bam and Roq and therefore also have no phy-
logenetic sequence conservation. Indeed, sequence searches
conducted with either Bam or Roq did not identify the re-
spective other protein as a CBM-containing protein.
CCR4–NOT complex recruitment is a recurring
mechanism for targeted repression of gene expression
With the expanding repertoire of RNA-binding proteins that
are known to interact with the CCR4–NOT complex, some
underlying principles of recruitment are emerging. First,
many RNA-associated proteins use extended peptide motifs
embedded in unstructured regions for binding to CCR4–
NOT. Interactions of such short linear motifs (SLiMs) are
generally characterized by high specificity and at the same
time relatively low individual affinity (Tompa 2012; Van
Roey et al. 2014). This aspect is important in regulatory com-
plexes such as the CCR4–NOT complex, because the com-
plex must be recruited in a highly specific manner and
need to be released again after exerting its specific function.
Additionally, these motifs usually show high evolutionary
plasticity (Tompa 2012; Van Roey et al. 2014) and are not
conserved in orthologous proteins accross species.
Another common theme is that RNA binding is often spa-
tially separated from CCR4–NOT complex recruitment. In
many cases including Nanos and Roq, RNA binding is medi-
ated by highly conserved RNA-binding domains, whereas
CCR4–NOT complex recruitment is mediated by SLiMs in
long unstructured regions of up to several hundred amino ac-
ids in length. In other cases, RNA binding and CCR4–NOT
recruitment are associated with different polypeptides. For
example, in the miRNA-induced silencing complexes
(miRISCs), RNA binding is achieved by Argonaute proteins
(AGOs), whereas CCR4–NOT complex recruitment is medi-
ated by the GW182 proteins that act as adaptor molecules
downstream from AGOs (Jonas and Izaurralde 2015). In
the case of Bam, it is unknown whether the RNA-binding ac-
tivity resides in the Bam protein itself or whether additional
factors mediate mRNA binding.
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Finally, it is interesting to note that some proteins such as
Bam and vertebrate Nanos (this study; Bhandari et al.
2014), use a single motif with relatively high affinity to in-
teract with the CCR4–NOT complex, whereas others such
as Dm Roq and the GW182 proteins, use avidity effects in
a distributive binding mode involving multiple lower-affin-
ity motifs in disordered protein regions for recruitment
(Chen et al. 2014a; Mathys et al. 2014; Sgromo et al.
2017). The highly diverse sequence motifs bind to several
structured surfaces on the complex. Nevertheless, indepen-
dently of the mode of interaction, the recruitment of the
CCR4–NOT complex by diverse RNA-binding proteins re-
sults in a common functional outcome: the repression of
the mRNA target through deadenylation-dependent and in-
dependent mechanisms and, in cellular contexts in which
deadenylation is coupled to decapping, the degradation of
the mRNA through the 5′-to-3′ mRNA decay pathway.
Thus, the CCR4–NOT complex, through its ability to provide
binding sites for diverse sequence motifs, is a major down-
stream effector complex in post-transcriptional mRNA
regulation.
MATERIALS AND METHODS
DNA constructs
The DNA constructs used in this study are described in the
Supplemental Material and are listed in Supplemental Table S1.
All of the mutants used in this study were generated by site-directed
mutagenesis using a QuikChange mutagenesis kit (Stratagene). All
constructs and mutations were confirmed by sequencing.
Coimmunoprecipitation and SBP pull-down assays
All coimmunoprecipitation and SBP pull-down assays in S2 and
HEK293T cell lysates were performed in the presence of RNaseA
as previously described (Sgromo et al. 2017). All western blots
were developed using an ECL western blotting detection system
(GE Healthcare). The antibodies used in this study are listed in
Supplemental Table S2. A detailed description of these assays is in-
cluded in the Supplemental Material.
Tethering and complementation assays
Knockdown of DCP2, NOT1 and CAF40 in S2 cells using dsRNA
was performed as previously described (Behm-Ansmant et al.
2006). For the λN-tethering assays in Dm S2 cells, 2.5 × 106 cells
per well were seeded in six-well plates and transfected using
Effectene (Qiagen). The transfection mixtures contained the follow-
ing plasmids: 0.1 µg of Firefly luciferase reporters (F-Luc-5BoxB, F-
Luc-V5 or F-Luc-5BoxB-A95C7-HhR), 0.4 µg of the R-Luc transfec-
tion control and various amounts of plasmids expressing λN-HA-
tagged full-length Bam or Bam fragments (0.05 µg for wild-type
or mutant full-length Bam, 0.02 µg for Bam-N, 0.1 µg for Bam-C,
0.1 µg GST-CBM and 0.05 µg of Bam ΔCBM). Cells were harvested
3 days after transfection.
In the experiment shown in Figure 2A, control and DCP2 knock-
down cells were additionally transfected with plasmids expressing
GFP-V5 (0.08 µg) and GFP-DCP2∗-V5 mutant (E361Q; 1 µg), re-
spectively. In the experiment shown in Figure 7A and B, cells were
also transfected with plasmids expressing GFP (0.05 µg) or GFP-
tagged CAF40 (1.5 µg) either wild-type or mutant. In the comple-
mentation assay shown in Figure 7E,F, knockdown cells were also
transfected with plasmids expressing GFP (0.002 µg) or GFP-tagged
CAF40 (0.005 µg) either wild-type or mutant (V186E). To measure
the mRNA half-life, S2 cells were treated with actinomycin D (5 µg/
ml final concentration) 3 d after transfection and collected at the in-
dicated time points. RNA samples were analyzed by northern
blotting.
A detailed description of the procedure to generate the
HEK293T CAF40-null cell line is included in the Supplemental
Material. For the Bam tethering assays in human cells, HEK293T
cells (0.7 × 106 cells per well) were seeded in six-well plates and
transfected using Lipofectamine 2000 (Thermo Fisher Scientific).
The transfection mixtures contained 0.5 µg of the β-globin reporter
containing six MS2-binding sites (β-globin-6xMS2bs), 0.5 µg of
the control plasmid containing the β-globin gene fused to a frag-
ment of the GAPDH gene inserted in the 3′ UTR but lacking
MS2-binding sites (control: β-globin-GAP), and various amounts
of pT7-MS2-HA plasmids for the expression of MS2-HA-fusion
proteins [full-length Bam (1 µg), MBP-Bam CBM (0.2 µg) and
Bam 4xMut (0.5 µg)].
Firefly and Renilla luciferase activities were measured 3 d (S2
cells) or 2 d (HEK293T cells) after transfection by using a Dual-
Luciferase Reporter Assay System (Promega). The total RNA was
isolated using a Trifast Reagent (Peqlab) and analyzed by northern
blotting, as previously described (Braun et al. 2011).
Protein expression and purification
All recombinant proteins were expressed in E. coli BL21 (DE3) Star
cells (Thermo Fisher Scientific) grown in LB medium overnight at
20°C. The cells were lysed with an EmulsiFlex-C3 homogenizer
(AVESTIN) in the indicated lysis buffer supplemented with
DNase I (5 µg/mL), lysozyme (1 mg/mL) and complete EDTA-
free protease inhibitor cocktail (Roche). Bam constructs were ex-
pressed as fusions with an N-terminal, TEV-cleavable MBP tag.
The cells were lysed in a buffer containing 50 mM HEPES (pH
7.5), 300 mM NaCl and 2 mM DTT. The proteins were purified
from cleared cell lysates by using amylose resin (New England
Biolabs), and this was followed by anion chromatography using a
HiTrapQ column (GE Healthcare). The Bam constructs were fur-
ther purified on a Superdex 200 26/600 column (GE Healthcare)
in a buffer containing 10 mM HEPES (pH 7.5), 200 mM NaCl
and 2 mM DTT.
The purification of Hs CAF40 (ARM domain, residues R19–
E285) was as previously described (Sgromo et al. 2017). Briefly,
the protein was expressed with an N-terminal His6 tag cleavable
by the HRV3C protease. Cells were lysed in a buffer containing 50
mM potassium phosphate (pH 7.5), 500 mMNaCl, 10% (v/v) glyc-
erol, 20 mM imidazole and 2 mM β-mercaptoethanol. The protein
was purified from cleared cell lysates with a HiTrap IMAC column
(GE Healthcare). The His6 tag was removed by overnight cleavage
using HRV3C protease during dialysis in a buffer containing 50
mM Tris–HCl (pH 7.5), 150 mM NaCl and 1 mM DTT. After
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cleavage of the tag, CAF40 was further purified using a HiTrap
Heparin column (GE Healthcare) followed by gel filtration on a
Superdex 200 26/600 column (GE Healthcare) in a buffer contain-
ing 20 mM Tris–HCl (pH 7.5), 150 mM NaCl and 1 mM DTT.
The purification of the Hs NOT1 CN9BD–CAF40 complex has
been previously described (Chen et al. 2014a). The complex was ob-
tained by co-expression of MBP-tagged NOT1-CN9BD (residues
V1351–L1588) with His6-tagged CAF40 (R19–E285). The cells
were lysed in a buffer containing 50 mM potassium phosphate
(pH 7.5), 300 mM NaCl and 2 mM β-mercaptoethanol. The com-
plex was purified from the cleared lysate by using amylose resin, and
this was followed by removal of the His6 and MBP tags by cleavage
with HRV3C protease overnight at 4°C during dialysis in a buffer
containing 50 mMHEPES (pH 7.5), 150 mMNaCl, 10% (v/v) glyc-
erol and 2 mM DTT. The complex was separated from the tags by
binding to a HiTrap Heparin column (GE Healthcare), and this
was followed by elution with a linear gradient to 1 M NaCl.
Finally, size exclusion chromatography was performed using a
Superdex 200 26/600 column in a buffer containing 10 mM
HEPES (pH 7.5), 150mMNaCl, 10% (v/v) glycerol and 2mMDTT.
A detailed description of the purification of the additional mod-
ules of the human and Drosophila CCR4–NOT complex can be
found in the Supplemental Material.
Crystallization, data collection, and structure
determination
A detailed description of the crystallization conditions and the struc-
ture determination process are included in the Supplemental
Material. Diffraction data sets of the CN9BD–CAF40–Bam CBM
complex were recorded on a PILATUS 6M detector at the PXII
beamline of the Swiss Light Source at a temperature of 100 K. The
best data set of the CAF40–Bam CBM complex was recorded on a
PILATUS 6M fast detector (DECTRIS) at the DESY beamline P11.
The diffraction data and refinement statistics are summarized in
Table 1.
In vitro MBP pull-down assays
Purified MBP (20 µg) or MBP-tagged full-length Bam or fragments
(40 µg) were incubated with equimolar amounts of purified CCR4–
NOT complex modules or subunits and amylose resin (New
England Biolabs) in pull-down buffer containing 50 mM HEPES
(pH 7.5), 200 mM NaCl and 2 mM DTT. After 1 h incubation,
the beads were washed five times with pull-down buffer and the pro-
teins were eluted with pull-down buffer supplemented with 25 mM
D-(+)-Maltose. The eluted proteins were precipitated with trichlo-
roacetic acid and analyzed by SDS-PAGE and subsequent
Coomassie staining.
In vitro competition assays
Purified GST-tagged CAF40 (ARM domain, 50 µg) was incubated
with equimolar amounts of either MBP-tagged Bam CBM or
MBP-Roquin CBM, increasing amounts of His6-NusA-tagged
Bam CBM as a competitor, and 50 µL 50% slurry of Protino gluta-
thione agarose 4B (Macherey-Nagel). Purified His6-NusA served as
a negative control. The experiment was performed in pull-down
buffer. After 1 h of incubation, the beads were pelleted and washed
three times with pull-down buffer. The proteins bound to the beads
were eluted by boiling the beads in 2× protein sample buffer. The
eluted proteins were analyzed by SDS-PAGE and subsequent
Coomassie staining.
Isothermal titration calorimetry (ITC)
and bioinformatics analysis
The ITC measurements were performed as previously described
(Igreja et al. 2014). A detailed description of the ITC conditions
and the bioinformatic analysis can be found in the Supplemental
Material.
DATA DEPOSITION
The coordinates for the structure of the Bam CBM peptide bound to
CAF40 and to the CAF40module were deposited in the Protein Data
Bank (PDB) under ID code 5ONB and 5ONA, respectively.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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Supplemental Table S1. Constructs and mutants used in this study. 
 
Name Bag of marbles (Uniprot P22745) 
Comment 
Bam λN-HA-Bam 1–442  
 SBP-Bam 1–442  
 MS2-HA-Bam 1–442  
 MBP-Bam 1–442  
Bam-N λN-HA-Bam 1–140  
 GFP-Bam 1–140  
 MS2-HA-Bam 1–140  
 MBP-Bam 1–140  
Bam-C λN-HA-Bam 141–442  
 GFP-Bam 141–442  
 MBP-Bam 141–442  
CBM λN-HA-GST-Bam 13–36  
 SBP-MBP-Bam 13–36  
 MS2-HA-MBP-Bam 13–36  
 MBP-Bam 13–36  
 His6-NusA-Bam 13–36  
ΔCBM λN-HA-Bam Δ13–36 Disrupts CAF40 binding 
 MBP-Bam Δ13–36 Disrupts CAF40 binding 
L17E λN-HA-Bam L17E Disrupts CAF40 binding 
 MBP-Bam 1–442 L17E Disrupts CAF40 binding 
M24E λN-HA-Bam M24E Disrupts CAF40 binding 
 MBP-Bam 1–442 M24E Disrupts CAF40 binding 
L28E λN-HA-Bam L28E Disrupts CAF40 binding 
V32E λN-HA-Bam V32E Disrupts CAF40 binding 
4xMut λN-HA-Bam L17E, M24E, L28E, V32E 
Disrupts CAF40 binding 
 SBP-Bam L17E, M24E, L28E, V32E 
Disrupts CAF40 binding 
 MS2-HA-Bam L17E, M24E, L28E, V32E 
Disrupts CAF40 binding 
 
Name Hs NOT1 (Uniprot A5YKK6) 
Comment 
NOT1 N Hs NOT1 1–1000  
NOT1 MIF4G His6-Hs NOT1 1093–1317 MIF4G-like domain 
NOT1 CN9BD MBP-Hs NOT1 1351–1588 CNOT9-binding domain 
NOT1 MIF4G-C MBP-Hs NOT1 1607–1815 Predicted MIF4G-like domain 
NOT1 SHD MBP-Hs NOT1 1833–2361 Superfamily homology domain 
 
Name Hs NOT2 (Uniprot Q9NZN8) 
Comment 
NOT2-C MBP-Hs NOT2 350–540  
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Name Hs NOT3 (Uniprot O75175) 
Comment 
NOT3-N MBP-Hs NOT3 2–212  
NOT3-C His6-Hs NOT3 607–748  
 
Name Hs CCR4a (Uniprot Q9ULM6) 
Comment 
CCR4a full-length MBP-Hs CCR4a  
 
Name Hs CAF1 (Uniprot Q9UIV1) 
Comment 
CAF1 full-length MBP-Hs CAF1  
 
Name Hs CAF40 (Uniprot Q92600) 
Comment 
CAF40-ARM wt His6-Hs CAF40 19–285  
 GST-Hs CAF40 19–285  
CAF40 wt SBP-MBP-CAF40 1–299  
V181E SBP-MBP-CAF40 1–299 V181E  
 
Name Hs NOT10 (Uniprot Q9H9A5) 
Comment 
NOT10 TPR Hs NOT10 25–707  
 
Name Hs NOT11 (Uniprot Q9UKZ1) 
Comment 
NOT11-C Hs NOT11 257–498-His6  
 
Name Dm CAF40 (1–304) (Uniprot Q7JVP2) 
Comment 
CAF40 wt λN-HA-CAF40 1–304  
 GFP-CAF40 1–304 dsRNA resistant 
CAF40-ARM wt His6-CAF40 25–291   
V186E GFP-CAF40 V186E Disrupts CBM binding; dsRNA resistant  
 His6-CAF40 25–291 V186E Disrupts CBM binding 
2xMut His6-CAF40 25–291 Y139E, G146E 
Disrupts CBM binding 
 
Name Dm NOT1  (Uniprot  A8DY81) 
Comment 
NOT1 λN-HA-NOT1  
NOT1-CN9BD λN-HA-NOT1 1467–1719 CAF40-binding domain 
 MBP-NOT1 1468–1719 CAF40-binding domain 
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Supplemental Table S2. Antibodies used in this study. 
 
Antibody Source Catalog 
Number 
Dilution Monoclonal/ 
Polyclonal 
Anti-HA-HRP Roche 12 013 819 001 1:5,000 Monoclonal 
Anti-GFP (for western 
blotting) 
Roche 11 814 460 001 1:2,000 Mouse 
Monoclonal 
Anti-GFP (for 
immunoprecipitation) 
In house   Rabbit 
Polyclonal 
Anti-Dm NOT1 Kind gift from 
E. Wahle 
T6199 1:1,000 Rabbit 
Polyclonal 
Anti-Dm CAF40 In house  1:1,000 Rabbit 
Polyclonal 
Anti-Hs NOT1 In house  1:2,000 Rabbit 
Polyclonal 
Anti-Hs NOT2 Bethyl A302-562A 1:2,000 Rabbit 
Polyclonal 
Anti-Hs NOT3 Abcam Ab55681 1:2,000 Monoclonal 
Anti-Hs CAF40 
(RQCD1) 
Proteintech 22503-1-AP 1:1,000 Rabbit 
Polyclonal 
Anti-tubulin Sigma-Aldrich T6199 1:10,000 Monoclonal 
Anti-Dm PABP In house  1:10,000 Rabbit 
Polyclonal 
Anti-V5 AbD Serotec MCA1360GA 1:5,000 Monoclonal 
Anti-mouse-HRP GE Healthcare NA931V 1:10,000 Monoclonal 
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SUPPLEMENTAL FIGURES 
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Supplemental Figure S1. Sequence alignment of Drosophila Bam. The secondary structure 
elements, as predicted by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/), are indicated in black. 
Residues conserved in all aligned sequences are shown with a dark red background, and residues 
with >70% similarity are highlighted in light red; conservation scores were calculated using the 
SCORECONS webserver (Valdar 2002). The CAF40-binding motif (CBM) is indicated. Black 
dots indicate residues in the CBM that directly contact CAF40. Green asterisks indicate residues 
mutated in this study.  
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Supplemental Figure S2. Bam promotes mRNA degradation. (A) Representative northern blot 
showing the decay of the F-Luc-5BoxB mRNA in S2 cells expressing λN-HA or λN-HA-tagged 
Bam or the Bam-N fragment after inhibition of transcription by actinomycin D. (B) F-Luc 
mRNA levels were normalized to those of the rp49 mRNA and plotted against time. (C,D) 
Tethering assay using the F-Luc reporter lacking BoxB sites and λN-HA-tagged Bam (full-length 
or the indicated fragments) in S2 cells. The samples were analyzed as described in Figure 1B–D. 
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The corresponding experiment with the F-Luc-5BoxB reporter is shown in Figure 1B. (E) 
Normalized F-Luc activity values corresponding to the experiment described in Figure 2A and B. 
The F-Luc-5BoxB activity was normalized to that of the R-Luc transfection control and set to 
100% in cells expressing the λN-HA peptide. The grey and green bars represent the normalized 
F-Luc-5BoxB activity in control cells expressing GFP-V5 and in DCP2-depleted cells expressing 
GFP-DCP2*-V5, respectively. (F) Normalized F-Luc-5BoxB activity values corresponding to 
the experiment described in Figure 2D and E. (G) Normalized F-Luc-5BoxB-A95-C7-HhR 
reporter mRNA levels corresponding to the experiment described in Figure 2F and G. 
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Supplemental Figure S3. Bam interacts with the CCR4-NOT complex. (A-E) 
Coimmunoprecipitation assays showing the interaction of HA-tagged Bam with the indicated 
GFP-tagged CCR4-NOT subunits in S2 cell lysates treated with RNase A. In all panels, GFP-F-
Luc served as a negative control. Inputs (1% for the HA-tagged proteins and 3% for the GFP-
tagged proteins) and immunoprecipitates (30% for the HA-tagged proteins and 10% for the GFP-
tagged proteins) were analyzed by western blotting. Protein size markers are shown on the right 
in each panel. (F) Schematic representation of the Hs CCR4-NOT complex. NOT1 contains two 
HEAT repeat domains (shown in blue and petrol), a MIF4G domain composed of HEAT repeats 
(green), a three-helix bundle domain (CN9BD, yellow), a connector domain (CD, light blue) and 
a NOT1 superfamily homology domain (SHD, gray), which also consists of HEAT repeats. The 
additional subunits of the complex are shown at their binding positions on NOT1. (G)  In vitro 
MBP pull-down assay testing the interaction of MBP-tagged full-length Bam with the indicated 
Hs CCR4-NOT subcomplexes. MBP served as a negative control.  
  
 	  
11	  
 
 
Supplemental Figure S4. Bam requires binding to the mRNA target to induce degradation. 
(A,B) Tethering assay using the F-Luc reporter lacking BoxB sites and λN-HA-tagged Bam (full-
length or the indicated fragments) in S2 cells. The samples were analyzed as described in Figure 
1B–D. The corresponding experiment with the F-Luc-5BoxB reporter is shown in Figure 3E and 
F. 
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Supplemental Figure S5. Crystal structure of the Bam CBM bound to CAF40 and the CN9BD–
CAF40 module. (A) Crystal packing of the CAF40–Bam CBM complex. The four copies of 
CAF40 (chains A, C, E and G) are shown in different shades of gray, the four Bam CBM 
peptides (chains B, D, F and H) in different colors. (B) Superposition of the four CAF40-Bam 
CBM complexes in the asymmetric unit in ribbon representation. Colors are as in (A). (C) 
Superposition of a CAF40 homodimer (orange and yellow, PDB 2FV2; Garces et al. 2007), with 
a CAF40 homodimer bound to the Bam CBM (chains A–D, colors are as in (A)). (D) Crystal 
packing of the NOT1 CN9BD-CAF40-Bam CBM complex in cartoon representation. The NOT1 
CN9BD is shown in cyan and blue (chains A and D, respectively), CAF40 in gray and black 
(chains B and E), and Bam in red and pink (chains C and F). (E) Superposition of the two NOT1 
CN9BD-CAF40-Bam complexes in the asymmetric unit. Colors are as in (D). (F) Superposition 
of the CAF40-Bam complex and NOT1 CN9BD-CAF40-Bam complex structures. (G) 
Superposition of the NOT1 CN9BD-CAF40-Bam CBM complex with the NOT1 CN9BD-
CAF40 complex with bound tryptophan (PDB 4CRV) (Chen et al. 2014). 
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Supplemental Figure S6. Simulated annealing electron density of the Bam CBM peptide. (A) 
Stereo view showing the 2FO-FC simulated annealing composite omit map surrounding the 
CN9BD-CAF40-bound CBM peptide contoured at 1.0 σ. This map was generated with 
Phenix.Composite_omit_map (Afonine et al. 2012) using the final refined CN9BD-CAF40-Bam 
model. (B) Stereo view showing the 2FO-FC simulated annealing composite omit map 
surrounding the CAF40-bound CBM peptide contoured at 1.0 σ. This map was generated with 
Phenix.Composite_omit_map (Afonine et al. 2012) using the final refined CAF40-Bam model. 
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Supplemental Figure S7. The CBM is required for Bam activity. (A) Representative isothermal 
titration calorimetry thermogram showing the interaction of the MBP-tagged Bam CBM with the 
NOT1 CN9BD-CAF40 complex. The upper panel shows raw data, and the lower panel shows 
the integration of heat changes associated with each injection. Data were fitted using a one-site 
binding model. (B) Coimmunoprecipitation assay showing the interaction of HA-tagged Bam 
with GFP-tagged CAF40 in S2 cell lysates treated with RNase A. GFP-F-Luc served as a 
negative control. Inputs (1% for the HA-tagged proteins and 3% for the GFP-tagged proteins) 
and immunoprecipitates (30% for the HA-tagged proteins and 10% for the GFP-tagged proteins) 
were analyzed by western blotting. (C,D) Tethering assay using the F-Luc reporter lacking BoxB 
sites and λN-HA-tagged Bam (wild-type or the indicated mutants) in S2 cells. The samples were 
analyzed as described in Figure 1B–D. The corresponding experiment with the F-Luc-5BoxB 
reporter is shown in Figure 6A and B. (E) Tethering assays using the β-globin-6xMS2bs reporter 
and MS2-HA-tagged Bam (full-length, MBP-Bam CBM or the 4xMut) in human HEK293T 
cells. A plasmid expressing a β-globin mRNA reporter lacking MS2-binding sites (Control) 
served as a transfection control. The β-globin-6xMS2bs mRNA level was normalized to that of 
the control mRNA and set to 100% in cells expressing MS2-HA. The mean values ± s.d. from 
three independent experiments are shown in (E). (F) Representative northern blot of samples 
shown in (E). (G) Western blot showing the equivalent expression of the MS2-HA-tagged Bam 
constructs used in (E) and (F). (H) Western blot showing the efficiency of the CAF40 depletion 
in HEK293T cells corresponding to the experiment shown in Figure 6D and E. Dilutions of 
control cell lysates were loaded in lanes (1–4) to estimate the efficacy of the depletion. Tubulin 
served as a loading control. KO: knockout. Protein size markers are shown on the right in each 
panel. (I,J) Coimmunoprecipitation assays showing the interaction of HA-tagged Bam with GFP-
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tagged CCR4 (I) and NOT2 (J) in S2 cell lysates treated with RNaseA. GFP-F-Luc served as a 
negative control. Inputs (1% for the HA-tagged proteins and 3% for the GFP-tagged proteins) 
and immunoprecipitates (30% for the HA-tagged proteins and 10% for the GFP-tagged proteins) 
were analyzed by western blotting. Protein size markers (kDa) are shown on the right in each 
panel. 
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Supplemental Figure S8. Profile-based sequence alignment. Profile-based sequence alignment 
of CBMs from Roquin and Bam of the indicated Drosophila species, as well as putative CBMs 
of proteins from Hs and Dm shown in red. Residues known or expected to interact with CAF40 
are highlighted by a light green background. Gray letters indicate residues that were not included 
in the crystallization setup. Numbers on both sides of the alignment indicate the residue numbers 
of the respective fragment boundaries.  
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SUPPLEMENTAL MATERIAL AND METHODS 
DNA constructs  
The plasmids used for the expression of subunits of the human and Dm CCR4-NOT complex and 
Dm Roq in cells have been previously described (Brau et al. 2011; Bawankar et al. 2013; Sgromo 
et al. 2017). The plasmids for the expression of Hs NOT2-C, NOT3-C, CAF40 ARM domain 
and the NOT1 MIF4G, CN9BD, CD and SHD domains in Escherichia coli have been previously 
described (Petit et al. 2012; Boland et al. 2013; Chen et al. 2014a; Sgromo et al. 2017). The 
plasmids for expression of the β-globin-6xMS2bs and the control β-globin-GAP mRNA in 
human cells were kindly provided by Dr. Lykke-Andersen and have been previously described 
(Lykke-Andersen et al. 2000). The plasmids for tethering assays in S2 cells (F-Luc-5BoxB, F-
Luc-V5, F-Luc-5BoxB-A95C7-HhR, and R-Luc) have been previously described (Behm-Ansmant 
et al. 2006; Zekri et al. 2013). 
For expression of Bam (full-length and fragments) in Dm S2 cells, the corresponding cDNA was 
amplified from total Dm oocyte cDNA and cloned between the XhoI and ApaI restriction sites of 
the pAc5.1-λN-HA and pAc5.1-GFP vectors (Rehwinkel et al. 2005; Tritschler et al. 2007). For 
expression in HEK293T cells, the cDNA encoding Bam was inserted between the BglII and 
BamHI restriction sites of the pT7-V5-SBP-C1 and pT7-MS2-HA vectors (Jonas et al. 2013). 
The plasmids for expression of Bam (full-length, Bam CBM and Bam fragments) in Escherichia 
coli were obtained by inserting the corresponding Bam cDNA fragments between the XhoI and 
AvrII restriction of the pnYC-vM plasmid (Diebold et al. 2011), thus yielding fusion proteins 
carrying N-terminal MBP tags cleavable by the TEV protease. For expression of the Hs NOT1-
10-11 complex, two plasmids were generated. A cDNA fragment encoding the Hs NOT1 N-
terminus (residues M1–D1000) was inserted into the AvrII restriction site of the pnYC vector, 
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which does not encode a solubility tag. cDNA fragments encoding Hs NOT10 (residues D25–
Q707) and Hs NOT11 (residues D257–D498) were cloned in a bicistronic plasmid based on the 
pnEA backbone, thus resulting in the expression of untagged NOT10 and NOT11 with a C-
terminal, TEV-cleavable His6 tag. For expression of the human catalytic module, the His6-tagged 
human NOT1 MIF4G domain (residues E1093-S1317) was coexpressed with a bicistronic 
plasmid expressing untagged CAF1 and CCR4a with an N-terminal MBP-tag cleavable by the 
HRV3C protease. Hs NOT1-CD cDNA was cloned in the pnYC-pM plasmid (Diebold et al. 
2011), thereby generating a fusion protein containing an N-terminal MBP tag that is cleavable by 
the HRV3C protease. The cDNA encoding the NOT3-N fragment (residues A2–D212) was 
inserted between the XhoI and BamH1 restriction sites of the pnEA-pM vector, thus resulting in 
an N-terminally MBP-tagged protein.  
 
Coimmunoprecipitation and SBP-pull-down assays  
For coimmunoprecipitation assays in S2 cells, 2.5×106 cells were seeded per well in 6-well plates 
and transfected using Effectene transfection reagent (Qiagen). The transfection mixtures 
contained plasmids expressing GFP-tagged CCR4-NOT of subunits (2 µg) or HA-tagged Bam (1 
µg). Cells were harvested 3 days after transfection, and coimmunoprecipitation assays were 
performed using RIPA buffer [20 mM HEPES (pH 7.6), 150 mM NaCl, 2.5 mM MgCl2, 1% NP-
40, 1% sodium deoxycholate supplemented with protease inhibitors (Complete protease inhibitor 
mix, Roche)] as previously described (Tritschler et al. 2008). For SBP pull-down assays in 
human cells, HEK293T cells (ATCC, wild-type or CAF40-null cells) were grown in 10-cm 
dishes (4×106 / 10-cm dish) and transfected using TurboFect transfection reagent (Thermo Fisher 
Scientific). The transfection mixtures contained 20 µg, 5 µg and 25 µg of plasmids expressing 
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Bam, MBP-CBM and Bam 4xMut, respectively. For the pull-down assays in Figure 6E and G, 
cells were also co-transfected with 8 µg of a plasmid expressing HA-tagged CCR4. The cells 
were harvested 2 days after transfection, and pull-down assays were performed as previously 
described (Bhandari et al. 2014).  
 
Generation of the CAF40-null cell line 
An sgRNA (sequence: 5’ CCCATGCTGTGGCATTCATT 3’) targeting the second exon of the 
Hs CAF40 gene was designed using CHOPCHOP (http://chopchop.cbu.uib.no) and inserted into 
the pSpCas9(BB)-2A-Puro (PX459) vector (a gift from F. Zhang, Addgene plasmid 48139) (Ran 
et al. 2013). HEK293T cells were transfected with the pSp-CAF40-sgRNA-Cas9(BB)-2A-Puro 
plasmid and selected with puromycin (3 µg/ml) to obtain stable CAF40 knockout cells. To obtain 
clonal cell lines, single cells were distributed in 96-well plates using serial dilutions. Expansion 
of single-cell clones was performed under non-selective conditions. CAF40-null clones were 
identified by western blotting using anti-CAF40 antibodies (Supplemental Table S2). Genomic 
DNA from single clones was isolated using a Wizard SV Genomic DNA Purification System 
(Promega) and the targeted CAF40 locus was amplified by PCR and sequenced to confirm gene 
editing. We observed a deletion of 22nt in one allele and an insertion of one nucleotide in the 
second exon of CAF40 in the other allele, both of which cause a frameshift.  
 
Protein expression, purification and competition assays 
To purify the Dm NOT1 CN9BD-CAF40 complex, MBP-tagged NOT1-CN9BD (residues 
Y1468-T1719) was co-expressed with His6-tagged CAF40 (ARM domain, residues E25–G291). 
The cells were lysed in a buffer containing 50 mM HEPES (pH 7.5), 300 mM NaCl, 20 mM 
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imidazole and 2 mM β-mercaptoethanol. The complex was purified from cleared cell lysates by 
Nickel affinity chromatography using a HiTrap IMAC column and eluted by a linear gradient to 
500 mM imidazole. The complex was further purified on a HiTrapQ column (GE Healthcare), 
and this was followed by removal of the His6 and MBP tags by cleavage with HRV3C protease 
overnight at 4°C. The complex was separated from the tags by size exclusion chromatography 
using a Superdex 200 26/600 column in a buffer containing 10 mM HEPES (pH 7.5), 200 mM 
NaCl and 2 mM DTT. 
For competition assays, the CAF40 ARM domain was expressed with an N-terminal GST tag. 
The cells were lysed in a buffer containing 50 mM HEPES (pH 7.5), 300 mM NaCl and 2 mM 
DTT. The protein was purified from cleared cell lysates by using Protino glutathione agarose 4B 
(Macherey-Nagel) followed by a HiTrapQ column and further purified by size exclusion 
chromatography on a Superdex 200 26/600 column in a buffer containing 10 mM HEPES (pH 
7.5), 200 mM NaCl and 2 mM DTT. The Roquin CBM fused to MBP was purified as previously 
described (Sgromo et al. 2017). Cells expressing either His6-NusA-tagged Bam CBM or His6-
NusA were lysed in a buffer containing 50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 20 
mM imidazole and 2 mM β-mercaptoethanol. The proteins were isolated from the crude cell 
lysate by Nickel affinity chromatography using a HiTrap IMAC column and eluted by a linear 
gradient to 500 mM imidazole. The eluted proteins were directly applied to size exclusion 
chromatography on a Superdex 200 16/600 column in a buffer containing 10 mM HEPES (pH 
7.5), 200 mM NaCl and 2 mM DTT. 
The assembled Hs NOT1-10-11 trimer was obtained by co-expression of C-terminally His6-
tagged NOT11 (residues D257–D498) and untagged NOT1 (residues M1–D1000) and NOT10 
(residues D25–Q707). The cells were lysed in 50 mM potassium phosphate (pH 7.6), 300 mM 
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NaCl, 20 mM imidazole and 2 mM β-mercaptoethanol. The complex was purified from cleared 
cell lysates by using a HiTrap IMAC column and eluted by a linear gradient to 500 mM 
imidazole. The complex was dialyzed in a buffer containing 50 mM HEPES (pH 7.5), 200 mM 
NaCl and 2 mM DTT, and was further purified over a HiTrap Heparin column (GE Healthcare), 
then subjected to size exclusion chromatography over a Superdex 200 26/600 column in a buffer 
containing 10 mM HEPES (pH 7.5), 200 mM NaCl and 2 mM DTT. 
To purify the assembled catalytic module, His6-tagged NOT1 MIF4G domain (residues E1093–
S1317), untagged CAF1 and MBP-tagged CCR4a were co-expressed. Cells were lysed in a 
buffer containing 50 mM potassium phosphate (pH 7.5), 300 mM NaCl and 2 mM β-
mercaptoethanol. The complex was purified from cleared cell lysates using amylose resin and 
eluted with in a buffer containing 50 mM potassium phosphate (pH 7.5), 300 mM NaCl, 20 mM 
imidazole, 25 mM D(+)-maltose and 2 mM β-mercaptoethanol. The complex was further 
purified using a HiTrap IMAC column (GE Healthcare) and eluted by a linear gradient to 500 
mM imidazole. The His6 and MBP tags were removed by cleavage with the HRV3C protease 
overnight at 4°C. The catalytic module was further purified over a Superdex200 (26/600 column; 
GE Healthcare) in a buffer containing 10 mM HEPES (pH 7.5), 200 mM NaCl and 2 mM DTT. 
The Hs NOT3 N-terminus (residues A2–D212) was expressed with an N-terminal MBP tag. 
Cells were lysed in a buffer containing 50 mM HEPES (pH 7.5), 300 mM NaCl and 2 mM DTT. 
The protein was purified from cleared cell lysates with amylose resin, then with a HiTrapQ 
column. The MBP tag was removed by cleavage using the HRV3C protease. After cleavage of 
the tag, the protein was further purified on a Superdex 75 26/600 column (GE Healthcare) using 
a buffer containing 10 mM HEPES (pH 7.5), 200 mM NaCl and 2 mM DTT. 
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The purification procedures for the human NOT1-CD (residues D1607–S1815) and of the NOT 
and CAF40 modules have been previously described (Chen et al. 2014; Raisch et al. 2016; 
Sgromo et al. 2017). The NOT module comprises the NOT1-SHD (residues H1833–M2361), 
NOT2-C (residues M350–F540) and NOT3-C (residues L607–E748). The Hs CAF40 module 
comprises NOT1-CN9BD (residues V1351–L1588) and the CAF40 ARM domain (residues R19-
E285). The Dm Bam CBM peptide (residues D13–E36) used for crystallization was obtained 
from EMC microcollections and solubilized in a buffer containing 10 mM HEPES (pH 7.5), 200 
mM NaCl and 2 mM DTT. 
 
Crystallization  
Crystals of Hs CAF40 (ARM domain) bound to Bam CBM peptide (residues D13–E36) were 
obtained at 22°C using the hanging-drop vapor diffusion method after the protein solution (6 
mg/ml CAF40 and 1.1 mg/ml Bam CBM peptide; 200 nl) was mixed with the crystallization 
reservoir solution (200 nl). Crystals appeared within one day in many conditions. Optimized 
crystals grew at 18°C in hanging drops consisting of 1 µl protein solution (6 mg/ml CAF40 and 
1.1 mg/ml Bam CBM peptide) and 1 µl crystallization reservoir solution containing 100 mM 
HEPES (pH 7.0), 200 mM CaCl2 and 15% PEG 6,000. Crystals were soaked in reservoir solution 
supplemented with 15% ethylene glycol for cryoprotection before being flash-frozen in liquid 
nitrogen. 
Crystals of the Hs NOT1 CN9BD–CAF40 complex bound to the Bam CBM peptide were 
obtained at 22°C by using the hanging-drop vapor diffusion method after mixing the protein 
solution (7.5 mg/ml NOT1 CN9BD–CAF40 and 0.8 mg/ml CBM peptide; 200 nl) with the 
crystallization reservoir solution (200 nl). Crystals appeared within one day in several conditions. 
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Optimized crystals grew in drops of 200 nl protein solution (5 mg/ml NOT1 CN9BD–CAF40 
complex and 0.5 mg/ml CBM peptide) mixed with 200 nl crystallization reservoir solution 
comprising 1.5 M ammonium sulfate, 20 mM MES (pH 6.0) and 80 mM MES (pH 6.5). Crystals 
were soaked in reservoir solution supplemented with 25% glycerol for cryoprotection before 
flash-freezing in liquid nitrogen.  
 
Data collection and structure determination 
X-ray diffraction data for the Hs NOT1 CN9BD–CAF40 bound to the Bam CBM were collected 
at a wavelength of 1.0000 Å on a PILATUS 6M detector (Dectris) at the PXII beamline of the 
Swiss Light Source (SLS) and processed in space group P3221 by using XDS and XSCALE 
(Kabsch 2010) to a resolution of 2.7 Å, aiming at a CC(1/2) value (Karplus and Diederichs 2012) 
of ~70 % as a high resolution cutoff. Initial phases were determined by molecular replacement, 
with two copies of the NOT1 CN9BD–CAF40 complex (PDB 4CRU) used as a search model in 
PHASER (McCoy et al. 2007) from the CCP4 package (Winn et al. 2011). The initial model was 
improved and completed by iterative cycles of building in COOT (Emsley et al. 2010) and 
refinement in PHENIX (Afonine et al. 2012), also optimizing TLS parameters (one TLS group 
per macromolecular chain). Finally, two copies of the Bam CBM peptide were manually built 
into the density (Supplemental Fig. S6A) and improved by further refinement cycles.  
The best crystal of the CAF40 (ARM domain) bound to the Bam CBM peptide was recorded at a 
wavelength of 1.0396 Å on a PILATUS 6M fast detector (DECTRIS) at the DESY beamline 
P11. The dataset was processed in XDS and XSCALE in space group P21212 to a resolution of 
3.0 Å, aiming at a CC(1/2) value (Karplus and Diederichs 2012) of ~70 % as a high resolution 
cutoff. Four copies of the CAF40 ARM domain (PDB 2FV2, chain A) were found in the 
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asymmetric unit by molecular replacement using PHASER from the CCP4 package. This initial 
model was improved and completed by iterative cycles of building in COOT (Emsley et al. 
2010) and refinement using PHENIX (Afonine et al. 2012) and BUSTER (Bricogne et al. 2011) 
using NCS restraints and TLS parameters (one TLS group per macromolecular chain). Finally, 
four copies of the Bam CBM peptide were manually built into the density (Supplemental Fig. 
S6B) and improved through further refinement cycles.  
The stereochemical properties for all of the structures were verified with MOLPROBITY (Chen 
et al. 2010), and illustrations were prepared using PyMOL (http://www.pymol.org). The 
diffraction data and refinement statistics are summarized in Table 1. 
 
Isothermal titration calorimetry (ITC) 
The ITC experiments were performed on a VP-ITC microcalorimeter (Microcal) at 20°C. A 
solution containing the Dm NOT1 CN9BD bound to CAF40 (ARM domain) (6.0 µM in the 
experiments with the Bam CBM and up to 10 µM in the experiments with the Roq CBM) in a 
calorimetric cell was titrated with a solution of MBP-tagged Bam CBM (60 µM) or MBP-tagged 
Roquin CBM (up to 100 µM). All proteins were dissolved in a buffer containing 10 mM HEPES 
(pH 7.5), 200 mM NaCl and 0.5 mM TCEP. The titration experiments consisted of an initial 
injection of 2 µl followed by 28 injections of 10 µl at 240 s intervals. The binding experiment 
was repeated three times. The thermodynamic parameters were calculated using a one-site 
binding model (ORIGIN version 7.0; Microcal). Correction for dilution heating and mixing was 
achieved by subtracting the final baseline, which consisted of small peaks of similar size. The 
first injection was removed from the analysis (Mizoue and Tellinghuisen 2004).  
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Bioinformatic analysis 
To identify proteins featuring potential CBMs in Dm and Hs, we followed a two-step approach. 
In the first step, we searched for homologs of Dm Bam and Roquin in the nonredundant (nr) 
protein sequence database using PSI-BLAST (Boratyn et al. 2013), as implemented in the MPI 
Bioinformatics toolkit (Alva et al. 2016), and extracted the CBMs from the obtained homologs 
originating from different Drosophila species. These motifs were then aligned, and a consensus 
pattern was derived by manual inspection (x-x-x-[LI]-[DENQ]-x(2,3)-[FLM]-x-x-[ILM]-x-x-x-
[IL]-x-x-[ILM]-[LIV]-x-x-x-x). In the second step, the aforementioned consensus pattern was 
submitted to the PatternSearch tool of the MPI Bioinformatics Toolkit to identify proteins in Dm 
and Hs with potential CBMs. This search yielded a total of 1,200 candidate proteins. We next 
analyzed this set further to discard all proteins in which the detected motifs showed no helical 
propensity or were embedded within a domain (as opposed to being embedded in an intrinsically 
disordered region). We also excluded all proteins with obvious functional irrelevance (e.g. 
membrane proteins) from further consideration. Finally, we chose the Hs and Dm homologs of 
four protein families, on the basis of the presence of known or predicted RNA-binding domains 
in the proteins and on the percentage similarity of the putative CBMs to the CBMs of Bam and 
Roquin. These candidate CBMs were then expressed as MBP fusions and tested for CAF40 
binding in in vitro MBP pull-down assays. 
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